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ABSTRACT 
Adverse blood pressure (BP) is a major risk factor for cardiovascular disease.  The World Health 
Organisation Global Burden of Disease Comparative Risk Analysis study (2000) reported that 
regular consumption of alcohol elevated BP and attributed 16% of all hypertensive disease 
worldwide to alcohol.  Epidemiological studies have demonstrated a positive relationship between 
heavy alcohol use and high BP, but few studies have directly addressed the role of drinking 
patterns, type of alcoholic beverages, nutrient intakes, foods and urinary metabolites.  The 
International Collaborative Study of Macro-/Micro-nutrients and Blood Pressure (INTERMAP) is a 
cross-sectional epidemiological study designed to investigate the role of macro and micronutrients 
in the aetiology of adverse BP patterns in populations.  This report investigates the relationship of 
alcohol consumption and BP in 4,680 men and women aged 40 to 59 years from 17 population 
samples in Japan, People‟s Republic of China, United Kingdom and the United States, using data 
including macro-/micro-nutrients from four 24-hour dietary recalls, two 7-day alcohol records, 
urinary electrolytes and urinary metabolites from two timed 24-hour urine collections, together with 
socioeconomic data.  Specific aims include investigation of the relationship between BP and 
alcohol drinking patterns and type of alcoholic beverage; the relationship between alcohol intake 
and other nutrients, the role of nutrient pattern and foods of non-drinker (teetotallers and ex-
drinkers) and drinkers (moderate and heavy drinkers) and their BP; the difference in urinary amino 
acid excretion among non-drinkers and current drinkers; identify urinary metabolites detected by 
nuclear magnetic resonance in relation to different alcohol intake levels and alcohol drinking 
pattern; use of INTERMAP data to explore country/population differences in alcohol metabolism. 
Findings from the INTERMAP Study show that the harmful effect of alcohol intake on blood 
pressure is related particularly to the quantity of alcohol consumed (average intake per day), not 
drinking pattern or type of beverage. 
Word count for abstract: 300 
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OR Odd ratio 
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1  AIMS 
The main objective of this research is to investigate the relationship between multiple aspects of 
alcohol intake and blood pressure (BP) with consideration of the possible confounding effects of 
nutrients/metabolites/social factors in the International Collaborative Study of Macronutrients, 
Micronutrients and Blood Pressure (INTERMAP) study.  It is based on high quality data assembled 
on macro/micro nutrient intake from four 24-hour dietary recalls, urinary electrolytes (sodium [Na], 
potassium [K], calcium [Ca] and magnesium [Mg]), creatinine, urea, urinary amino acids and 
urinary metabolites from two timed 24-hr urine collections, together with socioeconomic indicators, 
from each of the 4,680 men and women included in the study.  Specific aims of this research 
include: (1) to quantify the relationship between BP and alcohol drinking patterns (e.g. daily 
drinking, „binge‟ drinking) from two 7-day alcohol records and investigate relationship to BP of the 
type of alcoholic beverage consumed;  (2) study the relationship between alcohol intake and other 
macro- and micro-nutrients; (3) investigate the role of nutrient patterns of non-drinkers and drinkers 
and their BP; (4) assess whether there is any benefit of „moderate‟ drinking in relation to BP; (5) 
investigate the effect of specific alcoholic beverage on BP; and (6) relate data on urinary 
metabolites from nuclear magnetic resonance (NMR) spectroscopy of the stored INTERMAP 24-hr 
urinary specimens and urinary amino acid excretion to alcohol intake levels and drinking pattern 
and country/population differences in alcohol metabolism. 
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2  BACKGROUND 
2.1 Blood pressure 
Adverse blood pressure (pre-hypertension/hypertension) is a key independent risk factor for 
cardiovascular disease (CVD) (Stamler et al. 1993; van den Hoogen et al. 2000; Ezzati et al. 
2002).  Approximately 25% of the US adult population have hypertension (HTN), defined as 
systolic blood pressure (SBP) 140 mm Hg or higher and/or diastolic blood pressure (DBP) 90 mm 
Hg or higher and/or current use of antihypertensive medication (Muntner et al. 2002; Chobanian et 
al. 2003). Overall, 26·4% of the world adult population in 2000 were hypertensive and 29·2% were 
projected to have hypertension by 2025 (Kearney et al. 2005).  The estimated lifetime risk of 
developing HTN is 90% for men and women who were non-hypertensive at age 55 or 65 years and 
survived to 80 to 85 (Vasan et al. 2002).  Pre-hypertension (SBP 120 to 139 mm Hg or DBP 80 to 
89 mm Hg) also confers excess CVD risk (Stamler et al. 1993; Vasan et al. 2002; Chobanian et al. 
2003).   The National Health and Nutrition Examination Survey (NHANES) (1999-2000) reported 
31% of US adults had pre-hypertension (Wang and Wang 2004).  The Framingham Heart Study 
reported that BP values in the 130-139/85-89 mm Hg range were associated with a more than 2-
fold increase in relative risk of CVD compared with those with BP levels below 120/80 mm Hg 
(Vasan et al. 2002).  A meta-analysis from the Prospective Studies Collaboration of data on over 
one million adults demonstrated a two-fold higher CVD mortality associated with 20 mm Hg higher 
systolic BP or 10 mm Hg higher diastolic BP (Lewington et al. 2002).  The relationship between BP 
and risk of CVD events – coronary heart disease (CHD), stroke and heart failure – is continuous, 
graded and independent of other risk factors (Stamler et al. 2005; Elliott and Stamler 2005). 
Many epidemiological studies have investigated the relationship between nutritional and other 
lifestyle factors and adverse blood pressure. 
The INTERSALT Study  
The International Co-operative Study of Electrolyte Excretion and Blood Pressure (INTERSALT) 
assessed the association of urinary electrolytes and BP of 10,079 men and women ages 20-59 
years in 52 population samples from 32 countries (INTERSALT Co-operative Research Group 
1988; Rose and Stamler 1989): the population samples included the isolated Yanomamo and 
Xingu Indians of Brazil and rural populations from Kenya and Papua New Guinea (Mancilha-
Carvalho et al. 1989).  Mean SBP in these remote populations was 103 mm Hg, compared to 120 
mm Hg in the 48 other INTERSALT samples and mean DBP was 63 mm Hg compared to 74 mm 
Hg.  The rise of BP with age observed in the other INTERSALT samples (approximately 5 mm Hg 
higher SBP every 10 years) was small or absent in these remote populations.  Median 24-hr 
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urinary Na excretion (a biomarker for dietary salt intake) among these four populations was 
significantly lower compared to those among the 48 other INTERSALT populations (INTERSALT 
Co-operative Research Group 1988).  Mean body weight was also lower in the remote populations, 
and may have contributed to the observed differences in mean BP slope with age.  The 
INTERSALT Study also reported that dietary protein intake of individuals was independently 
related to their BP, based on 24-hr urinary total nitrogen (N) and urea N as indices of total protein 
intake (Stamler et al. 1996b).  
The INTERMAP Study  
The INTERMAP Study is a basic standardised cross-sectional epidemiologic investigation on the 
role of multiple dietary factors in the aetiology of unfavourable BP levels prevailing for middle-aged 
and older individuals (Stamler et al. 2003c; Beevers and Stamler 2003).  Comprehensive data 
included four 24-hr dietary recalls; two 7-day alcohol records; two 24-hr urine collections; eight BP 
readings; and questionnaire data for 4,680 men and women ages 40-59 years from 17 population 
samples in Japan, People‟s Republic of China (PRC), United Kingdom (UK) and United States of 
America (USA) (Stamler et al. 2003c).  The INTERMAP Study has reported the inverse relations to 
BP of dietary vegetable protein, glutamic acid, cystine, proline, phenylalanine and serine (the main 
dietary amino acids predominating in vegetable protein), omega 3 and omega 6 polyunsaturated 
fatty acids (PFAs) and their main individual constituent fatty acids (linolenic acid, long-chain omega 
3 PFAs, linoleic acid), starch, also dietary phosphorus, calcium, magnesium and iron (total and 
non-haem) (Elliott et al. 2006; Ueshima et al. 2007; Tzoulaki et al. 2008; Brown et al. 2009; Elliott 
et al. 2008; Stamler et al. 2009). 
A number of randomised trials on prevention and control of high BP by nutritional means have 
demonstrated ability to improve BP level with multiple dietary interventions. 
The Trial of Hypertension Prevention (TOHP) compared lifestyle changes (weight reduction, Na 
reduction and stress management) with non-intervention control of 2,182 men and women with 
pre-hypertensive DBP (DBP between 80 and 89 mm Hg); and reported that reduction in dietary Na 
intake by 50 mmol per day reduced mean BP in normotensive participants by approximately 1.7 to 
2.9 mm Hg (1992; The Trials of Hypertension Prevention Collaborative Research Group 1997) 
The Dietary Approaches to Stop Hypertension (DASH) and DASH-Na feeding trials and the 
Optimal Macronutrient Intake Trial to Prevent Heart Disease (OmniHeart) demonstrated that a 
„combination‟ diet substantially reduced SBP/DBP of both non-hypertensive and hypertensive 
adults (Appel et al. 1997; Appel et al. 2005; Sacks et al. 2001).  The DASH diet emphasises 
consumption of fruits, vegetables and low-fat/fat-free dairy products; includes whole grains, poultry, 
fish and nuts; and is reduced in fats, red meat, sweets and sugar-containing beverages (Appel et 
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al. 1997).  Participants with HTN on the DASH diet with a low Na level reduced SBP by 11.5 mm 
Hg and DBP by 5.5 mm Hg when compared to the control diet with a high Na level (Appel et al. 
1997; Sacks et al. 2001).  The OmniHeart diets followed the principles of the DASH dietary pattern 
with different amount of carbohydrates, protein and unsaturated fat consumed (Appel et al. 2005; 
Miller, III et al. 2006).  During this trial, 164 participants with pre-hypertension or stage 1 HTN were 
given a diet rich in carbohydrates; a diet rich in protein from plant sources; a diet rich in 
unsaturated fat.  Mean BP of participants on the carbohydrate diet reduced by 8.2 mm Hg for SBP 
and 4.1 mm Hg for DBP compared with baseline (Appel et al. 2005).  Compared with the 
carbohydrate diet, both the protein (1.4/3.5 mm Hg) and unsaturated fat  (1.3/2.9 mm Hg) diets 
significantly lowered systolic and diastolic blood pressure in all participants and in those who were 
hypertensive (Appel et al. 2005).  
Genetics and blood pressure 
Blood pressure is influenced by genetic inheritance, environmental exposures and gene-
environment interactions (Cicila 1999).  Family studies indicate that some BP variation in a 
population has a genetic basis (Cicila 1999), and individuals with a hypertensive first degree 
relative are estimated to be at 2- to 5-fold increased relative risk of HTN (Samani 2003).  
Investigation of rare genetic disorders affecting BP have identified genetic abnormalities 
associated with several rare forms of HTN, showing that mutations in genes influencing renal salt 
handling can have a severe impact on BP  (Lifton et al. 2001).  However, rare genetic 
abnormalities have not been shown to be responsible for a sizeable proportion of HTN in the 
general population.   
Recent discovery efforts have used hypothesis free association scans of the genome (genome-
wide association studies, GWAS) to identify new loci for HTN susceptibility and BP distribution 
(Newton-Cheh et al. 2009; Levy et al. 2009; Takeuchi et al. 2010; Cho et al. 2009).  A GWAS of 
Japanese (403 hypertensive cases and 452 normotensive controls) did not reveal significant loci 
associated with HTN (Takeuchi et al. 2010).  A small study of 350 Han Chinese (175 cases and 
175 controls) did not identify any genome-wide loci associated with HTN (Yang et al. 2010).  A 
genome-wide study of 8,842 individuals from two population  cohorts in Korea identified a single-
nucleotide polymorphism (SNP), chromosome 12q21 and variants near the ATP2B1 gene 
(rs17249754), associated with BP (Cho et al. 2009).  Two large GMAS meta-analyses of 
individuals of European ancestry, Global Blood Pressure Genetics (Global BPgen) Consortium 
(N=34,433) and Cohorts for Heart and Aging Research in Genome Epidemiology (CHARGE) 
Consortium (N=29,136), revealed about 13 new loci for BP traits (Newton-Cheh et al. 2009; Levy 
et al. 2009).  The association effect sizes were small (<1 mm Hg) and explained only a small 
proportion of the phenotypic variation.  Only two of these 13 loci harbour genes in a pathway 
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previously known to affect BP (CYP17A1 and NPPA/NPPB) and functional variants in these loci 
were unknown.   
Blood pressure and age 
Many epidemiologic studies have shown average BP is at or below the upper limit of normal BP 
range (120/80 mm Hg) in young adulthood, but in middle and older age average BP usually rises 
above normal, into the pre-hypertensive or hypertensive range (Whelton 1994; Burt et al. 1995).  
The Framingham Heart Study with participant follow-up for 30 years showed there was a 
continuous increase in SBP between ages 30 and 84 years or over.  Diastolic BP had a varying 
pattern with age, increasing from ages 30 to 49 years, then after ages 50-60 years, declining to at 
least 84 years of age (Franklin et al. 1997; Franklin et al. 2001).  NHANES (1999-2004) reported 
the prevalence of HTN among US adults was 7.3%, 32.6%, 66.3% in the 18 to 29, 40 to 59 and 
≥60 age groups respectively (Ong et al. 2007).   
Many studies have shown a gender difference in the age-related rise in BP.  NHANES (1988-1994) 
in the US found SBP was higher in men than women among adults less than 45 years old.  After 
age 45, SBP was higher in women and DBP lower in women across all age categories (Martins et 
al. 2001).  The Framingham Heart Study showed a higher prevalence of systolic HTN in elderly 
women than in elderly men (Franklin et al. 1997).  Primatesta and colleagues (2001) reported that 
average BP was higher in men than women up to the age of 65 from the Health Survey for 
England (1998) and SBP was higher in women than men from ages 65 years onwards.  Kearney 
and colleagues (2005) using worldwide data reported that men and women had similar overall 
prevalence of HTN (26.6% of men and 26.1% of women), and the prevalence increased with age 
consistently in all world regions.  The number of participants per study ranged from 665 (the 
Didima Study in Greece) to 484,185 (the cardiovascular program in Slovakia).  For adults at 
younger ages, the prevalence of HTN was higher in men than women, whereas in older people it 
was higher in women than in men (Kearney et al. 2005). 
A rise in BP with age that has been observed in many populations around the world is not universal 
(Whelton et al, 1994).  More than 20 populations with low average BP and little or no rise in BP 
with age throughout adulthood have been reported from isolated areas around the world 
(Mancilha-Carvalho et al. 1989).  Data from the INTERSALT Study showed that there was no rise 
in BP with age in the four remote populations, isolated Yanomamo and Xingu Indians of Brazil and 
rural populations from Kenya and Papua New Guinea (Mancilha-Carvalho et al. 1989).  When 
individuals from these environments migrate to less isolated areas, they are found to develop the 
age-related rise in BP that is common in most countries (Sever and Poulter, 2000).  This rapid 
change in the pattern of a biological trait indicates that environmental factors play a key role in 
determining age-related changes in BP. 
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Migration and blood pressure 
Migration from rural to urban areas and acculturation to western society has been suggested to 
relate etiologically to high BP (He et al. 1991; Poulter et al. 1984; Winkelstein, Jr. et al. 1975; 
Steffen et al. 2006; Marmot and Syme 1976), and to the rise in BP with age observed in individuals 
who migrate from traditional cultures to other societies (Poulter et al., 1984).  A meta-analysis of 
125 studies (published between 1962 and 2004) of 223,355 participants reported that more 
acculturated individuals had 4 mm Hg higher SBP and 3 mm Hg higher DBP than less acculturated 
individuals (Steffen et al. 2006).  The Kenyan Luo migration study reported significant differences 
in body weight, urinary Na to urinary K ratio as well as higher BP between migrants and those 
living traditional rural lifestyles (Poulter et al. 1990).  Changes in health behaviours associated with 
acculturation to western society include poorer diet (from a complex carbohydrate-based to a fat-
rich diet, higher salt intake), less physical activity, higher body weight and work stress.   
Stress and blood pressure 
Stress may contribute to high BP but the long-term effects of stress are not clear (Kaplan and 
Nunes 2003).  It has been suggested that stress management techniques (such as relaxation and 
meditation) may help to reduce the effects of stress, thereby reducing BP. The results of a 
systematic review and meta-analysis indicated that most stress reduction approaches did not 
significantly lower elevated BP (Rainforth et al. 2007).  Other behaviours linked to stress, e.g. 
overeating or eating unhealthy foods, smoking, drinking alcohol and poor sleeping habits, may 
cause high BP. 
Socioeconomic status and blood pressure 
Higher socioeconomic status (SES) has an inverse relationship with BP levels in many 
populations.  The most commonly used markers of SES are educational level, occupation and 
income.  Data from the INTERSALT Study showed that SBP was 1.3 mm Hg higher in men and 
4.5 mm Hg higher in women for each 10 fewer years of education (Stamler, R et al. 1992).  The 
study also demonstrated differences in Na, K, and alcohol intake with SES; which accounted for 
the observed SES differences in BP (Stamler, R et al. 1992).  Among 2,195 US participants in the 
INTERMAP Study, years of education was inversely related to SBP and DBP independent of 
ethnicity and non-dietary confounders (e.g., age, history of high BP, heart disease and stroke) 
(Stamler et al. 2003a).  Control for combinations of BMI and nutrients (e.g., sodium, potassium, 
vegetable protein intakes) reduced the education-BP association, in support of the concept that 
multiple dietary factors account for the more adverse BP levels of less educated compared to more 
educated Americans (Stamler et al. 2003a).   
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A systematic review of published articles between 1966 and 1996 showed that lower SES was 
associated with higher mean BPs in almost all studies in developed countries, and that this inverse 
gradient was stronger in women than in men (Colhoun et al. 1998).  In contrast, in undeveloped or 
developing countries, individuals with high SES have the highest prevalence of HTN (Bunker et al. 
1996).  It has been reported that the socioeconomic transition to salaried jobs among Papua New 
Guineans is associated with higher BP level (Sever and Poulter, 2000).  A study of 2,000 
Vietnamese adults ages 25–64 years reported that men in the low economic status group had a 
significantly lower risk for HTN than those in the high SES group (Hoang et al. 2007).  The China 
Health and Nutrition survey (CHNS) monitored the impact of social and economic development in 
China and reported a U-shaped association between SES and risk of HTN in 1,814 women ages 
30–65 years old (Colin Bell et al. 2004).  As countries become more developed, rates for HTN risk 
factors shift from highest in those in the highest SES groups to highest in those in the lowest 
socioeconomic groups.   
Body weight, physical activity and blood pressure  
Overweight and obesity are defined as an abnormal or excessive fat accumulation that may impair 
health (Haslam and James 2005).  Body mass index (BMI) is a simple index commonly used to 
classify overweight and obesity.  It is defined as weight (kg) divided by the square of height (m2).  
The World Health Organisation (WHO) defines overweight as a BMI ≥ 25 kg/m2 and obesity as BMI 
≥ 30 kg/m2 (WHO 2000).  The positive relationship between body weight (and indices of 
overweight including waist-to-hip ratio, WHR and BMI) and BP in adults has been reported 
consistently in observational studies (Stamler 1991; Elmer et al. 2006).  Abdominal obesity 
(defined as waist circumference ≥ 102 cm in men and ≥ 88 cm in women) was found to be 
associated with a two to three-fold increased risk of HTN in NHANES (1988-1994) data (Okosun et 
al. 1999).  Weight loss by overweight persons is important in both the prevention and treatment of 
HTN (WHO, 2000; Stamler et al. 2005).   
A meta-analysis of 25 randomised controlled trials (RCTs) (published between 1978 and 2002) of 
4,874 participants, in overweight and obese people showed reduction of 1.1 mm Hg systolic and 
0.9 mm Hg diastolic per kilogram of weight loss (Neter et al. 2003).  Most of the studies in this 
meta-analysis had relatively small sample sizes and short duration.  A more recent systematic 
review of 8 clinical trials with follow-up of ≥ 2 years and 8 cohort studies (published between 1990 
and 2008) reported that a 3-kg weight loss reduced BP by 2.9 mm Hg for SBP and 1.9 mm Hg for 
DBP (Aucott et al. 2009).  However, the data showed that initial reductions of BP seen with weight 
loss may be short lived, in the long term (> 3 years from the onset of the study), weight loss had 
little effect on change in BP levels as BP reverted back to higher levels among participants.  The 
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authors suggested that weight loss was important, but other aspects of lifestyle difference (such as 
increased physical activity, or improved diet) may also be critical for hypertension. 
In the Women On the Move through Activity and Nutrition (WOMAN) Study, 508 women were 
randomised to a lifestyle change (intervention) group, reporting a 17-lb weight loss at 18 months, 
and a health education group, reporting only 3 lb weight loss at 18 months.  At 6 months, there was 
a significant 5 mm Hg difference in SBP between the 2 groups, but by 18 months the difference in 
SBP was no longer significant (Kuller et al. 2006).  Many long-term non-pharmacological 
intervention trials have shown reduction in BP, but it is difficult to evaluate the effects of long-term 
weight loss on changes in BP as most of them included other dietary changes (e.g. sodium 
reduction, increase in fruits and vegetables, DASH diet) and exercise (Sjostrom et al. 1999; 
Eriksson and Lindgarde 1991; The Trials of Hypertension Prevention Collaborative Research 
Group 1997).   
Physical activity (at least 30 minutes of regular, moderate-intensity activity on most days) is 
important for maintaining a healthy body weight (WHO, 2000).  Aerobic exercise reduces blood 
pressure in both hypertensive and normotensive persons, and an increase in aerobic physical 
activity should be considered an important component of lifestyle modification for prevention and 
treatment of high blood pressure (Whelton et al. 2002).  A meta-analysis of 2,419 adults from 54 
RCTs (published between 1966 and 2001) reported that aerobic exercise reduced systolic and 
diastolic BP by 3.8 mm Hg and 2.6 mm Hg (p<0.001), irrespective of the type, frequency orduration 
of exercise.  Blood pressure was significantly reduced even in trials whose participants did not lose 
weight.  This suggests that the effect of aerobic exercise on BP was at least partially independent 
of change in body weight (Whelton et al. 2002).   
Macronutrients and blood pressure 
A meta-analysis by Liu and colleagues (2002) of 9 cross-sectional and two longitudinal studies 
(published between 1980 and 2001) showed a significant inverse association between dietary 
protein intake and BP; results with 24-hr dietary recall method and 24-hr urine collection method 
were consistent.  The INTERSALT Study and the PREMIER study have reported an inverse 
relationship between total dietary protein intake and BP (Wang et al. 2008; Stamler et al. 1996b).  
The INTERSALT Study also reported that dietary protein intake of individuals was independently 
related to their BP, based on 24-hr urinary total nitrogen (N) and urea N as indices of total protein 
intake (Stamler et al. 1996b).  Elliott and colleagues reported (2006) that vegetable protein intake 
was inversely related to SBP and DBP and animal protein intake tended to be positively related to 
BP in the INTERMAP Study.  A subgroup of 491 persons with the highest country-specific quartile 
of vegetable protein intake and the lowest country-specific quartile of animal protein intake had 
significantly higher intakes of dietary glutamic acid (the most common dietary amino acid), cystine, 
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proline, phenylalanine and serine, when compared to a subgroup of 471 participants in the lowest 
quartile of vegetable protein intake and the highest quartile of animal protein intake (Elliott et al. 
2006).  Subsequently, Stamler and colleagues (2009) reported an inverse relation to BP of dietary 
glutamic acid in the INTERMAP Study.  A recent systematic review of 46 studies published before 
June 2010 (15 observational studies, 13 biomarker studies and 20 trials) on the association 
between different dietary protein types and BP suggested a small beneficial effect of protein on BP, 
especially plant protein (Altorf-van der Kuil 2010).  Altorf-van der Kuil and colleagues (2010) 
suggested that high protein intake may influence the pathways in BP regulation and a higher 
concentration of tyrosine and tryptophan in blood vessel wall may play a role in vasodilatation.  
However, the underlying mechanisms for a potential beneficial effect of protein on BP are still 
unclear. 
The INTERMAP Research Group also reported inverse relations to BP of dietary total 
polyunsaturated fatty acids (PUFA), omega 6 polyunsaturated fatty acids (PFA) and its main 
component linoleic acid, omega 3 PFA and its vegetable and marine components (linolenic acid 
and long-chain omega 3 PFAs) (Ueshima et al. 2007).   These results are consistent with data from 
meta-analyses of RCTs and other studies on fatty acids and BP (Appel et al. 1993; Geleijnse et al. 
2002; Wendland et al. 2006; Cicero et al. 2010).  The INTERMAP Research Group also reported 
that dietary starch intake was significantly inversely related to BP after adjustment for multiple 
confounders (e.g., age, sex, height, body weight, physical activity, urinary Na, urinary K, alcohol 
intake) (Brown et al. 2009).  This finding was similar to that of the Honolulu Heart Program, in 
which starch intake was inversely associated with BP with adjustment for age, BMI and alcohol 
(Joffres et al. 1987), but contrary to the positive association observed in the Multiple Risk Factor 
Intervention Trial (MRFIT) (Stamler et al. 1996a). 
Micronutrients and blood pressure 
The INTERSALT Study assessed the association of dietary electrolytes and BP of 10,079 men and 
women and reported that median 24-hr urinary Na excretion among the four remote populations 
ranged from 0.2 mmol/day in the Yanomamo to 51.3 mmol/day in the Kenyans, compared to a 
median of 160 mmol/day among the 48 other INTERSALT populations (Mancilha-Carvalho et al. 
1989).  The within-population analyses for all participants yielded significant direct relations 
between SBP and 24-hr urinary Na and Na/K ratio, BMI, heavy alcohol use (≥300 ml of absolute 
alcohol per week) and significant inverse associations with 24-hr urinary K (Elliott et al. 1989; Dyer 
and Elliott 1989; Elliott et al. 1996).   
Elliott and colleagues (2008) reported findings on the relations dietary Ca, Mg and P intakes to BP 
in INTERMAP.  Dietary P related inversely to BP in serial regression analyses controlled for 
multiple non-dietary (e.g., age, sex, physical activity) and dietary (e.g., Na, K, alcohol) 
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confounders.  The inverse relations of Ca and Mg were consistent with results from both 
observational studies and RCTs (Allender et al. 1996; Griffith et al. 1999; van Mierlo et al. 2006; 
Jee et al. 2002; Joffres et al. 1987).  The INTERMAP Study further showed that intakes of total Fe 
and non-haem Fe from food were inversely related to BP (Tzoulaki et al. 2008), and that red meat 
intake was directly associated with BP after adjustment for multiple confounders.  These new 
findings were similar to those reported in the Health Professional Follow-up Study; an inverse 
association for total Fe and a positive association for haem Fe in relation to risk of CHD (Ascherio 
et al. 1994). 
Summary 
The role of multiple dietary factors in the aetiology of unfavourable population BP levels is one of 
the important challenges for cardiovascular research (Stamler et al. 1993).  High dietary Na and 
inadequate K, excess alcohol consumption, inactivity and overweight are known to contribute to 
the population-wide BP problem (Nevill et al. 1997; Appel 2003).  Studies such as PREMIER have 
shown that healthy lifestyles – reduced dietary sodium intake (<6 g/day), increased dietary 
potassium intake, alcohol moderation (<30 ml alcohol, 2 units, per day in men and <15 ml alcohol, 
1 unit, per day in women), weight loss (if overweight or obese), aerobic exercise (>30 min/day, 
most days of the week) and a DASH diet can achieve decreases in SBP of approximately 10 to 15 
mm Hg when applied together (Funk et al. 2008; Elmer et al. 2006; McGuire et al. 2004; 
Chobanian et al. 2003).  The two DASH feeding trials (Appel et al. 1997; Sacks et al. 2001) and the 
OmniHeart randomised trial (Appel et al. 2005) have demonstrated the ability to improve BP level 
with multiple dietary interventions.  Nutritional and lifestyle factors are key determinants of BP 
across populations, and lifestyle modifications are effective in reducing BP (Elliott et al. 2005; 
Appel et al. 2006).  The remit of this thesis focuses in one small modifiable lifestyle factor 
associated with BP levels – namely, alcohol drinking. 
2.2 Alcohol and blood pressure 
The relationship between regular alcohol consumption and BP elevation was first described by 
Lian in 1915 among young French servicemen (Lian 1915).  Lian (1915) reported that French 
servicemen drinking 2.5 litres of wine or more per day had higher prevalence of HTN.  
Epidemiologic data support a relationship of heavier drinking to adverse BP (Burger et al. 2004; 
Marmot et al. 1994; Klatsky 1996a).  Evidence indicates that a reduction in alcohol intake among 
heavy drinkers can reduce systolic and diastolic BP among hypertensive or non-hypertensive 
people (Xin et al. 2001).  The importance of this alcohol-BP relationship has been recognised in 
national and international guidelines on the prevention and management of HTN (Muntner et al. 
2002; Chobanian et al. 2003). 
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2.2.1 Experimental studies in animals  
Many experimental studies have examined the associations of chronic alcohol consumption with 
cardiovascular dysfunction and HTN.  However, the mechanisms involved in the relation of alcohol 
intake to BP are not yet completely understood.  Possible mechanisms include secretion of 
hormones (Altura and Altura 1982), stimulation of sympathetic nervous system (Chan et al. 1985) 
and impairment of baroreceptor activity (bdel-Rahman and Wooles 1987).  Findings from 
experimental studies on BP and alcohol consumption are not consistent.  
Puddey and colleagues (1995) reported an elevation of SBP (9.3 mm Hg) and erythrocyte 
membrane fluidity and alteration in the membrane lipids composition, after the chronic 
administration of alcohol to rats.  Strickland and Wooles (1989) also reported that BP increased in 
rats after ethanol administration of different concentrations (5% to 20% in drinking water).  Blood 
pressure in the ethanol-fed group was similar to that of the control group when blood ethanol 
concentration was low, suggesting that ethanol must be present in the blood to exert the 
cardiovascular effects.  Husain and colleagues (2005) investigated the dose response effect of 
ethanol on BP in rats for 12 weeks.  The study showed that SBP decreased slightly with 1 g/kg 
dose, but was significantly elevated with 2, 4 and 6 g/kg doses 7-12 weeks after ethanol ingestion, 
and DBP also increased with 4 and 6 g/kg doses of ethanol over 8-12 weeks.  Resstel and 
colleagues (2006) reported BP increased with ethanol feeding in rats after 2 weeks and suggested 
that the cardiovascular system was altered in the early stages of ethanol consumption. 
However, several studies have shown that chronic alcohol intake lowered or did not affect BP in 
animals.  Howe, Rogers and Smith (1989) reported BP values lower in alcohol-fed (starting with 
5% alcohol and gradually increasing to 20% over 2 weeks) normotensive and hypertensive strains 
of rats compared to control rats during a 6-month observation period.  Beilin and colleagues (1992) 
reported a decrease in BP of ethanol-treated rats after 12 weeks of ethanol administration (20% in 
drinking water).  Hatton (1992) also observed a BP decrease during chronic ethanol administration 
for 18 weeks in rats. 
Vasdev, Sampson and Pabhakaran (1991) observed an increase in BP of Wistar-Kyoto (WKY) rats  
during the administration of ethanol for 1 week (5% ethanol in drinking water), continuing over the 
remaining 6 weeks (10% ethanol in drinking water) of the study.  The authors also reported 
increases in platelet cytosolic free calcium and vascular calcium uptake, which may be associated 
with ethanol-induced HTN.  In a later study of rats on relatively low ethanol intake (0.5% ethanol in 
drinking water equivalent to approximately two drinks per day in humans), Vasdev and colleagues 
(1999) reported there was no BP difference between ethanol-fed and control WKY rats.  A dose of 
0.5% ethanol in the drinking water of spontaneously hypertensive rats (SHR) produced a 
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significantly decreased BP compared to SHR controls.  This low ethanol dose also produced a 
significant decrease in platelet cytosolic free calcium in SHR.  Consumption of 3.5% ethanol in 
drinking water one day per week (equivalent to the weekly amount of alcohol consumption over a 
one day period each week, simulating weekend drinking in humans) did not affect BP in 
normotensive rats or hypertensive rats compared to their respective controls.   The results suggest 
that daily low ethanol intake may lower BP by reducing tissue aldehyde conjugates and cytosolic 
free calcium  (Vasdev et al. 1999).   
The reasons for the inconsistent results in experimental studies are not clear; they may be 
explained by differences in daily dose of alcohol administration, the periods of alcohol 
administration and the timing of BP measurement.  The mechanisms of the antihypertensive effect 
of low alcohol consumption remain uncertain.  More studies are needed to confirm or reject 
inconsistently reported direct associations between alcohol and BP in animals.  
2.2.2 Population studies on alcohol and blood pressure 
The Comparative Risk Assessment Collaborating Group reported that both high BP (64 million 
disability-adjusted-life-years [DALY], healthy years of life lost) and alcohol (58 million DALY) were 
leading causes of global burden of disease; almost 200 studies with over 450,000 participants on 
BP were reviewed in this report (Ezzati et al. 2002).  The WHO Global Burden of Disease 2000 
Comparative Risk Analysis study assessed the risks and benefits of alcohol globally and reported 
that regular consumption of alcohol elevated BP and attributed 16% of all hypertensive disease to 
alcohol (Rehm et al. 2003a).  
Strong and consistent epidemiologic data support a relationship of heavy drinking to BP (Fuchs et 
al. 2001; Dyer et al. 1990; McFadden et al. 2005; Xin et al. 2001; Sesso et al. 2008).  The 
independent influence of alcohol intake on BP is evident.  The results of studies across different 
populations are largely consistent in demonstrating a positive association of BP with alcohol 
consumption independent of a number of confounders (e.g. age, BMI). However, the exact 
relationship between the quantity of alcohol and the extent of BP elevation is still unsettled.  Some 
studies have reported a linear relationship between alcohol intake and BP (Okubo et al. 2001a; 
Paulin et al. 1985); others have reported a threshold level of alcohol intake, below which alcohol 
has no effect on BP and others have suggested that light alcohol intake may decrease BP, 
producing a U or J-shaped dose-response curve (Gillman et al. 1995; Keil et al. 1989).  Blood 
pressure of non-drinkers was greater than that of minimal alcohol consumers in most of the U.S. 
studies. The lack of consistency between studies may be due to methodological and analytic 
differences.  The categorisation of alcohol consumption precluded examination of the effect of light 
drinking on BP in certain studies (Arkwright et al. 1982) and alcohol consumption has often been 
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analyzed as a continuous variable which may not be appropriate considering its highly skewed 
distribution.  The methodology of alcohol consumption data collection was also different in studies, 
some studies used 7-day recall while others used estimate of usual consumption.  In some of the 
studies, the samples investigated were not representative of defined communities (Klatsky et al. 
1977).  Many longitudinal studies excluded treated hypertensive people at the time they were 
enrolled into the study (Sesso et al. 2008), who represented a sizeable proportion of the study 
population.   
Burger and colleagues (2004) conducted a systematic review of studies (published between 1988 
and 1999) of moderate alcohol consumption (<40 g/day) in relation to BP and  reported a linear BP 
association at drinking levels of >30 g/day for men and >20 g/day for women.  A cross-sectional 
study by Okubo and colleagues (2001) of 2,194 normotensive Japanese men reported that alcohol 
consumption increasesd BP linearly in normotensive workers aged 45 to 54 years.  In many cross-
sectional studies, alcohol consumption of three or more drinks per day is associated with higher 
systolic and diastolic BP, and with higher prevalence of HTN (Klatsky et al. 1986; Klatsky et al. 
1977; Marmot et al. 1994).  Klatsky and colleagues (1977) reported that in the Kaiser-Permanente 
Multiphase Health Examination Study of 83,947 men and women, those who drank ≥3 drinks per 
day had a greater prevalence of HTN.  The INTERSALT Study found that heavy drinking (3 or 
more drinks per day, ≥300ml alcohol per week) was associated with higher blood pressure after 
adjustment for key confounders (Marmot et al. 1994).  In a study of 901 men and women (surveyed 
in 1981) reported by Paulin and colleagues (1985), there was a positive association between 
alcohol intake and BP for men, after adjustment for age and BMI.  The mean SBP and DBP of 
male heavy alcohol users (≥300 g alcohol per week) were 9.8 and 8.9 mm Hg higher respectively, 
than those of male non-drinkers.  In contrast to other studies, alcohol intake in women was not 
associated with higher BP (Paulin et al. 1985).  
In some studies, the relationship of alcohol consumption to BP appears to be J-shaped with 
teetotallers and ex-drinkers manifesting higher BP than moderate drinkers (Klatsky 1996a; Gillman 
et al. 1995; Keil et al. 1989; Keil et al. 1998).  The Luebeck Blood Pressure Study, a cross-
sectional study of 3,100 adults ages 30 to 69 years, reported a J-shaped relationship between 
alcohol consumption and SBP in men with adjustment for confounders (e.g., smoking, physical 
activity and education level), where male teetotallers had a higher BP than male moderate drinkers 
(Keil et al. 1989).  Gillman and colleagues (1995) reported a J-shaped curve when comparing 
alcohol intake of 316 young adults (aged 18 to 26 years); the lowest SBP occurred in adults taking 
<2 drinks per day.  Several studies have shown a lower prevalence of HTN in persons drinking two 
or fewer drinks per day than in non-drinkers (MacMahon 1987; Okubo et al. 2001b; Keil et al. 1989; 
Witteman et al. 1990; Nakanishi et al. 2002).  The Nurses Health Study reported that 20 to 34g of 
alcohol per day (about 1.5 to 3 drinks) was associated with a 40% increase in risk of HTN 
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compared with non-drinkers (Witteman et al. 1990).  Thadhani, Camargo and colleagues (2002) 
reported a similar finding in young women.  Sesso and colleagues (2008), using data from the 
Women‟s Health Study and the Physicians‟ Health Study, reported a J-shaped association 
between alcohol intake and HTN in age- and lifestyle-adjusted regression models in women 
(Sesso et al. 2008).   
A report from the British Regional Heart Study (BRHS) showed that ex-drinkers had the highest 
percentage of men with multiple doctor-diagnosed disorders;  they had high prevalence rates of 
high blood pressure, peptic ulcer, diabetes, gall bladder disease and bronchitis, as well as the 
highest use of medication (Wannamethee and Shaper 1988).  Several studies have reported that 
many ex-drinkers stopped drinking alcohol due to pre-existing diseases; unless controlled for, this 
may confound analyses on the relationship between alcohol consumption and health status, i.e., 
„reverse causation‟ (Fillmore et al. 1998; Kerr and Ye 2010).  Therefore, the general category of 
non-drinkers, which includes a large proportion of ex-drinkers, should not be used as a baseline 
against which to measure the effects of alcohol consumption on BP.  
Randomised control trials by Puddey, Beilin and colleagues have demonstrated that reduction in 
alcohol intake among individuals who drink heavily (i.e., 3 or more drinks per day) can lower blood 
pressure in normotensive and hypertensive men (Puddey et al. 1985b; Puddey et al. 1987; Zilkens 
et al. 2003).  Xin, He and colleagues (2001) did a meta-analysis of 15 RCTs (published between 
1984 and 1999) with 2,234 hypertensive and normotensive persons on the effects of alcohol 
reduction on BP.  Study duration varied from 1 to 104 weeks, with a median length of 8 weeks.  In 
8 trials, a low-alcohol beer substitute was used; in the remaining 7 studies behavioural 
interventions were used as a means to encourage a reduction in alcohol consumption.  The 
percentage of alcohol reduction ranged from 16% to 100%.  This meta-analysis concluded that 
alcohol reduction was associated with a significant reduction in BP (-3.3 mm Hg for SBP and -2.0 
mm Hg for DBP).  A dose-response relationship was observed between mean percentage of 
alcohol reduction and net change in both systolic and diastolic BP (Xin et al. 2001).  A meta-
analysis of 105 RCTs (published between 1998 and May 2003) with 6,805 participants by 
Dickinson and colleagues (2006) investigated the effectiveness of lifestyle interventions for HTN 
reporting alcohol intake reduction in heavy drinkers (those consuming 3-6 drinks per day) resulted 
in a 3.3 mm Hg reduction in SBP and 2.0 mm Hg reduction in DBP.  Although most RCTs had a 
small sample size, these findings strongly support recommendations for moderation of alcohol 
consumption to prevent and treat HTN. 
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2.2.3 Type of alcohol, drinking pattern and blood pressure 
The type of alcoholic beverage consumed and the alcohol drinking pattern are reported to affect 
the relationship between alcohol and BP (Trevisan et al. 1987; Marques-Vidal et al. 2001a; 
Takashima et al. 1997).   
Type of alcoholic beverage and blood pressure 
A few studies have suggested that beer and spirit consumption may be associated with higher BP 
levels than wine consumption (Klatsky et al. 1986; Brenn 1986).  Drinking sake (Japanese rice 
wine) and shochu (traditional Japanese spirits) was associated with elevated BP while drinking 
beer was associated with lower BP in 563 middle-aged Japanese men (Takashima et al. 1997).  
The mean weekly alcohol consumption levels were different between alcoholic beverage types; 
145.8 g/week for 131 „exclusively beer‟ drinkers and 314.7 g/week for 124 „exclusively sake‟ 
drinkers.  The study reported that mean BPs adjusted for age, BMI and alcohol consumption of 
„sake‟ drinkers were significantly higher than that of beer drinkers.  A similar result was seen in a 
study of 4,335 Japanese male workers who were grouped according to the type of alcoholic 
beverage that provided two-thirds or more of the total alcohol consumption: beer, sake, shochu, 
whiskey, wine and other (Okamura et al. 2004).  „Shochu‟ drinkers (N=343) had the highest alcohol 
intake of 58.5 g/day while beer drinkers (N=1,293) had 17.4 g alcohol per day.  Blood pressure 
was highest with the consumption of Japanese spirits, but this finding for the shochu group 
disappeared after adjusting for total alcohol consumption (Okamura et al. 2004).   
The Kaiser Permanente study reported that there were differences in BP with beverage 
preference; those who preferred spirits had higher adjusted BP than those preferring wine or beer 
(Klatsky et al. 1986).  However, the study did not investigate the amount of alcohol in different 
beverage types and its effect on BP.  A recent crossover trial of 24 healthy normotensive men with 
similar periods of daily consumption of red wine, de-alcoholised red wine and beer found no BP 
differences between control (abstinence) and de-alcoholised red wine interventions (Zilkens et al. 
2005).  Compared with the control group, red wine (39 g alcohol/day) and beer (41 g alcohol/day) 
intervention increased BP to similar levels.  These findings suggested that polyphenolics in red 
wine but not beer or spirits, may not have a significant role in mitigating the blood pressure-
elevating effects of alcohol in men.  
There are epidemiological data indicating that alcoholic drinks, especially red wine, may reduce the 
risk of death from CVD, CHD in particularly (Chapter 2.3).  The French paradox, a relatively low 
mortality rate from CHD and cardiovascular diseases despite a higher level of risk factors, has 
been observed in several studies  (Renaud and De 1992).  The moderate consumption in France 
of fresh vegetables, fruits and vegetable fats may contribute to healthy effects of the French diets 
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(Criqui and Ringel 1994).  The mechanisms for this protective effect are not completely understood 
and may involve effects of alcohol per se and possibly also effects of the antioxidant and 
vasodilator phenolic compounds present in some alcoholic beverages. 
Patterns of alcohol drinking and blood pressure  
The Prospective Epidemiology Study of Myocardial Infarction (PRIME) showed that alcohol 
consumption varied little throughout the week in France, with a slight increase during weekends, 
whereas in Northern Ireland, Fridays and Saturdays accounted for 66% of total alcohol 
consumption (Marques-Vidal et al. 2001a).  Average alcohol consumption was slightly higher in 
Northern Ireland than in France (325 vs. 317 ml of alcohol per week, p<0.01).  French drinkers 
drank less beer, less spirits and more wine than their Northern Irish counterparts.  After adjustment 
for age, BMI, heart rate, smoking, education, marital status and professional activity, BP levels of 
Northern Irish drinkers increased on Monday and decreased until Thursday following heavy 
drinking sessions on Friday and Saturday; whereas BP levels were constant throughout the week 
for French drinkers.  Rakic et al. (1998) demonstrated in a randomised, controlled cross-over trial 
of 55 male regular drinkers that there was a Monday to Thursday difference in BP in drinkers who 
drank predominantly at the weekend.  Among regular daily drinkers, there was no significant 
difference in BP throughout the study (Rakic et al. 1998).  In the INTERSALT Study, episodic 
drinkers had greater differences in BP compared to non-drinkers than did drinkers with a less 
variable alcohol intake (Marmot et al. 1994).  For SBP in heavy drinkers (≥300 ml/ week), mean 
differences in BP in comparison with non-drinkers were 4.5 mm Hg in the group with high variability 
and 1.0 mm Hg in the group with low variability.  For DBP the corresponding figures were 3.1 and -
0.8 mm Hg.  Murray and colleagues (2002) reported from a prospective study that  binge drinking 
(consumption of eight or more drinks at one sitting) increased the risk of hypertension in men but 
not in women. 
The Italian National Research Council Study, a cross-sectional study of 6,699 Italian men and 
women, reported a direct association between heavy alcohol consumption (>484 ml alcohol/week) 
and high BP (Trevisan et al. 1987).  Wine was the major source of alcohol intake in this study.  In 
male drinkers, the amount of alcohol consumed weekly had a small but significant effect on SBP 
and DBP.  The weekly alcohol consumption had a significant effect only on SBP among female 
drinkers.  After adjustment for the differences in weekly alcohol consumption, drinkers of wine 
(both with and without meals) had a higher prevalence of HTN than other drinking pattern groups 
(drinkers only of wine taken with meals; drinkers of wine and small amount of spirits; drinkers of 
wine and large amount of spirits).  Stranges and Wu (2004) investigated the association of alcohol 
consumption and drinking pattern with HTN risk in 2,609 Americans. The findings confirmed that 
high alcohol consumption (≥2 drinks per day) is associated with risk of HTN.  Daily drinkers and 
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participants consuming alcohol without food exhibited a significantly higher risk of HTN compared 
with those drinking less than weekly and those drinking mostly with food.  There were no 
consistent beverage-specific associations with HTN risk among drinkers in this study (Stranges et 
al. 2004).     
In conclusion, alcoholic beverage type and drinking patterns within study populations need to be 
considered with amount of alcohol consumed in order to better understand complex associations of 
alcohol consumption and BP.  
2.2.4  Alcohol, genetic differences and blood pressure 
Alcohol is metabolised to an intermediate compound, acetaldehyde (AA), which is further 
metabolised to carbon dioxide and water and eliminated from the body (see Chapter 2.3).  The 
major enzyme responsible for the elimination of AA is aldehyde dehydrogenase 2 (ALDH2).  
Individuals with the ALDH2*2 polymorphism in the ALDH2 gene (common in some East Asian 
populations) are unable to fully metabolise alcohol, leading to an accumulation of AA in the blood 
and symptoms including facial flushing, nausea, drowsiness and headache (Enomoto et al. 1991; 
Edenberg 2007).  Chen and colleagues (2008) undertook a systematic review and meta-analysis of 
eight studies reporting associations of ALDH2 genotype and BP or HTN in Japanese populations.  
In the two largest studies (n=4,057 and n=2,035), alcohol intake in men was around 20-30 g/day in 
*1*1 homozygotes, 10-15 g/day in heterozygotes (those with one copy of the ADLH2*2 
polymorphism) and 0-2 g/day in *2*2 homozygotes (those with two copies of the ALDH2*2 
polymorphism).  Meta-analysis for risk of HTN (4,219 participants from 3 studies) revealed a 
pooled odds ratio for men of 1.7 (95% confidence interval [CI], 1.2-2.5) for *1*1 versus 
heterozygous individuals and 2.4 (95% CI 1.7-3.6) for *1*1 versus *2*2 individuals.  Meta-analysis 
for continuous increases of BP, based on 7,658 participants from 3 studies, revealed mean SBP 
differences for men of 4.2 mm Hg (95% CI 2.2-6.1) for *1*1 versus heterozygous individuals and 
7.4 mm Hg (95% CI 5.4-9.5) for *1*1 versus *2*2 individuals. Smaller significant differences were 
observed for DBP.  No associations were observed for women, for whom alcohol intakes were low 
irrespective of genotype.  Based on observed genotype-BP associations, the alcohol intake-BP 
relationships in men were 0.24 mm Hg/g alcohol (95% CI 0.16-0.32) and 0.16 mm Hg/g alcohol 
(95% CI 0.11-0.21) for systolic and diastolic BP respectively (Chen et al. 2008). These data from a 
natural „Mendelian randomisation‟ experiment in humans, support the hypothesis that alcohol 
intake has a direct effect on BP, and may indicate that higher BP levels observed in non-drinkers 
compared to moderate drinkers in observational studies are the result of inadequate control for 
confounding (e.g., BMI, SES). 
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2.2.5  Alcohol and other environmental factors and blood pressure 
The relationship between alcohol intake and BP is confounded by social and cultural factors and 
lifestyle.  The impact of alcohol on BP interacts with other components of the environment, 
including lifestyle habits such as smoking, exercise and diet (Van Leer et al. 1994; Keil et al. 1989).  
Data from the WHO project Monitoring Trends and Determinants in Cardiovascular Disease 
(MONICA) study (1984-1985) showed a consistent interaction between alcohol consumption and 
smoking in 5,312 men and women; smoking was associated with an increased effect of alcohol on 
SBP and DBP (Keil et al. 1991).   
The hypotensive effects of green coffee bean extract in spontaneously hypertensive rats were 
reported but roasted coffee extract did not have these antihypertensive effects (Suzuki et al. 2002).  
The blood pressure-lowering effect of green coffee bean extract is attributed to the effects of 
cholorogenic acid and its metabolites on vascular reactivity (Kozuma 1998).  A few epidemiological 
studies investigated the relationship between coffee intake and BP and reported a positive 
association between coffee intake and BP (Corti et al. 2002; Klag et al. 2002).  A meta-analysis of 
11 trails of coffee drinking by Jee and colleagues (1999) found that it was associated with a mild 
increase in SBP and DBP. However, a recent review of epidemiological evidence on coffee 
consumption and BP by Geleijnse (2008) reported that regular intake of caffeinated coffee did not 
increase the risk of hypertension.  A few studies reported that coffee protected against liver 
damage, coffee intake was inversely related to the serum gamma glutamyl transferase (GGT) level 
and serum aminotransferases; suggesting increase in BP in alcohol drinkers may be lowered by 
coffee intake (Poikolainen and Vartiainen 1997; Funatsu et al. 2005).  In the Kaiser Permanente 
study, coffee use and tea use showed no interaction with higher BP associated with alcohol 
consumption (Klatsky et al. 1986).    
More favourable health-related behaviours in low-to-moderate alcohol drinkers suggest that their 
lower risk of HTN could be mediated by lifestyle.  Different beverage types and different drinking 
patterns are accompanied not only by different levels of alcohol intake but also by different nutrient 
intakes and other differences in drinker traits and habits (Fillmore et al. 1998; Breslow et al. 2006; 
Barefoot et al. 2002).  Moderate alcohol drinkers (1-19 g alcohol per day) or wine drinkers from the 
three French MONICA Centres (Lille, Strasbourg and Toulouse) exhibited healthier behaviours 
compared to other drinkers or abstainers (Ruidavets et al 2004).  The moderate drinkers (mostly 
wine drinkers) had the highest mean educational level, lowest percentage of current cigarette 
smokers and practised more moderate or high intensity physical activity.  They also had a higher 
consumption of vegetables and fruit and higher diet quality index (a collection of scores applied to 
selected dietary components deemed to be representative of a healthy diet) compared to other 
drinkers and non-drinkers.  In the Danish Diet Cancer and Health Study, a preference for wine was 
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associated with a higher intake of fish, fruits and vegetables compared with a preference for beer 
or spirits (Tjonneland et al. 1999).  
In summary, the association between alcohol consumption and BP is influenced not only by 
quantification of alcohol intake and pattern of drinking, but also by various confounding factors, like 
age, gender, BMI, smoking, physical activity, nutrition and psychosocial factors.  The finding of 
heavy drinking (≥30 g alcohol per day) as an important risk factor for HTN is consistent among 
cross-sectional (Keil et al. 1989; Marmot et al. 1994; Dyer et al. 1990), prospective cohort (Gordon 
and Kannel 1983; Witteman et al. 1990) and intervention studies (Puddey et al. 1985a; Puddey et 
al. 1987). 
2.3 Alcohol metabolism 
Alcohol consumption is a common lifestyle choice in many cultures.  Alcohol is consumed in large 
quantities by some, placing a substantial load on the hepatic oxidative systems in the body.  About 
90% of ingested alcohol is metabolised (mostly in the liver) while 5-10% is excreted unchanged 
from the lungs into the air and from the kidneys into the urine (Rang et al. 2003).  The rate and 
extent of absorption, distribution and the metabolism of alcohol, (i.e. the pharmacokinetics), and in 
the effects (i.e., the pharmacodynamics) of alcohol are determined by genetic and environmental 
factors (e.g., body composition, liver volume and food composition). 
Figure 2.1 Oxidative pathways of alcohol metabolism 
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Alcohol (i.e., ethanol, CH3CH2OH) is metabolised differently at high and low concentrations.  The 
primary product of alcohol oxidation is acetaldehyde (AA, CH3CHO), a highly reactive intermediate 
which has potent vasoactive properties.  At low concentrations, alcohol is metabolised by alcohol 
dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), which involves an intermediate 
carrier of electrons (nicotinamide adenine dinucleotide, NAD+), both reactions resulting in the 
production of reduced nicotinamide adenine dinucleotide (NADH).  This creates a reductive 
environment, decreasing oxidative stress and increasing the tissue levels of the antioxidants 
cysteine and glutathione.  The ADH pathway is responsible for most of the alcohol breakdown in 
liver cells (Equation 1).  With chronic high alcohol intake, alcohol is metabolised to AA without 
producing reduced NADH by the microsomal ethanol oxidising system (MEOS) (Lieber 1990).  In 
this pathway, the cytochrome P450 2E1 (CYP2E1) assumes an important role in metabolising 
alcohol and reduced nicotinamide adenine dinucleotide phosphate (NADPH) is converted to 
nicotinamide adenine dinucleotide phosphate (NADP+) creating an oxidative environment 
(Equation 2).  Acetaldehyde is then metabolised to acetate (CH3COOH) (Equation 3).  
Acetaldehyde is an extremely toxic first intermediate of alcohol metabolism, it binds rapidly to 
cellular proteins and with deoxyribonucleic acid (DNA) to form carcinogenic DNA adducts (Zakhari 
2006).  
Equations of alcohol metabolism pathways (Rang et al. 2003): 
 
Although alcohol metabolism occurs predominantly in the liver via the oxidative pathway (Equation 
1), a small amount of alcohol is metabolised by non-oxidative routes in the kidneys, lungs and skin 
to fatty acid ethyl esters (FAEE) (Laposata and Lange 1986; Lange 1991) and phosphatidylethanol 
(PEth) (Varga and Alling 2002), which tend to accumulate in tissues.  A small amount (<0.1%) of 
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alcohol becomes conjugated with glucuronic acid and sulphate to form ethyl glucuronide (EtG) 
(Dahl et al. 2002; Wurst et al. 2000) and ethyl sulphate (EtS) (Helander and Beck 2004). 
Alcohol use and alcohol-related problems are influenced by individual variations in alcohol 
metabolism, or the way alcohol is broken down and eliminated by the body.  A fast ADH enzyme or 
a slow ALDH enzyme can cause toxic AA to build up in the body, creating dangerous and 
unpleasant effects that may affect an individual‟s risk for various alcohol-related problems. 
Studies have demonstrated that gender differences in alcohol distribution, blood alcohol 
concentration, bioavailability and metabolism with greater production of AA may contribute to 
women‟s vulnerability to alcohol consumption (Ward and Coutelle 2003; Frezza et al. 1990).  In 
addition, evidence has accumulated that genetic variation related to ethnicity may complicate the 
metabolism of alcohol (Luczak et al. 2004; Li et al. 2000; Bosron et al. 1993).  Variation in the 
genes encoding ADH and ALDH produce alcohol- and acetaldehyde-metabolising enzymes that 
vary in activity (Edenberg 2007).  It has been consistently reported that alcohol dehydrogenase-2 
(ADH2) and ALDH2 are the most important alcohol metabolising polymorphic enzymes in Japan 
and other East Asian populations (Cook et al. 2005) (see also Chapter 2.2.4).  Some Asians have 
inactive ALDH2 and these individuals metabolise alcohol at normal rates but show greatly reduced 
rates of AA oxidation.  About 50% of Japanese (Takeshita et al. 1994) experience 
acetaldehydemia and alcohol flushing responses, which may inhibit them from heavy drinking 
(Harada et al. 1982; Enomoto et al. 1991).  
Metabolism of alcohol is not only influenced by individual genetic composition but by concurrent 
nutrient status, including deficiencies of various nutrients (Gloria et al. 1997; Ahmed et al. 1994; 
Leo and Lieber 1999). Chronic alcohol consumption affects vitamin A metabolism, including retinol 
absorption, enhanced degradation in the liver and increased mobilisation of retinol from the liver to 
other organs (Leo and Lieber 1999; Seitz 2000).  A reduction in the blood levels of micro and 
macronutrients, mainly B-complex vitamins, can impair cognitive functions, reduce activity of 
methionine syntheses and decrease levels of glutathione (Lieber 1994a; Lieber 1994b; Speisky et 
al. 1985).  Ingestion of food before intake of ethanol is likely to slow absorption of alcohol and 
increase the rate of metabolism of ingested alcohol.  Alcohol elimination rates have shown an 
average 45% increase following food consumption, compared with that following fasting 
(Ramchandani et al. 2001).  There are many possible metabolic consequences of alcohol 
ingestion, including alcohol oxidation, AA and acetate formation, redox (NADH/NAD) changes, 
enzyme induction and inhibition.  The relative contributions of these various effects are determined 
by the alcohol load, amount of alcohol intake, concomitant drug ingestion, nutritional status and the 
genetic makeup of the individual. 
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2.3.1 Alcohol metabolites  
Acetaldehyde (AA) is a major metabolite of alcohol oxidation by ADH and MEOS pathways mainly 
in the liver, but some alcohol metabolism also occurs in other tissues, including the pancreas and 
the brain, causing damage to cells and tissues. It is metabolised to acetate by ALDH.  AA is a toxic 
intermediate of alcohol metabolism which binds rapidly to cellular proteins and forms both stable 
and unstable adducts.  Acetaldehyde is linked to most of the clinical effects of alcohol. It has been 
shown to increase the risk of developing cirrhosis of the liver (Carithers and McClain 2006), 
multiple forms of cancer (Seitz and Becker 2007) and alcoholism.  The estimated half-life of AA in 
circulating blood has been reported as <15 minutes (ACGIH 1991).  Acetaldehyde has been 
detected in expired air but only its metabolites have been detected in the urine (ACGIH 1991). 
Acetaldehyde has a widespread natural occurrence (e.g. tobacco leaves, coffee), is a product of 
alcohol fermentation and is used as a flavouring agent and food additives (e.g., added to milk 
products, fruit juices and soft drinks). 
Acetate is the metabolite of AA by the ALDH pathway and is then broken down to carbon dioxide 
and water.  It is the primary acid in vinegar and is used for food flavouring and preservation.  
Ethyl glucoside is a component of rice wine and sake (Imamura and Tamura 1971). The 
INTERMAP study reported recently detection of ethyl glucoside in the urines of participants who 
consumed Chinese rice wine or Japanese Sake (Teague et al. 2004). 
Ethyl glucuronide (EtG) is a highly effective and sensitive marker of recent alcohol use.  It is 
formed from a conjugation reaction of alcohol with glucuronic acid with uridine diphosphate 
glucuronyl transferase (UGT) (Wurst et al. 2003).  Ethyl glucuronide is detected in urine for a few 
days after minimal consumption (e.g. cooking wines, flavouring extracts, mouthwash and over-the-
counter cold medications) and is usually is measured by liquid chromatography-mass spectrometry 
(LC-MS) (Helander et al. 2009).   
Ethyl sulphate (EtS) is a minor alcohol metabolite formed from the sulfate conjugation of alcohol, 
a reaction catalyzed by sulfotransferase (Helander et al. 2009). Ethyl sulphate is detectable in 
urine around 30 hours after alcohol consumption; it has a short window of assessment and can be 
measured by LC-MS. 
Fatty acid ethyl esters (FAEE) are non-oxidative alcohol metabolites that accumulate in adipose 
tissue (Laposata and Lange 1986).  The concentration of FAEE found in hair has been used as an 
indicator of excessive alcohol consumption (Wurst et al. 2008).  Serum FAEE is a potential short-
term and a long-term marker of alcohol intake given the appearance in the blood rapidly after 
alcohol ingestion and continued presence when alcohol is no longer detectable (Laposata 1997).  It 
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has been reported that FAEEs can be detected up to 99 hours post-consumption in the blood of 
heavy drinkers (Borucki et al. 2007). 
Phosphatidylethanol (PEth) is a phospholipid formed only in the presence of ethanol by the 
enzyme phospholipase D.  It is detectable 1 to 2 week post-consumption, depending on the level of 
alcohol consumption (Stewart et al. 2009). 
2.4.2 Other biomarkers of alcohol intake 
Alanine aminotransferase (ALT), previously known as serum glutamic pyruvic transaminase, is a 
sensitive indicator of liver cell damage and is involved in amino acid metabolism.  It is used as 
biomarker of heavy alcohol consumption (Conigrave et al. 2003) 
Aspartate aminotransferase (AST), previously known as serum glutamic-oxaloacetic 
transaminase, is a liver enzyme measured in routine screening for liver damage.  As AST also 
occurs in heart, kidney, pancreas, lung tissues, it has limited specificity as a biomarker of heavy 
alcohol consumption (Conigrave et al. 2003).   
Carbohydrate deficient transferrin (CDT) is a biomarker of chronic moderate to heavy alcohol 
consumption that has been used in clinical practice (Arndt 2001). Carbohydrate deficient transferrin 
is a glycoprotein synthesised by the liver.  It is influenced by smoking, body weight and gender 
(Fleming et al. 2004).  Mass spectrometry and high performance liquid chromatography (HPLC) 
can be used for quantification of CDT (Jeppsson et al. 2007). 
Gamma glutamyl transferase (GGT) is the most widely used biochemical marker of excessive 
alcohol consumption and also a marker of hepatic damage. Gamma glutamyl transferase is an 
enzyme abundantly found in the cell membranes of multiple tissues, including liver, kidney, 
pancreas and prostate gland, and is a general marker of liver damage (Javors et al. 2010).  
Chronic heavy drinking elevates GGT levels in the blood, which has is detectable for 2 to 3 weeks 
post heavy drinking (Conigrave et al. 2003). 
2.4 Alcohol and coronary heart disease 
Coronary heart disease (CHD) is the most common type of heart disease.  Coronary heart disease 
is a narrowing of the small blood vessels that supply blood and oxygen to the heart, and is usually 
caused by atherosclerosis.  It is the leading cause of death in Europe, North and South America, 
Australia and New Zealand for both men and women (Mackay 2004). 
43 
 
Epidemiological data suggest that the relation between alcohol and CHD follows a J-shaped or U-
shaped curve (Corrao et al. 2000; Marmot and Brunner 1991; Rimm et al. 1996; Murray et al. 
2002).  In many studies, light to moderate drinkers have lower CHD risk than non-drinkers, with 
heavy drinkers displaying the highest level of risk.  Jackson and colleagues (1991) reported that 
light and moderate alcohol consumption was associated with reduced risk of CHD.  Jackson and 
colleagues (2005) later investigated the issues of bidirectional confounding in population studies 
and proposed „uncontrollable confounding‟ as an explanation for some “protective” association of 
low levels of alcohol consumption and coronary heart disease.  For heavy drinking different study 
biases have the potential to act in opposing directions, and as such, the true effects of heavy 
drinking on vascular risk are uncertain. 
A meta-analysis by Corrao and Rubbati (2000) of epidemiological literature from 1966 to 1998 
found that consumption of between one and three standard alcoholic drinks per day (a standard 
drink included about 10 g of alcohol) was associated with a 20–25% lower risk of CHD; greater 
consumption beyond this level saw attenuation of any beneficial effect.  However, this association 
has not been observed in all populations (Hart et al. 1999; Fuchs et al. 2004).  A few large 
prospective studies have shown there are differences in the effect of alcohol in different age 
groups; in some studies only those already at higher risk of CVD seem to benefit from a light to a 
moderate alcohol intake (Thun et al. 1997; White et al. 2002).  Andreasson and colleagues (1988) 
reported there was no U-shaped alcohol and CVD mortality relation among young Swedish men.  
This „protective‟ effect of alcohol consumption on CHD is observed mostly in older populations. 
In some studies, non-drinkers is defined to include both lifelong teetotallers and ex-drinkers 
(Klatsky et al. 1981; Marmot et al. 1981).  Wannamathee and Shaper (1997) suggested that these 
two categories of non-drinkers should be separated in analyses, as they had different 
characteristics and reasons for non-drinking were likely to be different.  Klatsky and colleagues 
(1990a) reported ex-drinkers at a higher cardiovascular and coronary artery disease mortality risks 
than lifelong teetotallers, possibly due to past alcohol use, smoking and underlying ill health.  The 
reasons for being a teetotaller may be determined by environmental, social, religious or health 
conditions, so it is necessary to study ex-drinkers and lifelong teetotallers separately.  
The relationship between average volume of alcohol consumption and CHD is modified by different 
patterns of drinking and alcohol beverage type.  It has been suggested that both the pattern of 
drinking and type of alcohol consumed (beer, wine or spirits) may have contributing effects on CHD 
risk that are separate from those of the total amount of alcohol consumed.   
Renaud and De Lorgeril (1992) observed a lower mortality rate of CHD in France in comparison 
with other Northern European countries, despite a similar intake of SFA.  It was explained by 
ingredients of the Mediterranean diet, with an abundance of fruits, vegetables and especially red 
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wine, with their relatively high concentrations of flavonioids.  There are some indications that wine 
is more “protective” than other forms of alcoholic beverages (Klatsky et al. 2003; Gronbaek 2004), 
but overall, beverage type does not seem to have much impact (Rimm et al. 1996; Fuchs et al. 
2004; Brenner et al. 2001; Rehm et al. 2003b).  A meta-analysis of 26 studies (published before 
September 2001) by Di Castelnuovo and colleagues (2002) reported that both wine and beer 
drinking were associated with a reduced risk of CHD.  In another meta-analysis of the effects of 
beer, wine and spirits on CHD risk, Rimm and colleagues (1996) concluded that most of the benefit 
associated with alcohol consumption was due to ethanol itself, rather than any other components 
of each type of drink.   
Socioeconomic and lifestyle differences (e.g., in dietary habits and other health behaviours, such 
as cigarette smoking and physical activity) among drinkers of different type of alcoholic beverage 
and non-drinkers play a role in the association between alcohol and CHD risk (Ruidavets et al. 
2004).  Ruidavets and colleagues (2004) reported that in a cross-sectional study of 1,110 French 
men ages 45-64 years, wine consumption was associated with a better lifestyle and after 
controlling for diet and social class, the beneficial effects of wine over beer were eliminated.  In the 
Copenhagen study, wine drinkers appeared to have a lower relative risk for CVD of 0.66 (95% CI 
0.55 to 0.77) compared with non-drinkers; however, wine drinkers also reported an intake of a 
healthier diet other strata (Gronbaek 2004).  Wine drinking was significantly associated with a 
higher parental education level and a higher socioeconomic status.  Therefore, wine drinking might 
just an indication of a healthier lifestyle which have been cardio-protective (Mortensen et al. 2001).  
In order to prove cause and effect of all types of alcohol, randomised and blinded trials are needed. 
Drinking alcohol separately from meals is related to increased CHD risk, independently of volume 
of drinking (Murray et al. 2002; Rehm et al. 2003b).  Several studies have found that for a given 
level of total alcohol consumption, people who drink in binges rather than regularly tend to have 
higher rates of CHD (Murray et al. 2002; McElduff and Dobson 1997; Rehm et al. 2001).  
Differences between populations may relate to drinking patterns, with binge drinkers at greater risk 
of coronary events (McElduff and Dobson 1997; Pletcher et al. 2005).  McElduff and Dobson 
(1997) found that binge drinkers had higher risks for coronary events than teetotallers even at low 
alcohol intake.  Data obtained from a study 1,154 men and women aged 18-64 years showed that  
binge drinking (consumption of eight or more drinks at one sitting) increased the risk of CHD in 
both and women (Murray et al. 2002).  The Health Professionals Follow-up Study of 38,077 men 
investigated alcohol consumption, drinking pattern (as number of days per week), type of alcohol 
consumed and risk of CHD (Mukamal et al. 2003).  This study suggested that alcohol consumption 
of 3 or more days per week was the primary determinant of the inverse association between 
alcohol intake and CHD.  However, in a Russia population sample of the MONICA study, episodic 
binge drinking was not significantly related to an increased risk of death from CHD after controlling 
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for smoking (Malyutina et al. 2002).  A prospective study of 25,052 men and 28,448 women in 
Denmark reported alcohol drinking pattern (days per week) was inversely associated with risk of 
CHD among men and independent of alcohol intake (Tolstrup et al. 2006).  Among women, 
amount of alcohol (drinks per week) and not drinking pattern was inversely associated with CHD.  
Moderate alcohol intake is known to have a beneficial effect on CVD including atherosclerosis, 
hypertension and CHD (Corrao et al. 2004; Camargo, Jr. et al. 1997; Di et al. 2002; Di et al. 2006; 
Mukamal et al. 2005).  Different dose-dependent effects and divergence between acute and 
chronic actions make the interaction of alcohol and CHD a complex one and it is unlikely that a 
single mechanism accounts for the association between alcohol intake and CHD.  The reduced risk 
of CHD associated with moderate alcohol consumption may be explained by its ability to 
alterations in plasma lipoproteins (increase plasma high-density lipoprotein [HDL] and decrease 
low density lipoprotein [LDL]), decrease platelet aggregation and improve insulin resistance 
(Veenstra et al. 1990b; Facchini et al. 1994; Rozenberg et al. 2003).   
Changes in lipoproteins, particularly increases in HDL, represent the most plausible mechanism of 
the apparent protective effect of alcohol consumption on CHD.  HDL cholesterol is produced in 
liver and intestines and then released into the blood stream.  It binds with cholesterol and brings it 
back to the liver for elimination or degradation, lowering total cholesterol levels in the body.  The 
increase in HDL levels with moderate alcohol consumption has been repeatedly described and is 
presumed to be one of the major mechanisms for the protective effect of moderate alcohol 
consumption on CHD (Marques-Vidal et al. 2001b; Gaziano et al. 1993; Ernst et al. 1980).  It is 
possible that other variables, highly correlated with HDL and protective for CHD also increases 
with alcohol intake (Criqui, 1995).   
High intakes of flavonoids have been associated with lower CVD risk in epidemiological studies 
(Huxley and Neil 2003; Lagiou et al. 2004).  Antioxidants (e.g. flavonioids, isoflavonioids, 
anthocyanins) in red wine were suggested to be the protective effect of regular alcohol 
consumption against atherosclerotic CVD (Fuhrman et al. 1995; Frankel et al. 1993).  Intervention 
trials on the effect of red wine or red wine polyphenols on established cardiovascular risk factors 
are few and the studies were mostly small and low-power.  A small study of 15 people with 
coronary artery disease showed short-term ingestion of purple grape juice improved flow-mediated 
vasodilation and reduces LDL susceptibility to oxidation (Stein et al. 1999).  Goldberg and 
colleagues (1996) reported no significant differences in HDL cholesterol concentration among red 
wine drinkers, white wine drinkers and grape juice.  Van der Gaag and colleagues (2000) 
investigated the effect on lipoprotein metabolism of moderate consumption of red wine or red 
grape juice with evening dinner for 3 weeks in premenopausal women; after wine consumption, the 
overall HDL cholesterol level was increased in postmenopausal women (12%) and the plasma LDL 
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cholesterol level was reduced in premenopausal women (12%) as compared with grape juice 
consumption.  The favourable effects of wines in modulating plasma lipid and lipoprotein 
concentrations were probably due to their alcohol content and cannot be reproduced by grape 
juices. 
Alcohol in large quantities can result in thrombocytopaenia and decreased platelet aggregation.  
Renaud and colleagues (1979; 1981; 1986) reported moderate alcohol consumption with reduced 
risk of CHD through the effect of alcohol on platelet aggregatibility.  In the Caerphilly Heart Study, 
Renaud and colleagues (1992) showed that the intake of alcohol (in a dose-dependent way), was 
inversely associated with platelets aggregation induced by collagen and adenosine diphosphate 
(ADP).  However, Veenstra and colleagues (1990a) reported no significant effects on platelet 
aggregability over 4 days moderate alcohol consumption of wine or red port.  One possible 
explanation may be moderate alcohol intake has no acute effect on platelet aggregation in habitual 
moderate drinkers; daily moderate alcohol consumption may cause a decreased platelet 
aggregability.  Rapid intake of alcohol increases platelet aggregation, which might contribute to the 
increased mortality associated with binge drinking.  A study of 20 volunteers drinking three glasses 
of alcohol or red wine in a 45-min period was set up to investigate the effect of rapid consumption 
of a large dose of alcohol on platelet aggregation and adhesion (de Lange et al. 2004).  The rapid 
wine consumption did not show increased platelet aggregation, which might support the reduction 
of cardiovascular disease in red wine drinkers.  
The relationship between alcohol consumption and CHD is complex.  On one hand there is 
sufficient evidence to conclude that alcohol consumption is positively related to adverse BP which 
is a significant risk factor for CHD.  On the other hand, there is growing epidemiological evidence 
that moderate drinking is associated with reduced risk of CHD among older adults, especially when 
consumed in small daily quantities.  Alcohol drinking patterns, beverage types, dietary habits, 
lifestyle and biomarkers should be considered in future epidemiologic studies in order to establish 
CHD risk and to test hypotheses about pathways. 
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3 METHODS 
The International Collaborative Study of Macronutrients, Micronutrients and Blood Pressure 
(INTERMAP) is an epidemiologic investigation on the role of multiple dietary factors in the 
aetiology of unfavourable BP levels prevailing for middle-aged and older individuals (Stamler et al. 
2003c; Beevers and Stamler 2003).  Data include four 24-hr dietary recalls; two 7-day alcohol 
records; two 24-hr urine collections; eight BP readings; and questionnaire data for 4,680 men and 
women ages 40-59 years from 17 population samples in Japan, People‟s Republic of China (PRC), 
United Kingdom (UK) and United States of America (USA) (Stamler et al. 2003c).  This report 
focuses on the alcohol-BP relationship and the aspects of drinking patterns and type of alcoholic 
beverage with BP in the INTERMAP Study; the relationship between alcohol intake and other 
nutrients; the role of nutrients in the alcohol-BP relationship.  Urinary amino acid excretion and 
urinary metabolite data from nuclear magnetic resonance (NMR) spectroscopy of the stored 
INTERMAP 24-hr urinary specimens are also analysed in relation to alcohol intake and BP levels. 
3.1 INTERMAP Study method 
3.1.1  INTERMAP Study design 
The INTERMAP Study is a basic international cross-sectional epidemiological study of 4,680 
participants (2,359 men and 2,321 women) ages 40-59 years from 17 diverse population samples: 
four in Japan (n=1,145), three in the PRC (n=839), two in the UK (n=501) and eight in the USA 
(n=2,195), investigating the role of multiple dietary factors in the aetiology of unfavourable BP 
levels (Table 3.1).  Fieldwork was carried out between August 1996 and April 1999.  Ethical 
approval was obtained locally for each participating site and all participants gave informed consent 
prior to data collection.  Methods for staff training and certification, participant recruitment, data 
collection, urine collection, transmission and quality control are documented in the INTERMAP 
Manuals of Operations (Stamler et al. 2003c). 
There were three International Coordinating Centres, two for the study overall, in Chicago, USA, 
and London, UK, and the third, for nutrition, in Chapel Hill, North Carolina, USA.  Chicago and 
London International Coordinating Centres were jointly responsible for development of the Protocol 
and Manuals of Operations to facilitate staff training and certification, data collection, 
computerisation, editing and analysis of data.  Chapel Hill Coordinating Centre was responsible for 
the Nutrition Protocol and Nutrition Manual of Operations in collaboration with the International 
Coordinating Centres in Chicago and London and Nutrition Coordinating Centre (NCC), University 
of Minnesota, Minneapolis, USA. The International Central Laboratory (Leuven, Belgium) and the 
Metabonomics Laboratory (London, UK) were responsible for urinary specimen analyses.  Study 
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leadership nationally was accomplished by country centres in Shiga (Japan), Beijing (PRC), 
London (UK) and Chicago (USA) (See Figure 3.1).  Stamler and colleagues (2003c) have provided 
lists of members of the Steering and Editorial Committee, Advisory Committees, local, national and 
international centres in detail for the INTERMAP Study. 
Table 3.1 Sample characteristics for the INTERMAP Study 
 
Country Sample Population 
n 
Men Women Total 
Japan 
10: Toyama 
Employees of the Kurobe and 
Namerikawa factories of the YKK 
Corporation 
149 150 299 
12: Sapporo 
Employees of an iron manufacturing 
company and the adjacent hospital 
149 148 297 
14: Aito Town 
Rural population mostly employed in 
manufacturing 
130 129 259 
15: Wakayama 
Employees of the Sumitomo Metal 
Industry Life Insurance company and 
their spouses 
146 144 290 
 574 571 1145 
People‟s 
Republic  
of China 
20: Beijing 
 
Northern rural population from 4 
villages involved in agriculture, 
Pinggu County   
133 139 272 
21: Guangxi 
 
Southern rural population from 12 
villages involved in agriculture,  
Wuming County 
140 138 278 
22: Shanxi 
 
Northern rural population from 10 
villages involved in agriculture or local 
business, Yu County 
143 145 289 
 416 422 838 
United 
Kingdom 
30: Belfast 
Civil service employees and General 
Practice registered population 
125 97 222 
31: West 
Bromwich 
General Practice registered 
population and fire brigade 
employees 
141 138 279 
 266 235 501 
United 
States of 
America 
40: Baltimore 
Residents of the city of Woodlawn, 
Maryland 
146 134 280 
41: Chicago 
Employees of the Allstate Insurance 
Company, Deerfield, Illinois 
156 159 315 
42: Honolulu 
Japanese American offspring of 
Honolulu Heart Program participants 
136 131 267 
43: Jackson 
Employees of the University of 
Mississippi Medical Centre 
132 134 266 
44: Minneapolis 
Participants of the Minnesota Heart 
Survey, sampled from the population 
of the Twin Cities 
130 130 260 
45: Pittsburgh 
Residents of Allegheny County, 
Pennsylvania 
132 128 260 
46 Corpus 
Christi 
Hispanic residents of Nueces County, 
Texas 
135 140 275 
47 Corpus 
Christi 
Non-Hispanic residents of Nueces 
County, Texas 
136 136 272 
 1,103 1,092 2,195 
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Figure 3.1 Organisation and leadership for the INTERMAP Study 
 
 
3.1.2 Selection of participants 
(a) Study power  
The goal in analyses of nutrient/metabolite-BP associations in INTERMAP is to estimate the 
associations of average intake of nutrients/excretion of metabolites by individuals with their 
average BP levels.  Information on nutrients from multiple 24-hr recalls and urinary metabolite 
excretion is subject to substantial within-person variability due to day-to-day variability in intake by 
most individuals, i.e., random measurement error (Grandits et al. 1997; Liu 1988).  Such data are 
also subject to person-specific bias, i.e. systematic error.  Multiple 24-hr recalls were used in the 
INTERMAP Study to reduce the impact of random variation on observed associations.  To estimate 
the person-specific bias in associations of nutrients with BP, 24-hr urinary nitrogen (total N or urea 
N) excretion for protein intake, 24-hr urinary Na for dietary Na intake and 24-hr urinary K excretion 
for dietary K intake were measured in INTERMAP. 
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The target sample size of 4,420 individuals was selected such that an attenuated correlation 
between a nutrient and BP of 0.06 could be detected with >90% power for all primary hypotheses 
(alpha=0.01). The study was designed to detect partial correlations of 0.06 or greater for 
nutrient/metabolite-BP associations, with >90% power for all primary hypotheses (alpha=0.01) and 
with 80% power in subgroup (alpha=0.05) and exploratory analyses (alpha=0.001).  An observed 
partial correlation of 0.06 is estimated to correspond to a true correlation of 0.10 or greater, 
attenuated by the effect of regression dilution bias (MacMahon et al. 1990b).  Power estimates 
were obtained from tables in Kraemer and Thiemann (Kraemer and Thiemann 1987) and 
computed using Fisher‟s Z transformation for the Pearson product-moment correlation coefficient 
(Snedecor and Cochran 1989).  
 (b) Sampling and recruitment 
Once the target population was identified, stratified random samples were selected for recruitment. 
Based on the power calculations described above (Chapter 3.1.2(a)), the recruitment programme 
for each centre aimed to randomly select 260 participants (65 from each of four age-sex 
subgroups: men 40-49, 50-59 years; women 40-49, 50-59 years) from the target general 
population, which was either a local community or workplace.  If recruitment targets were not met 
by the original sample, a further random sample of the base population was taken.  The samples 
are listed in Table 3.1.  Mean participation rate was 49% overall: 45% in Japan, 83% in PRC, 22% 
in the UK and 44% in the US (Elliott et al. 2006).   
(c)  Exclusions 
After recruitment, 215 participants were excluded according to the following criteria: failed to 
complete all four clinic visits (n=110); had less than 500ml of urine volume in either collection or 
incomplete urine collections (n=37); had dietary recalls considered unreliable by observers (n=7); 
reported energy intake lower than 500 kcal/day or higher than 5,000 kcal/day for women or higher 
than 8,500 kcal/day for men in one or more dietary recalls (n=37); SBP>200 and/or DBP>120 at 
first visit  (immediately referred for antihypertensive treatment) (n=6); having incomplete data or 
violated study protocol (n=18) (Elliott et al. 2006).  
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3.1.3 Data collection  
(a) Staff training and certification for fieldwork 
Standardised training was provided for all INTERMAP staff to minimise observer error, bias, inter-
observer and inter-centre variation.  For BP measurement, in-depth training including practical 
experience and certification was compulsory for all observers.  All dietary interviewers attended a 
4-day training workshop (a combination of lectures, demonstrations and practice) developed by the 
Chapel Hill International Nutrition Coordinating Centre.  Each observer was required to code four 
24-hr dietary recalls with <6% line errors before collecting and coding five tape-recorded 24-hr 
recalls and five additional self-collected recalls to gain certification in dietary collection and 
processing procedures (Conway et al. 2004; Dennis et al. 2003).  Each centre had to complete a 
„dry run‟, including recruitment (volunteers); completion of the medical questionnaire and dietary 
recalls; data input; nutrient coding; data transmission; the packing and shipping of 24-hr urine 
collections; and all associated quality check (QC) procedures, following the protocol with 10 
volunteers before it was certified to collect study data.  
(b) Clinic visits 
Four appointments were completed by each participant.  The first two visits were completed on 
consecutive days before a gap of 2 to 6 weeks (average: 3 weeks), followed by the second two 
consecutive visits.  One visit was scheduled after a day off work to account for possible varying 
dietary habits on work and non-work days of participants.  At the first appointment, a detailed 
questionnaire was used to collect information on possible confounders of dietary-BP relations, 
including family history of HTN, cigarette use, alcohol consumption, current medication use, 
educational attainment and amount of habitual exercise, together with height and weight 
measurements.  At each of the four visits, two blood pressure measurements were made using a 
random-zero (RZ) sphygmomanometer.  Pairs of appointments were arranged for the same time 
each day to keep measurements broadly comparable and to facilitate the collection of a timed 24-
hr urine sample (Stamler et al. 2003c).  Questionnaire data on vitamin and other dietary 
supplement intake were collected at all four visits, and data on current medication use and on 
alcohol consumption over the previous 7 days were recorded at the first and third visits. 
(c) Blood pressure measurement 
Eight blood pressure measurements were taken for each participant, twice at each clinic visit, 
using Hawksley RZ Sphygmomanometer (with RZ of 0-20 mm Hg) by trained and certified 
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observers following a standard protocol (Stamler et al. 2003c).  Participants were asked to refrain 
from eating, drinking, smoking and exercise for 30 minutes prior to their clinic visit.  The timed 24-
hr urine collection was started at the clinic, prior to the BP measurement (to avoid the effect of 
bladder distension on BP) (Fagius and Karhuvaara 1989).  The participant was seated with 
measurement arm resting on a flat surface at heart level; BP measurements were taken from the 
right arm whenever possible.  The participant rested with the cuff fitted for five minutes before 
inflation, an interval of at least 30 seconds between measurements was required (O'Brien et al. 
1997, p.11).   Readings were calibrated and calculated at the clinic after both measurements were 
completed; any difficulty in measuring BP was recorded. 
(d) 24-hr dietary recall method 
The in-depth 24-hr dietary recall method was selected to obtain dietary data, for four days of intake 
of all foods, beverages and dietary supplements of all 4680 participants, to minimise the burden on 
participants and reduce effect of inter-individual measurement variability (Bingham 1991).  The four 
24-hr dietary recalls, one per clinic visit, were recorded by trained and certified interviewers 
following the protocol (Dennis et al. 2003), with use of neutral probing techniques and memory aids 
(e.g., food models and photographs).  All interviews were taped with participant‟s consent.  A 
standard 24-hr dietary recall „multiple pass‟ procedure was implemented in all centres.  In this 
procedure, the participant freely reported foods and beverages consumed over the previous day 
(midnight to midnight), including eating times and places of consumption, without particular 
attention to quantities and other details.  Once the list of foods consumed was obtained and 
reviewed, open questioning techniques were used to acquire details like brands of foods and 
drinks, quantities, portion sizes, processing methods and additions (e.g., table salt, soy sauce).  
The interviewer then recounted the recall form, line-by-line, to the participant.  This provided an 
opportunity to recheck for areas left unclear or unspecified or omitted and correct any inaccurate 
details on the recall form.  In the US, the online Nutrient Data System (NDS) Version 2.91, an 
automated database system, was used to code dietary data and calculate nutrient intakes, 
enabling direct ongoing computer entry of 24-hr recall data by the interviewers (Buzzard et al. 
1995).  At each visit, participants were asked if their reported intake was different from their usual 
intake on a similar day.  On the first and third visits, they were asked if they were following a 
special diet, for example, a weight loss, diabetic or reduced salt diet.  All 24-hr recall forms were 
reviewed by the Site Nutritionist (SN) following the interviews, to identify incomplete documentation 
that could be followed up at later clinic visits or over the phone.  The SN also evaluated a random 
10% of the taped interviews collected by each interviewer.  In addition, a randomly selected 
sample of these tapes was evaluated by the Country Nutritionist (CN) to check and enhance 
comparability across interviewers and centres (Dennis et al. 2003). 
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(e) Nutrient database  
In Japan, the PRC and the UK, intake information recorded on dietary recall forms was manually 
coded and then entered into a computer system with use of country specific INTERMAP 
codebooks (Conway et al. 2004; Schakel et al. 2003; Conway et al. 2004; Dennis et al. 2003).  
One in ten recalls was re-coded by the SN.  If coding differences exceeded 6% of entered items, 
then all 10 recalls were re-coded.  Once the first QC stage was completed, a batch of 30 recalls 
was passed to the SN for a final check.  A 10% random sample was reviewed by the CN, batches 
with >6% line errors were returned to the SN for correction.  In the US, 601 (6.9%) of 24-hr recalls 
were re-entered by SN; 473 (5.4%) of 24-hr recalls were re-entered by CN; these multiple checks 
were performed to achieve high quality nutrient data with the use of the NDS (version 2.91) 
automated online method.  Once coding was completed, nutrient intakes (83 nutrients) were 
calculated from the country-specific nutrient database (updated and standardised from an existing 
national nutrient databases).  Extensive modifications of the Japan, PRC and UK nutrient 
databases were done by the NCC, in co-operation with the CN of each country, to make the final 
dietary intake data as comparable as possible across the four countries (Dennis et al. 2003).  
Nutrient composition of new foods (those not included in the country‟s coding manual) and 
preparation methods reported in the dietary recalls were added by NCC together with new nutrient 
fields and values.  Where the methods used to derive nutrient values differed across countries, the 
most comparable methodologies were selected and adjustment factors applied appropriately 
(Schakel et al. 2003).   
Each participant collected two timed 24-hr urine specimens according to the protocol (see Chapter 
3.1.3(g)).  Timed 24-hr urinary excretion of Na, K and urea were used for quality assessment of 
INTERMAP dietary data (Bingham and Cummings 1985; Day et al. 2001).  Pearson partial 
correlations (adjusted for centre and gender) between dietary and urinary measurements for all 
participants were 0.51 for dietary total protein and urinary urea; 0.50 for dietary protein and 
estimated protein intake (EPI); 0.42 for Na; 0.55 for K; 0.42 for Na/K ratio (Dennis et al. 2003).  EPI 
is calculated as [(urea N + 0.031 (body weight in kg)] x 6.25.  The fact that correlation coefficients 
were less than 1.00 is possible attributable in part to dyssynchrony in time between ingestion, 
absorption and excretion.   
Interviews assessing dietary supplement use (vitamins, minerals, herbs, amino acids, et al.) were 
completed after the 24-hr dietary recall.  Name, description, amount and frequency of use were 
recorded, and the interviewer reviewed each reported supplement with the participant.  Where data 
on nutrient composition of supplements were available, information on consumed dietary 
supplements was entered into the INTERMAP databases (automatically via the NDS in the USA 
and manually in Japan, PRC and UK using the country-specific codebooks).  For supplements not 
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present in the nutrient databases, a separate supplement ingredient form was completed.  While it 
was not possible to determine the nutrient content of all the supplements consumed, micronutrient 
estimates for vitamin and mineral supplements were comprehensively estimated (Archer et al. 
2005). 
(f) Foods database 
24-hr dietary intakes were recorded manually and entered into the database system in Japan, PRC 
and UK based on country-specific codebooks; amounts of foods consumed (grams) were 
estimated using the name and description from the dietary recalls.  The amount (gram in weight) of 
foods consumed in the USA was based on NCC classification system; 24-hr dietary intakes were 
classified automatically into 116 food subgroups by the NDS system.  The food subgroups were 
then aggregated into 58 groups by INTERMAP colleagues.  Table 3.2 shows the list of 13 food 
groups being used in this report. 
Table 3.2 Estimated food groups, from the INTERMAP Study  
 
 
(g) 7-day alcohol records 
At the first and third visits, daily alcohol consumption (amount and type of alcoholic beverage per 
day) was obtained for the preceding 7 days; these data were in addition to those on alcohol intake 
from the four 24-hr dietary recalls, as alcohol intakes vary greatly from day to day (Knupfer 1987).  
Information on previous drinking habits was recorded; for ex-drinkers, their reasons for stopping 
alcohol consumption were also noted at the first clinic visit.  Mean 7-day alcohol intake from two 
records (14 days total) was used in most analyses for this study as it is known to estimate habitual 
intake reliably, at least for regular moderate drinkers (Dawson 1998).   
Food group Descriptions 
  
Total vegetables (g/1000kcal) Raw vegetables, cooked vegetables (fresh, frozen or canned) 
Total fruits (g/1000kcal) Fresh fruits, sweetened fruits, dried fruits, fruit juices and drinks 
Total grains (g/1000kcal) Breads, rolls, biscuits, pasta, rice, cereals, grains and flour 
Nuts and legumes (g/1000kcal) Nuts, mature dried beans and peas 
Seafood (g/1000kcal) Fish, fish roe, shellfish 
Meat (g/1000kcal) Beer, lamb, pork, veal, game 
Poultry (g/1000kcal) Poultry 
Vegetarian meat substitutes (g/1000kcal) Vegetarian meat substitutes 
Processed meat (g/1000kcal) Cold cuts and sausages 
Dairy (g/1000kcal) Milk, cream, cheese, ice-cream, yogurt 
Oil (g/1000kcal) Vegetable oils (e.g. sunflower oil, olive oil) 
Animal fat (g/1000kcal) Butter and other animal fats (e.g. duck fat, bacon fat) 
Non-alcoholic beverages (g/1000kcal) Nov-alcoholic beverages (e.g. soft drinks, squash) 
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(h) Anthropometric and questionnaire data 
Height and weight without shoes were measured at the first and third visits, two readings on each 
occasion.  Questionnaire data were obtained by interview on demographic and other possible 
confounding factors, including personal medical history, family history of HTN, personal education, 
occupation, hours of moderate to heavy physical activity per day, current and past smoking, 
current special diet, medication use, and for women data on menopause, parity, use of 
contraceptive or hormone replacement medication. The time of each appointment and time since 
participant‟s last meal were also recorded at all four visits (Stamler et al. 2003c). 
 (i) 24-hour urine collections 
Two timed 24-hr urine collections were completed across each of the two pairs of visits, according 
to collection guidelines. The collections provided data on biomarkers of Na, K and protein intake, 
also Ca, Mg, urea, creatinine, amino acids, albumin excretion and multiple metabolites (Dyer et al. 
2004b; Holmes et al. 2007; Kaspar et al. 2009; Dennis et al. 2003; Stamler et al. 2003c).   
The timed collections began at the clinic on the first and third visits; participants returned their 
specimen jars on the second and fourth visits. If more than a few drops of urine were reported as 
missing, if 24-hr urine volume was less than 250 ml, or if the duration of collection fell outside 22 to 
26 hours, then the urine sample was invalid and another collection was scheduled.  From each 
urine collection, four 9 ml aliquots were shipped to and stored frozen at the Central Laboratory in 
Leuven, Belgium for analysis, and one aliquot was retained locally as a backup.  Methods for urine 
collection, transmission and quality control were detailed in the protocol (Stamler et al. 2003c). 
Urinary Na and K concentrations were measured by emission flame photometry.  Creatinine was 
measured by the modified Jaffé method (Bartels and Bohmer 1971).  Urinary albumin was 
quantitatively determined by means of immunoturbidimetric assay using automated clinical 
chemistry analyzers (Roche/Hitachi 717; Roche Diagnostics, Indianapolis, IN, USA). The lowest 
detectable level of albumin was 1 mg/L (Daviglus et al. 2005).  Urinary Ca and Mg were analysed 
by atomic absorption flame photometry; urea N, by means of autoanalyzer, with use of an 
adaptation of the Fearon condensation method.  Individual excretion values were calculated as the 
product of concentrations in urine and urinary volumes corrected to 24 hours. The average of the 2 
excretion values was used. 
As part of QC procedures, 781 urine samples (an approximately 8% random sample) were split at 
the clinical centres and sent to the Central Laboratory with different identification numbers for 
external assessment of measurement precision.  Coefficient of variation (CV) and technical error 
(TE) of biochemical measurements for the 781 QC pairs were used to evaluate quality of the 
56 
 
laboratory analyses.  CV is the ratio of the standard deviation (SD) to the mean.  TE is defined as 
(∑d2/2N)1/2 where d is the within-pair difference and N is the number of split sample pairs.  Among 
these 781 QC pairs, 13 were reported to have high within-pair CV for several biochemical 
analyses, i.e., Na, K, creatinine, urea, Ca and Mg.  Average percent TE were 2.37% for Na; 2.30% 
for K; 2.98% for creatinine; 3.73% for urea; 4.54% for Ca; 4.22% for Mg and 29.59% for albumin 
(Dyer et al. 2004a). 
3.1.4 Urinary amino acid analysis 
Ion-exchange chromatography with ninhydrin post-column derivatisation by Biochrom 20 plus 
amino acid analyser (Biochrom Ltd., Cambridge, UK) was performed to quantify urinary amino 
acids for all participants at the INTERMAP central laboratory in Leuven.  Sample preparation and 
analysis were performed following manufacturer standard protocols and study standard operation 
procedure.  Urinary amino acid variables (Table 3.3) were calculated as products of urinary 
concentration and timed volumes standardised to 24-hour.  Urinary amino acid excretion was 
expressed as micromoles per 24-hour.  Only 22 urinary amino acids were analysed on all urine 
specimens of the first urine collection in the INTERMAP Study due to high technical errors of 
measurement for some urinary amino acids. 
Amino acids were separated by a cation exchanger; differential elution was obtained by varying the 
pH, the ionic strength of the eluting buffers (Li-citrate) and the temperature of the high pressure 
analytical column.  Different amino acids were identified by their retention time, specific for each 
amino acid.  Quantification was achieved by post-column derivatisation with ninhydrin and 
detection of the coloured complexes at 570 nm (purple colour for amino acids except imino acids) 
and 440 nm (yellow colour for imino acids such as hydroxyproline and proline).  The absorbance 
was recorded in EZChrom Elite program, a software package that integrated the peaks and 
calculated concentration automatically.  Midas auto-sampler, EZChrom Elite, Biochrom analysis 
program, PC and printer were components of the Biochrom 20+ amino acid analyser system.  The 
lab technicians also carried out visual checks of the spectra. 
(a)  Urine sample preparation 
Urine samples were usually prepared on Monday or Thursday morning and put in a water-bath at 
37°C for a maximum of 15 min to thaw, then cooled down to 0°C with ice and water.  Some urine 
samples were diluted with phosphate and sodium chloride (NaCl), so that the creatinine content did 
not exceed 30 mg/dL, to obtain adequate sensitivity.  All urine samples were centrifuged at 1500 g 
for 10 min before dilution with phosphate buffer if needed.  Urine samples were then deproteinised 
with sulphasalicylic acid containing internal standard (IS) for at least 30 min at 4°C to obtain a 
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complete protein precipitation.  Urine samples were centrifuged for 5 mins below 10°C, filtered and 
loaded with Li-citrate buffer before being centrifuged again for 5 mins below 10°C.  Vials were then 
placed on the autosampler of the amino acid analyser. 
(b) Internal standards  
An internal standard (IS) of L-2,4-diaminobutyric acid dihydrochloride (Catalogue [Cat.] No D8376) 
from Sigma-Aldrich (Taufkirchen, Germany) was used to monitor physical and chemical losses and 
variations during amino acid analysis.  Aliquots of IS were stored at -80°C for a maximum of 6 
months.  IS was added to all standards and urine samples to ensure accuracy of sample injection 
into the Biochrom 20+ system. 
(c) Standard mixture of amino acids 
Amino acids standard (Cat. No A6407, Appendix A and Cat. No A6282, Appendix B) from 
Sigma-Aldrich (Taufkirchen, Germany) was used to create mixtures of known concentrations of the 
different amino acids following manufacturer guidelines.  The aliquots were stored at -80°C for a 
maximum of 6 months.  The standard mixture was analysed at least once with every preparation of 
ninhydrin.  The standard was treated exactly as a sample but the results were logged in a separate 
file.   
(d) Quality control 
As part of the study standard QC procedures, 781 urine samples (an approximately 8% random 
sample) were split and given different identification numbers for assessment of measurement 
precision (Chapter 3.1.3[g]).  Additional quality controls were performed by adding an identical 
(pooled) urine sample as a control.  Fresh urine of 850 ml with a creatinine content of 30-50 mg/dL 
was collected.  About 400 ml urine was mixed with the amino acids mixture and adjusted to 800 ml 
with the pooled urine.  From this pooled urine sample, 1000 aliquots of approx. 400μL were 
pipetted into Eppendorf tubes as high control.    100 ml urine was taken from the urine pool and 
diluted with 300 ml of 0.9% NaCl to make 1000 aliquots of Eppendorf tubes as low control.  A low 
or high control sample (alternatively) was run for every 10 urine samples. 
(e) Calibration 
The standard mixture of amino acids was analysed at least once with every preparation of 
ninhydrin.  Each time, a standard was run with a blank sample (phosphate buffer with NaCl).  
These results were used for calibration. 
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(f) Data processing 
EZChrom Elite, computing software of the Biochrom 20+ system, automatically identified each 
amino acid based on the retention time of amino acids.  The quantification was done automatically 
in EZChrom Elite during the integration on the basis of calibration factors.  Results of each urine 
sample were then exported as two files (one for 570 nm and one for 440 nm) with data on the peak 
areas, retention times and concentrations (μmol/L and mmol/mol creatinine) and the 
chromatogram. 
Table 3.3 Names and abbreviations of amino acids analysed by Biochrom 20 plus amino acid 
analyser 
 
Amino Acid Abbreviation Initial Analysis Final Analysis
alfa-Aminoadipic acid Aad √
alfa-Aminobutyric acid Abu √
Alanine               Ala √ √
Anserine              Ans √
Arginine     Arg √ √
Argininosuccinic acid Asa √
Asparagine            Asn √ √
Aspartic acid Asp √
beta-Amino isobutyric acid bAib √
beta-Alanine          bAla √
Carnosine             Car √ √
Citrulline            Cit √
Cystathionine         Cth √
Cystine               Cys √ √
delta-Hydroxylysine dHyl √
Ethanolamine          EtN √ √
gamma-Amino butyric acid GABA √
Glutamine             Gln √ √
Glutamic acid Glu √
Glycine               Gly √ √
Homocystine Hcys √
Histidine His √ √
Hydroxyproline        Hyp √
Isoleucine            Ile √ √
Leucine               Leu √ √
Lysine                Lys √ √
1-Methylhistidine     M1His √ √
3-Methylhistidine     M3His √ √
Methionine            Met √ √
Ornithine             Orn √
Phosphoethanolamine   PEtN √
Phenylalanine          Phe √ √
Pipecolic acid Pip √
Proline               Pro √
Phosphoserine           Pser √
Sarcosine             Sar √
Serine                Ser √ √
Taurine               Tau √ √
Threonine             Thr √ √
Tryptophan Trp √ √
Tyrosine              Tyr √ √
Valine                Val √ √
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3.1.5  Proton nuclear magnetic resonance spectroscopic analysis 
INTERMAP urine samples were analysed by proton nuclear magnetic resonance (1H-NMR) 
spectroscopy at 600 MHz using a Bruker DRX-600 spectrometer (Bruker Biospin, Rheinstetten, 
Germany) in flow-injection mode at the London Metabonomics Laboratory.  Urine samples were 
automatically delivered to the spectrometer by a Gilson robot incorporated into the Bruker Efficient 
Sample Transfer (BEST) system.  One-dimensional (1D) 1H-NMR spectra were acquired using a 
standard 1D pulse with water pre-saturation during both the recycle delay and the mixing time, tm, 
of 150 ms.  The 90 pulse length was set to ~10s and an acquisition time of 2.73 s was used.  In 
total, 64 transients (free induction decays, [FIDs]) were collected into 32K data points using a 
spectral width of 20 ppm (Holmes et al. 2007; Holmes et al. 2008).  
(a) Urine sample preparation 
Urine samples were thawed completely prior to mixing at room temperature and centrifuged at 
3,000 rpm for 5 minutes using a Centra CL 3 centrifuge to remove any debris.  An aliquot of 500 L 
of urine was mixed with 250 L of phosphate buffer (made from sodium phosphate solution, 
Na2HPO4 and sodium dihydrogen phosphate solution, NaH2PO4) for urinary pH stabilization (pH 
7.4±0.5) and 75 L of trimethylsilyl-2,2,3,3-tetradeuteropropionic acid (TSP) in heavy water 
(deuterium oxide, [D2O]).  TSP served as a chemical shift reference and D2O served as a field-
frequency lock for the NMR spectrometer. The resulting solution was then transferred into a 96-
well plate and left to stand for 10 min. before centrifuging at 1,500 g for a further 10 min. to remove 
any precipitate prior to NMR analysis (Holmes et al. 2007; Dumas et al. 2006). 
(b) Quality control 
About 780 urine samples were split in local centres and given different identification numbers for 
assessment of measurement precision (Chapter 3.1.3[g]).  Additional QC was performed by 
adding 24-hr urine samples of three individuals for NMR analysis.  Six quality control specimens (3 
individuals x 2 aliquots) were interspersed among INTERMAP specimens on every well plate in 
random order. Altogether, 24 well plates were measured over 7 months, with 144 quality control 
specimens for the study (Dumas et al. 2006). 
(c) Boric acid preservative of urine samples  
Boric acid (borate) was used as a preservative in all INTERMAP 24-hr urine ollections.  Borate is 
known to form covalent adducts and is reactive toward diols and compounds with adjacent 
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hydroxyl and carboxylate groups (e.g. carbohydrates, hydroxylated fatty acids).  Effects of borate 
preservation on 1H-NMR spectra of urine were assessed; minor spectral changes due to 
interactions between borate and citrate, mannitol and methylmalonate were reported (Smith et al. 
2009).  It was shown that changes in the urinary spectra caused by borate addition were negligible 
in comparison with inter-individual biological variation.   
(d) Data processing 
XWIN-NMR software (Version 3.5, Bruker) was used to acquire and process data (phase, correct 
baseline and calibrate the NMR spectra).  All free induction decays were multiplied by an 
exponential function equivalent to a 0.3 Hz line-broadening factor prior to Fourier transformation.  
The spectra were referenced and corrected for phase and baseline distortion.  The spectral region 
 4.5 - 6.4 containing residual water and urea resonances were removed prior to normalisation by 
the probabilistic quotient method.  The remaining spectrum ( 0.5 - 9.5, excluding  4.5 - 6.4) was 
digitized to 7,100 variables (bin width 0.005 ppm) using in-house MATLAB routines (MATLAB 
version 7.3.1, MathWorks, Natick, MA). 
3.2 Statistical methods 
All statistical analyses were performed using SAS 9.1 for Windows (Statistical Analysis System, 
SAS Institute Inc., Cary, North Carolina, USA).   
3.2.1  Descriptive statistics  
Measurements for each individual were averaged across the four visits.  Dietary data were 
reported as absolute daily intakes (amount per day); for nutrients supplying energy, they were also 
expressed as percentage of total calorie intake (%kcal); for others, as nutrient density, i.e., 
amount/1000kcal.  For foods/food subgroups, intake was calculated as grams/1,000 kcal.  7-day 
alcohol intakes from the two 7-day alcohol daily records were expressed as amount in grams per 
day. Urinary amino acid excretion was expressed as micromoles per 24-hour.  Timed 24-hr urinary 
Na and K excretion were used in all analyses, as reliable biochemical markers of dietary Na and K 
intakes (Day et al. 2001).  Current alcohol drinking status (i.e., teetotaller, ex-drinker, moderate 
drinker and heavy drinker) of each individual was classified based on prevailing guidelines and with 
reference to any past alcohol consumption.  Heavy drinkers were classified as consuming more 
than 2 drinks (>26 g alcohol) per day for men and more than 1 drink (>13 g alcohol) per day for 
women (US Department of Agriculture and US Department of Heath and Human Services 2005).  
Moderate drinkers were those normally drank alcohol and with no more than 2 drinks (0-26 g 
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alcohol) a day for men and no more than 1 drink (0-13 g alcohol) per day for women.  Ex-drinkers 
were individuals who used to drink alcohol and stopped alcoholic beverage consumption prior to 
the data collection and teetotallers were participants who were life-long abstainers of alcoholic 
beverages. 
Summary descriptive statistics for all continuous and categorical variables were calculated by 
alcohol drinking status of participants, type of alcoholic beverage consumed (i.e., wine, beer, 
spirits, combination) and alcohol drinking pattern (number of drinking days in the two 7-day alcohol 
records).  Means and SD or frequencies and percentages were given for each group.  For nutrient 
intakes, urinary amino acids and other continuous variables, least square means (also known as 
adjusted means) and standard errors (SE) were used. Analyses were adjusted for possible 
confounders, i.e., country or sample; age; gender; years of education; marital status; employment; 
cigarette smoking; dietary supplement use; special diet; history of heart attack, other heart disease, 
stroke, or diabetes mellitus (CVD-DM diagnosis); family history of HTN; hours of moderate to 
heavy physical activity per day; BMI; urinary Na and K excretion.  Histograms were used to 
summarise mean alcohol intake and number of alcohol drinking days of current drinkers from the 
two 7-day alcohol records. 
3.2.2  Partial correlations 
Partial Pearson correlation coefficients (adjusted for sample, age and sex, and pooled across 
countries and weighted by sample size) were used to investigate the association between four 24-
hr dietary alcohol intake recalls and two 7-day alcohol intake records in this report.  Partial 
correlations were also used to explore the inter-correlations among dietary variables. 
3.2.3  Multiple regression and analysis of variance  
Multiple regression analyses of SBP and DBP regressed on alcohol intake (amount of alcohol, or 
daily drinking pattern [number of drinking days of 14 days] or type of alcoholic beverage 
consumed) were carried out with adjustment for potential confounders by using linear regression 
and generalised linear models (GLM).  Two sets of analyses were performed.  In the first set, 
lifetime teetotallers were the reference category.  In the second set, only those participants who 
were current drinkers were included and the reference category varied according to the specific 
analysis.  The second analysis enabled adjustment for total amount of alcohol consumed. 
Analysis of variance (ANOVA) was used to compare mean nutrient intakes and other variables 
across drinking status categories of participants (i.e., teetotallers, ex-drinkers, moderate drinkers 
and heavy drinkers).   The F-test in the ANOVA tested the significance of inter-group differences (F 
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value > 3.24 significant p<0.05).  Cross-adjusted sums of squares (SS) (called Type III SS in SAS) 
was used to measure the effect of one variable adjusted for the confounders in the regression 
model.   
The estimate size of an observed regression coefficient as a percentage of the theoretical 
coefficient in a univariate regression analysis of BP on alcohol intake (mean of two 7-day alcohol 
intake) was calculated by using the formula 1/[1+(ratio/2)] x 100, where ratio is the variance within 
a participant divided by the variance between participants, calculated separately for sex and 
country strata and pooled by weighting of each stratum specific estimate by n-1 (Grandits et al. 
1997). 
3.2.4 Stepwise regression model  
Stepwise regression models were used to assess the relationships between a group of variables, 
alcohol consumption and BP.  A sequence of F-tests were carried out on age, country, years of 
education, marital status, employment; cigarette smoking, dietary supplement use, special diet, 
CVD-DM diagnosis, family history of HTN, moderate to heavy physical activity, BMI, urinary Na 
and K excretion, mean alcohol consumption, alcohol drinking pattern and type of alcoholic 
beverage consumed, in order to select the variables statistically significantly related to BP.  These 
variables were added sequentially, one-at-a-time to the models, only variables with F statistics 
significant at the 0.01 level were included in the model.  After a variable was added, the stepwise 
method was used to eliminate any variable that did not produce an F statistic significant at the 0.01 
level. The stepwise process was completed when every variable was significant at the 0.01 level. 
3.2.5 Tree structured regression model  
Tree structured regression models were used to assess the associations of BP with alcohol 
consumption (alcohol drinking status, drinking pattern and type of alcoholic beverage) and possible 
confounders (age, country, years of education, marital status, employment; cigarette smoking, 
dietary supplement use, special diet, CVD-DM diagnosis, family history of HTN, moderate to heavy 
physical activity, BMI, urinary Na and K excretion).  An algorithm known as recursive partitioning 
was used; this was an iterative process of splitting the data into partitions, and then splitting it up 
further on each of the branches. The algorithm chose the split that partitioned the data into two 
parts such that it minimized the sum of the squared deviations from the mean in the separate 
parts.  The tree structured process continued until each node reaches a user-specified minimum 
node size and became a terminal node.   
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3.3 Chemometric data analysis  
1H-NMR spectroscopy generates highly complex dimensional metabolic data which are often 
simplified for easier interpretation using chemometric dimension reduction techniques.  Multivariate 
statistical or pattern recognition methods were carried out in SIMCA-P+ (version 10.0, Umetrics 
AB, Sweden) and MATLAB to explore inherent population differences based on the data reduced 
1H-NMR spectra.  All datasets were mean centred before analysis.   
3.3.1 Unsupervised modelling of 1H-NMR spectral data 
Principal Components Analysis (PCA), an “unsupervised” (i.e. data driven) multivariate statistical 
method, was used initially to provide an overview of the vast amount of 1H-NMR urinary spectral 
data and to reduce its complexity.  The data were preliminarily analysed using PCA to identify 
outliers within the dataset  and to reveal any clustering patterns within different alcohol drinking 
groups (Beckwith-Hall et al. 2002).   
3.3.2 Supervised modelling of 1H-NMR spectral data 
Supervised pattern recognition techniques such as partial least squares (PLS), projections to latent 
structures-discriminant analysis (PLS-DA) or orthogonal-projections to latent structures-
discriminant analysis (OPLS-DA) were used to maximise separation and identify characterising 
metabolites (Trygg et al. 2007).  In this report, OPLS-DA with unit variance scaling was used to 
identify metabolites discriminating different alcohol drinking groups/subgroups (e.g. non-drinkers 
and current drinkers, wine drinkers and spirits drinkers), based on models constructed from one 
predictive and two orthogonal components using MATLAB (Cloarec et al. 2005).  A post-
processing step was used with transformation of the data and the reconstruction of a spectral 
representation of loadings plot.  This was constructed with a weighted scale based on the data 
scaled to unit variance and it is highlighted by a colour code projected onto the spectrum to 
indicate the correlation of the metabolites discriminating between the two drinking groups (such as 
non-drinker and drinkers; moderate drinkers and heavy drinkers).  Red indicates a high correlation 
and dark blue denotes no correlation between two drinking groups.  The direction and magnitude 
of the signals relate to the covariation of the metabolites with the drinking groups in the model. A 
permutation test was carried out to validate the OPLS-DA for pair-wise comparisons between 
different drinking groups. Analyses were done separately for first and second 24-hr urine spectral 
data.   
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3.3.3 Metabolite identification 
Structural identification of discriminatory metabolites between different alcohol drinking groups was 
performed using Statistical Total Correlation SpectroscopY (STOCSY) in MATLAB (Cloarec et al. 
2005).  STOCSY is a mathematical approach to aid structural identification of metabolites, based 
on statistical correlations of variable intensities between signals from nuclei of the same molecule 
present in a urine sample.  A calculated correlation matrix generates an NMR pseudo-spectrum for 
a given peak (the STOCSY „driver‟ peak), displaying the highly correlated peaks between this and 
all other peaks in a urine sample.  This information, directly leads to the identification of peaks from 
the same molecule and aids in metabolite identification. These data are also useful to provide 
insight into pathway of metabolites with intensities interdependent or under a common regulatory 
mechanism. 
3.3.4  Quantification of discriminatory 1H NMR metabolites  
Of 4,680 INTERMAP participants, 1H NMR spectra were not acquired for one of the two urine 
collections from 50 participants and a further 9 participants were excluded following the outlier 
analysis, leaving 4,621 individuals for the present report.  Four discriminatory metabolites (alanine, 
formate, hippurate and N-methylnicotinate, NMNA) from 1H NMR spectra were quantified (for both 
first and repeat urine collections) in the INTERMAP Study for 4,570 participants (Holmes et al. 
2008).  The chemical shifts used for quantification were δ1.48 for alanine (amino acid); δ8.45 for 
formate (gut microbial and 1 carbon metabolite); δ7.85 for hippurate (gut microbial co-metabolite) 
and δ4.44 for NMNA (vitamin B3 metabolite).  Urine specimens were excluded in the quantification 
where the estimation procedure failed or the values fell outside the method tolerance limits, for 
either urine collections. Therefore, there were 4,232 participants with quantified alanine readings, 
4,145 participants with measurements of formate, 4,180 with quantified hippurate readings and 
4,081 participants with quantified NMNA.  
Quantification of metabolites in NMR spectroscopy was computed using an in-house MATLAB 
routine employing the trapezoidal area calculation (Crockford et al. 2005).  The metabolite content 
was determined by calculating the area under the peak for each metabolite; a numerical value that 
reflected the concentration of the corresponding molecules in urine specimen (Coron et al. 2001).  
This measurement was calibrated first to the creatinine peak (δ4.06) and then to 24-hour creatinine 
excretion measured externally using the Jaffé method at the Central Laboratory (Bartels and 
Bohmer 1971); this enabled calculation of the 24-hour excretion of each metabolite. 
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4 RESULTS 
4.1 Summary descriptive statistics 
The INTERMAP Study includes 4,680 participants, 2,359 men (50.4%) and 2,321 women (49.6%) 
ages 40-59 years from 17 population samples.  All participants in the four Japanese and three 
Chinese samples were ethnic Japanese and Chinese respectively.  In the UK, 93.0% were non-
Hispanic whites and 4.6% were Indian (sub-continent).  There was one ethnic Japanese population 
sample in the US – Honolulu (266 ethnic Japanese participants).  Overall, in the US (n=2,195), 
there were 1,190 (54.2%) non-Hispanic white, 369 (16.8%) African-American, 269 (12.3%) 
Japanese-American, 175 (8.0%) non-white Hispanic-American and 113 (5.1%) white Hispanic-
American participants.  Characteristics are described by country and gender in Table 4.1 and 
Table 4.2. 
Chinese participants had the lowest education level (mean years of education 6.5 years for men 
and 4.3 years for women) and US participants the highest (mean years of education 15.4 for men 
and 14.5 for women).  More than 90% of men were employed except in the UK, where the 
employment rate was approximately 85%.  Over 80% of Japanese, UK and US women, but only 
48% of Chinese women were employed.  About 96% of East Asian men were married compared to 
77% of Western men; Asian women and men had a similar marital rate (88%); 63% of Western 
women were married. 
Mean BMI differed between East Asian and Western populations.  Chinese men and Japanese 
women had the lowest gender-specific BMI; the highest were the US for men and for women.  PRC 
participants performed more moderate to heavy physical activity than people from the other three 
countries.  More women (16.1%) than men (10.8%) were following a special diet (weight loss, 
weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet), about 22% 
of UK and US women compared to less than 9% of Japanese or Chinese women.  About 47% of 
US men and 57% of US women were taking dietary supplements compared to only about 4% of 
Chinese participants (Table 4.1 and Table 4.2).    
Overall 35.5% of men and 11.6% of women were current cigarette smokers; 51.7% of Japanese 
men and 68.3% of Chinese men, compared to 8.6% of Japanese women and 5.0% of Chinese 
women.  In the UK, 16.9% of men and 17.9% of women were current smokers; in the US, smoking 
rates were 19.1% for men and 14.5% for women.  About 52% of men and 58% of women had a 
known family history of HTN in their first degree relatives. 
In the US, 15.9% of men and 15.4% of women had a medical history of heart attack, other heart 
disease, stroke, or diabetes mellitus (DM); this rate was slightly lower in the UK (12.4% for men 
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and 8.9% for women).  In the PRC, 4.8% of Chinese men and 7.6% of Chinese women, and about 
5% of Japanese reported a history of CVD or DM.  The prevalence of antihypertensive drug 
treatment in the UK was 13.9% for men and 12.3% for women; in the PRC, 5.3% for men and 
9.7% for women. The US had the highest rate of prescribed drug treatment for HTN - 21.6% for 
men and 22.4% for women, compared to only 5.9% for Japanese men and 6.8% for Japanese 
women.   
Table 4.1 and Table 4.2 show that mean BP levels were higher in men than women except SBP 
for the Chinese samples.  UK men had the highest SBP and DBP; mean DBP was lowest in 
Chinese men.  Among women, Japanese women had the lowest SBP and DBP.  Chinese women 
had the highest SBP and UK women the highest DBP.  
In Japan, 97% of men and 85% of women were current alcohol drinkers, in the PRC 73% of men 
and 19% of women.  Overall, mean daily alcohol intake from two 7-day records among current 
drinkers was higher in men than women. Among male drinkers, Japan had the highest mean daily 
alcohol intake from 7-day records (30.9 g/day), the US the lowest (13.8 g/day).  Among women 
who drank, mean daily alcohol intake from 7-day records was highest in the UK (10.0 g/day), 
lowest in PRC (2.4 g/day).     
4.2 Dietary alcohol intake from four 24-hr dietary recalls and from two 7-day 
records 
In the INTERMAP Study, data on alcohol consumption were obtained by two methods: four 24-hr 
dietary recalls and two 7-day records.  416 men (17.6%) and 866 women (37.3%) were not current 
alcohol drinkers (i.e. teetotallers or ex-drinkers) and had a zero value for mean daily alcohol intake 
from 7-day records (some non-drinkers had mean 24-hr dietary alcohol intake value greater than 
zero due to alcohol consumed in foods).  3,398 participants (72.6%) described themselves as 
current alcohol drinkers (consuming alcohol beverages) in their questionnaires; about 16% of these 
self-reported current alcohol drinkers (n=532) did not report alcoholic beverage in their two 7-day 
records during data collection.  This information (no alcohol intake from beverages) was confirmed 
(cross-checked) in their four 24-hr dietary recalls. Therefore, these 170 men and 362 women were 
grouped as „occasional‟ drinkers with no alcoholic beverage intake during data collection.  Some 
occasional drinkers had consumed alcohol from foods, with resultant mean 24-hr dietary alcohol 
intake greater than zero.  Occasional drinkers were classified as moderate drinkers in the following 
analyses unless otherwise specified.  
Figures 4.1 and 4.2 show the distribution of mean daily alcohol intake from two 7-day records for 
male and female current drinkers (occasional drinkers with no alcoholic beverage intake during 
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data collection excluded).  There were 1,773 male current alcohol drinkers and 1,093 female 
current alcohol drinkers (i.e. daily alcohol intake from 7-day records > 0).  Male drinkers had higher 
daily alcohol consumption than female drinkers.   
Coefficient of intra-individual variation (CV) in alcohol intake from four 24-hr dietary recalls (80.0%) 
was higher than that from two 7-day records (65.5%), (occasional drinkers with no alcoholic 
beverage during data collection excluded) (Table 4.3).  Results were similar for men and women.  
Pearson partial correlation coefficient (adjusted for country and gender) between mean 24-hr 
dietary alcohol intake of 4 days (g/day) and mean daily alcohol intake from 7-day records of 14 
days (g/day) was 0.86 for current drinkers (p<0.001) (Table 4.4).  Mean daily alcohol intake from 
two 7-day records was used in most analyses in this report. 
Univariate estimates of intra-individual reliability on the basis of two 7-day records were: for each of 
the 4,680 participants, observed regression coefficient 88.4% of theoretical coefficient; for men 
only, 89.4%; for women, 87.4%; for drinkers only, 87.4%; for male drinkers only, 88.1% and for 
female drinkers only, 86.6%.  This means, theoretically, that true associations might be larger than 
the observed associations, e.g., 1.1 (1/0.884) times larger for 7-day alcohol intake for both all 
4,680 participants. 
4.3 Alcohol drinking status and characteristics of non-alcohol drinkers and 
current alcohol drinkers 
4.3.1 Alcohol drinking status: amount of alcohol consumed  
Table 4.5 shows the numbers of non-alcohol drinkers (i.e. teetotallers and ex-drinkers) and current 
alcohol drinkers in the INTERMAP Study: 1,943 (82.4%) men and 1,455 (63.7%) women were 
current alcohol drinkers.  Mean daily alcohol intake, the average alcohol intake per day (g/day) 
from their two 7-day alcohol records, was used to describe the amount of alcohol consumed.  
Heavy drinkers were classified as consuming more than 2 drinks (>26 g alcohol) per day for men 
and more than 1 drink (>13 g alcohol) per day for women (US Department of Agriculture and US 
Department of Heath and Human Services 2005).  Among the current drinkers, 170 men and 362 
women reported that they drank alcohol, though no alcoholic beverage intake was reported in their 
two 7-day alcohol records.  They were considered to be occasional drinkers and were classified as 
moderate drinkers in the analyses unless specified otherwise.   
PRC had the highest percentage of teetotallers - 20.2% of Chinese men and 78.5% of Chinese 
women.  The US had the highest percentage of ex-drinkers (18.5% of US men and 20.4% of US 
women).  Most ex-drinkers stopped drinking more than 2 years ago and most considered 
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themselves to be ex-moderate drinkers.  Of all ex-drinkers, 34.9% reported cessation of drinking 
due to a health reason; 14.3% stopped drinking following advice from a doctor or other health 
worker.  The US had the highest percentage of moderate (i.e., not heavy) drinkers for men and the 
UK had the highest percentage of moderate drinkers for women.  Japan had the highest rate of 
heavy drinkers among men; 22.1% of UK women were heavy drinkers; there were only 4 heavy 
drinkers among female alcohol drinkers in the PRC (Table 4.5). 
The values of mean alcohol intake per day from four dietary recalls and from two 7-day records 
were similar in both male and female current drinkers, e.g., for male moderate drinkers (including 
occasional drinkers), 8.2 g/day and 8.3 g/day; and for male heavy drinkers, 47.3 g/day and 50.3 
g/day (Table 4.6).  US male moderate drinkers had the lowest mean values, 7.2 g/day and 7.3 
g/day respectively.  Chinese male heavy drinkers had the highest (59.6 g/day and 58.6 g/day).  
Among female drinkers, Chinese moderate drinkers had the lowest and UK heavy drinkers had the 
highest alcohol intake per day both from 24-hr dietary recalls and 7-day alcohol records (Table 
4.7). 
4.3.2  Characteristics of non-alcohol drinkers and current alcohol drinkers 
Among men, there were 166 teetotallers, 250 ex-drinkers, 599 heavy drinkers and 1,344 moderate 
drinkers in the study (Table 4.8).  Male teetotallers had the lowest country-adjusted mean urinary K 
excretion.  They were the most inactive group, did only on average 3.0 hours of moderate or heavy 
physical activity per day.  Male ex-drinkers had the lowest education level and the lowest rate of 
employment compared to teetotallers and current drinkers; 44% of ex-drinkers were taking dietary 
supplements, the highest percentage among men.  They also had the highest adjusted mean BMI 
(26.3 kg/m2).  Over 20% of male ex-drinkers were on a special diet (weight loss, weight gain, 
vegetarian, salt reduced, diabetic, fat modified, or any other special diet) compared to only 6% of 
heavy drinkers (p<0.01).  Nearly 20% of male ex-drinkers had a medical history of heart attack, 
other heart disease, stroke, or diabetes and about 23% of them were on antihypertensive 
treatment.  Male moderate drinkers had the highest urinary K excretion.  Heavy male drinkers had 
the highest percentage of cigarette smokers (51%) compared to non-drinkers and moderate 
drinkers and the highest employment rate at 94.8%.  Male heavy drinkers had the lowest adjusted 
mean urinary Na excretion. 
There were 1,259 female moderate drinkers and only 196 female heavy drinkers (Table 4.9).  
Urinary Na excretion was similar among women in different strata of alcohol drinking.  Female 
teetotallers had the lowest employment rate and least likely to be taking any dietary supplements.  
They also had the highest values of urinary Na excretion and BMI.  Female ex-drinkers had the 
highest rate of CVD-DM diagnosis and the highest prevalence of anti-hypertensive treatment; 
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about 24% were on a special diet and nearly 48% were taking dietary supplements.  Female heavy 
drinkers were younger (mean age 47.9 years) with higher education level, more likely to be 
employed and more likely to smoke compared to other strata.   Female heavy drinkers had the 
lowest mean BMI.  They also had a lower prevalence of history of heart disease, heart attack, 
stroke or diabetes, and were less likely to be on antihypertensive treatment.   
4.4  Daily alcohol drinking pattern and characteristics of current alcohol drinkers 
4.4.1 Daily alcohol drinking pattern: number of alcohol drinking days from two 7-
day alcohol records 
Current drinkers were classified by pattern of alcohol intake: drank alcohol on 1-6 days, 7-9 days, 
10-12 days or 13-14 days (of the 14) from the two 7-day alcohol records during data collection.  
Figure 4.3 shows the number of alcohol drinking days of male current drinkers (excluding 
occasional drinkers with no alcoholic beverage intake during data collection) from their 7-day 
alcohol records.  About 36% of male moderate drinkers drank alcohol on 1-2 days only of the 14.  
Nearly 40% of male heavy drinkers consumed alcohol daily.  The number of heavy drinkers who 
drank alcohol on only 1 to 2 days of the 14 was low.  More than half of female moderate drinkers 
had alcoholic beverage on 1-2 days only of the 14; 18% of female heavy drinkers consumed 
alcohol daily (Figure 4.4).   
Table 4.10 shows the alcohol drinking pattern of male and female drinkers respectively; excluding 
occasional drinkers with no alcoholic beverage intake during data collection.  Among male 
moderate drinkers, 75% consumed alcohol drinks on only 1-6 days of the 14.  More than half of 
male heavy drinkers consumed alcohol daily.  About 78% of Japanese male heavy drinkers drank 
alcoholic beverage on most days (13-14 days).  In the UK, 21% of male heavy drinkers had an 
alcoholic beverage on 1-6 of the 14 days.  Among women, 87% of moderate drinkers consumed 
alcohol on only 1-6 days of the 14; less than 2% of female moderate drinkers drank on 13-14 days 
of the 14.  About 30% of female heavy drinkers drank on 13-14 days of the 14. 
Male drinkers who drank on only 1-6 of the 14 days had a significantly lower mean daily alcohol 
intake than those who drank on 7-9, 10-12 and 13-14 days adjusted for confounders (country; age; 
year of education; marital status; employment; cigarette smoking; dietary supplement use; special 
diet; CVD-DM diagnosis; family history of HTN; hours of moderate to heavy physical activity per 
day; BMI; urinary Na and K).  The more days alcohol was consumed, the greater the mean daily 
intake over all 14 days for male drinkers and female drinkers.  Those who consumed an alcoholic 
beverage on only 1-6 days of the 14 had a significantly higher adjusted mean daily alcohol intake 
on drinking days only compared to other strata.  The fewer days alcohol was ingested, the greater 
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the mean intake on drinking days for both moderate and heavy drinkers (Table 4.11 and Table 
4.12).  Male heavy drinkers on 1-6 days had the highest adjusted mean daily alcohol intake on 
drinking days only (Table 4.11).  Female drinkers who drank on only 1-6 days of the 14 had a 
significantly lower adjusted mean daily alcohol intake over 14 days, but a higher adjusted mean 
daily alcohol intake on drinking days compared to other drinking pattern groups (Table 4.12). 
4.4.2 Characteristics of current drinkers by daily alcohol drinking pattern 
Male current drinkers who consumed alcoholic drinks on only 1-6 of the 14 days were younger and 
had a significantly higher BMI than other current drinkers (Table 4.13).  About 12% of male 
drinkers who drank on 1-6 days were on a special diet, 14% were on antihypertensive medication 
and 56% had a family history of HTN.  Male drinkers who drank on 7-9 days of the 14 had higher 
education level, urinary Na excretion and urinary K excretion compared to other male drinkers.  
Male drinkers who had alcoholic drinks on 13-14 of the 14 days had higher cigarette smoking rate 
(55%) and employment rate (97%), lower country-adjusted mean BMI and urinary Na excretion 
compared to other male drinkers.  They also had the lowest prevalence of anti-hypertensive 
treatment, less than 5% of them were on a special diet and only 25% were taking dietary 
supplements.  
Among women, there was no significant age difference among drinkers with different alcohol 
drinking patterns (Table 4.14).  Female drinkers who drank on only 1-6 of the 14 days had higher 
BMI and lower cigarette smoking rate compared to other female current drinkers.  Female drinkers 
who consumed alcoholic beverage on 7-9 days had lower BMI, higher education level and urinary 
K excretion compared to other female drinkers.  About 25% of female drinkers who drank on most 
days were smokers, 10% were on a special diet and only 3% had a medical history of heart 
disease or diabetes.  
4.5  Type of alcoholic beverage consumed and characteristics of current alcohol 
drinkers 
4.5.1 Type of alcoholic beverage consumed 
Type of alcoholic beverage consumed by current drinkers was recorded in the two 7-day alcohol 
records.  For Japanese drinkers, alcoholic beverages reported were beer, white wine, red wine, 
sake (an alcoholic beverage brewed mainly from rice), shochu (a distilled alcoholic beverage made 
from rice, barley, sweet potato or sugar cane) and spirits.  Beer, champagne, red wine, rice spirits 
and other spirits were reported by Chinese drinkers.  From the alcohol records of the UK drinkers, 
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beer (including ale, bitter and lager), white and red wine, spirits and liqueur were reported.  Only 
three types of alcoholic beverage: beer, wine and spirits were reported by US drinkers.  From the 
standardised detailed alcohol records, each drinker was classified into one of four alcoholic 
beverage groups: drinkers with more than 70% alcohol intake from beer; drinkers with more than 
70% alcohol intake from wine; drinkers with more than 70% alcohol intake from spirits; and 
drinkers of combinations of different alcoholic beverage.   
In Japan, beer was the most popular alcoholic beverage among male moderate drinkers; male 
heavy drinkers showed no preference on type of alcoholic beverage (Table 4.15).  Most Chinese 
male drinkers had their alcohol intake from spirits (particularly rice spirits).  Among male drinkers, 
beer was the most popular alcoholic beverage in the UK and the US.  Nearly half of Japanese 
female drinkers had their alcohol intake mostly from beer (Table 4.16).  Most of Chinese female 
drinkers drank mostly spirits.  Wine was the most popular alcoholic beverage for UK and US 
female drinkers. 
Male moderate drinkers with >70% alcohol intake from wine had a significantly lower adjusted 
mean daily alcohol intake over 14 days and mean daily alcohol intake on drinking days only 
compared to those consuming other alcoholic beverage types (Table 4.17).  Among male heavy 
drinkers, those who drank mostly spirits had the highest adjusted mean daily alcohol intake over 14 
days and mean daily alcohol intake on drinking days.   Female moderate wine drinkers had a lower 
mean daily alcohol intake over 14 days compared to other female moderate drinker groups (Table 
4.18).  Among female heavy drinkers, there were no significant differences in daily alcohol intake 
by beverage type.  
4.5.2 Characteristics of current drinkers by type of alcoholic beverage consumed 
Male beer drinkers had significantly lower country-adjusted mean age and education level and less 
likely to be employed compared to male wine drinkers and other male drinkers (Table 4.19).  Male 
beer drinkers had the highest percentage of family history of HTN and the highest moderate or 
heavy physical activity.  Male wine drinkers had the lowest adjusted mean BMI and the highest 
excretion of urinary K compared to other male drinkers.  38% of male wine drinkers were taking 
dietary supplements.  Male spirits drinkers had the highest BMI and the lowest rate of taking 
dietary supplements, were much more likely to smoke and less likely to be on a special diet 
compared to other current male drinkers.  Male spirits drinkers had lower urinary Na and K 
excretion compared to beer, wine and „mixed‟ drinkers. 
 Female beer drinkers had the highest percentage of smokers and the lowest employment rate 
compared to other drinkers (Table 4.20).  They were least likely to take dietary supplements. 
Female beer drinkers had higher urinary Na excretion and lower urinary K excretion than other 
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strata.  Female wine drinkers had the lowest adjusted mean BMI and the highest education level 
compared to other female current drinkers.  Female wine drinkers had the lowest percentage of 
cigarette smokers, were more likely to take dietary supplements.  Female spirits drinkers had the 
lowest country-adjusted education level, the highest rate of CVD-DM diagnosis and prevalence of 
anti-hypertensive treatment compared to female beer drinkers, wine drinkers and „mixed‟ drinkers. 
4.6  Alcohol use: amount, drinking pattern, type of alcoholic beverage and blood 
pressure 
Analysis of variance (ANOVA) was used to compare risk factors for adverse BP across groups of 
participants stratified on their alcohol use: daily alcohol consumption (alcohol drinking status), 
alcohol drinking pattern and type of alcoholic beverage consumed. 
4.6.1 Blood pressure of non-alcohol drinkers and current drinkers 
Amount of alcohol: Comparison of BP by use and amount of alcohol (drinking status) showed 
that male heavy drinkers had significantly higher mean BP adjusted for confounders (country; age; 
years of education; marital status; employment; cigarette smoking; dietary supplement use; special 
diet; CVD-DM diagnosis; family history of HTN; hours of moderate to heavy physical activity per 
day; BMI; 24-hr urinary Na and K) compared to male moderate drinkers, occasional drinkers, ex-
drinkers and teetotallers (Table 4.21).  Among women also, heavy drinkers had higher adjusted 
mean SBP and DBP than other strata.  For both genders, adjusted BPs of teetotallers, ex-drinkers, 
occasional drinkers and moderate drinkers were similar.  When occasional drinkers were grouped 
as moderate drinkers in the analysis, the results were similar (Figure 4.5 and Figure 4.6). 
Pattern of alcohol intake: Male alcohol drinkers who drank on 13-14 days of the 14 had 
significantly higher mean SBP compared to male non-drinkers (teetotallers and ex-drinkers), 
occasional drinkers and drinkers who drank on 1-6 days of the 14 adjusted for the same set of 
confounders as above (Table 4.22).  Male drinkers who consumed alcohol on 7-9 or 10-12 or 13-
14 days of the 14 had higher adjusted DBP than male non-drinkers, occasional drinkers and 
drinkers who drank only on 1-6 days of two 7-day records.  Daily alcohol drinking pattern was not 
related to BP for female drinkers.  
Type of alcoholic beverage: Among men, current drinkers who had more than 70% alcohol 
intake from spirits (i.e. spirits drinkers) had the highest mean SBP and DBP adjusted for same set 
of confounders as above (Table 4.23).  There were no significant BP differences among female 
drinkers consuming different type of alcoholic beverage (beer, wine, spirits or mixed drinkers) and 
female non-drinkers (teetotallers and ex-drinkers). 
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4.6.2 Blood pressure of current drinkers 
Results from multiple regression analysis (Table 4.24) show that BP difference per unit of alcohol 
consumed (13 g alcohol) were 1.1 mm Hg for SBP and 0.5 mm Hg for DBP among male current 
drinkers.  The adjusted BP difference per unit of alcohol consumed for female current drinkers was 
1.9 mm Hg for systolic and 1.5 mm Hg for diastolic BP. 
Pattern of alcohol intake: Figure 4.7 shows that male drinkers who drank on 13-14 days had a 
significant higher SBP than those who drank on 1-6 days, 7-9 days or 10-12 days with adjustment 
for country; age; education; marital status; employment; cigarette smoking; dietary supplement 
use; special diet; CVD-DM diagnosis; family history of HTN; physical activity per day; BMI; urinary 
Na and K.  There was a significant SBP difference between female drinkers who consumed alcohol 
on 1-6 days and 13-14 days (Figure 4.7).  Male drinkers who consumed alcohol on 1-6 days had a 
significant lower DBP than those drank on 7-9 days and 13-14 days; among female drinkers, DBP 
difference was significant between those consumed alcohol on 1-6 days and 13-14 days (Figure 
4.8).  However, for both genders, there were no significant BP differences by drinking pattern with 
an additional adjustment for mean amount of daily alcohol intake (from two 7-day alcohol records) 
(Table 4.25). 
Type of alcoholic beverage: Male drinkers who consumed mostly spirits had a significantly higher 
SBP than male wine or mixed drinkers (Figure 4.9). With adjustment for all confounders and 
amount of alcohol (average of 14 days or per drinking day), SBP differences were no longer 
significant (Table 4.26). Figure 4.10 shows no significant differences in DBP by type of alcoholic 
beverage for men.  Female wine drinkers had a lower adjusted mean SBP compared to beer 
drinkers, spirits drinker and mixed drinkers (Figure 4.9).  Adjusted mean SBP of female wine 
drinkers was lower compared to other strata.  There were no significant DBP differences among 
female drinkers who consumed different types of alcoholic beverage (beer, wine, spirits or mixed 
drinkers) with adjustment for mean alcohol intake (Table 4.26).   
In the multiple regression model for SBP of current alcohol drinkers with adjustment for mean 
alcohol intake (g/day) from two 7-day records, alcohol drinking pattern (number of days of the 14 
days), type of alcoholic beverage consumed and other cited confounders, SBP difference per unit 
of alcohol consumed (13 g alcohol) was 1.1 mm Hg for male drinkers and 1.3 mm Hg for female 
drinkers (Table 4.27).  From stepwise regression, for male current drinkers, age, family history of 
HTN, BMI and mean alcohol intake (g/day) were positively related to SBP; country, years of 
education and urinary K were inversely related to SBP.  For female current alcohol drinkers, age, 
history of HTN, BMI and drinking pattern (as number of days of 14 alcohol consumed) were 
significantly and positively related to SBP; education was inversely related to SBP.  
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From multiple regression analyses, DBP difference per unit of alcohol consumed was 0.5 mm Hg 
for male drinkers and 1.4 mm Hg for female drinkers (Table 4.28).  Among male drinkers, country 
(inversely), family history of HTN, BMI and mean alcohol intake (g/day) were significantly related to 
DBP in stepwise regression; among female drinkers, age, family history of HBP, BMI, urinary Na 
excretion and mean daily alcohol intake were positively related to DBP.   
Figure 4.11 shows alcohol drinking pattern (number of alcohol drinking days) predicted alcohol 
drinking status in relationship to SBP.  Moderate alcohol drinkers were identified as current alcohol 
drinkers who drank 1-6 days of 14, or non-smokers who drank on 7-9/10-12 days of 14 from 
Japan, PRC and US.  Drinkers who drank 13-14 days of 14, cigarette smokers who drank on 7-
9/10-12 days and UK smokers who drank on 7-9/10-12 days of 14 were identified as heavy 
drinkers in the tree structured classification analysis.  The tree classification analysis for DBP 
showed similar results, alcohol drinking pattern identified alcohol drinking status among current 
drinkers (Figure 4.12).  
4.7 Nutrient intake by drinking status 
Mean intakes of protein (vegetable, animal and total), fatty acids (including PUFA, SFA, Oemga-3 
and Omega 6 fatty acids), carbohydrates, starch, alcohol, cholesterol, fibre, vitamins (e.g., vitamin 
B6, B12, vitamin C and vitamin E) and minerals (calcium, magnesium and copper) and the intake 
composition of 18 dietary amino acids are reported here by amount of alcohol intake (alcohol 
drinking status) and drinking categories of current drinkers. 
4.7.1 Nutrient intake of non-drinkers and current drinkers 
Male heavy drinkers had a significantly higher mean total energy intake from food and alcoholic 
beverages compared to other drinking status groups, adjusted for age, country, years of education, 
marital status, employment, cigarette smoking, dietary supplement intake, special diet, CVD-DM 
diagnosis, family history of HBP, anti-hypertensive treatment, hours of moderate to heavy physical 
activity per day, BMI, urinary Na and K excretion (Table 4.29).  The adjusted mean food-derived 
energy intake for non-drinkers was similar to their total energy intake since little alcohol was 
present in their foods.  Male heavy drinkers had a significantly lower adjusted mean food-derived 
energy compared to other strata with an average of 333 kcal/day from alcoholic beverage 
(accounting for 13% total energy intake).   
Results of ANOVA (Table 4.29) show that male heavy drinkers had significantly higher adjusted 
mean intakes of animal protein, haem iron (Fe), niacin and vitamin B12 than teetotallers, ex-
drinkers and moderate drinkers.  Male heavy drinkers had the lowest adjusted mean intakes of 
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vegetable protein, fibre, carbohydrates, starch, fatty acids (total fat, saturated fatty acids [SFA], 
monounsaturated fatty acids [MUFA], omega 3 fatty acids and linolenic fatty acid), vitamin C and E, 
calcium (Ca), phosphorous (P), non-haem Fe, copper (Cu), glutamic acid, cystine, proline, 
phenyalanine, serine, tryptophan, leucine, valine and isoleucine compared to other groups.  
Adjusted mean intakes of animal protein, fatty acids (polyunsaturated fatty acids [PUFA], omega 6 
fatty acids, oleic acid and linoleic acid) and cholesterol were significantly higher for male moderate 
drinkers compared to male teetotallers; intakes of vegetable protein, starch and carbohydrate were 
lower for male moderate drinkers than male teetotallers (Table 4.29).   
Compared to ex-drinkers, male teetotallers had significantly different nutrient intakes: higher 
adjusted mean intakes of vegetable protein, starch and carbohydrate, and lower mean intakes of 
animal protein, total fat, SFA, PUFA, omega 6 fatty acids, oleic acid and linoleic acid (Table 4.29).   
Mean nutrient intakes for women are listed in Table 4.30.  Female heavy drinkers had the highest 
adjusted mean total energy intake and the lowest mean food-derived energy intake; their adjusted 
mean alcohol-derived energy was 171 kcal/day (about 10% of total energy intake).  The adjusted 
food-derived energy intake values of female teetotallers, ex-drinkers and moderate drinkers were 
similar.  Female heavy drinkers had significantly higher cholesterol intake and lower intakes of 
vegetable protein, starch, carbohydrate, fibre, fatty acids (SFA, PUFA, omega 3 fatty acids, linoleic 
acid and linolenic acid), vitamin C, beta-carotene and thiamin compared to female non-drinkers 
and moderate drinkers.   
Female drinkers had the highest intake of Ca and the lowest intake of cholesterol compared to 
other drinking groups.  Comparing the nutrient intakes between female teetotallers and moderate 
drinkers, teetotallers had significantly higher intakes of vegetable protein, starch, carbohydrate, 
fibre, omega 3 fatty acids, linolenic acid vitamin C and folacin and lower intakes of SFA than 
moderate drinkers.  Among female non-drinkers, ex-drinkers had significantly lower intakes of 
vegetable protein, starch, omega 3 fatty acids, linolenic acid, glutamic acid and proline than 
teetotallers (Table 4.30).   
4.7.2 Nutrient intakes of current drinkers 
Pattern of alcohol intake: Male drinkers who drank alcohol only on 1-6 days of 14 days had 
substantively lower adjusted mean values of total energy intake, alcohol-derived energy and haem 
Fe and significantly higher intakes of total protein, starch, carbohydrate, fibre, Ca, P, non-haem Fe, 
Cu, vitamin C and E, pantothenic acid and several of dietary amino acids (glutamic acid, cystine, 
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proline, phenyalanine, serine, tryptophan, leucine, valine and isoleucine) than other male current 
drinkers who drank alcohol on 7-9 days, 10-12 days or 13, 14 days (Table 4.31).  For male 
drinkers who consumed alcohol on 13-14 days, 14.3% of their total every intake was from alcoholic 
beverages.  
Among female drinkers, those who drank alcohol on 1-6 days of 14 days had the lowest adjusted 
mean alcohol-derived energy and the highest adjusted mean values of fibre, starch and 
carbohydrate compared to other strata (Table 4.32).  Over 10% of the total energy intake (kcal per 
day) of female drinkers who drank on 13-14 days was obtained from alcoholic beverages; they also 
had significantly lower adjusted mean intakes of vegetable protein, starch, carbohydrate, fibre, 
vitamin C and a few dietary amino acids than other female drinkers. 
Type of alcoholic beverage: Among male drinkers, those who drank mostly beer had the lowest 
adjusted mean alcohol-derived energy intake compared to other male drinkers (Table 4.33).  There 
was no significant difference in total energy intake among different groups.  Male wine drinkers had 
the highest intakes of vegetable protein, starch, carbohydrate and non-haem Fe; they also had the 
highest value of adjusted mean food-derived energy and the lowest value of cholesterol.  Male 
drinkers who drank mostly spirits had the highest intake of alcohol-derived energy; they had a 
significantly lower intake of vegetable protein and fibre compared to male beer drinkers and wine 
drinkers. 
Among female current drinkers, mixed drinkers had the highest alcohol-derived energy intake, 
while wine drinkers had the lowest adjusted mean food-derived energy.  Female wine drinkers had 
lower animal protein, total fat, cholesterol, omega 6 fatty acids, oleic fatty acid and linoleic fatty 
acid and higher intakes of vegetable protein, vitamin C, starch, carbohydrate compared to other 
female drinkers (Table 4.34).  Female beer drinkers had higher intakes of total fat, PUFA, MUFA, 
omega 3 fatty acids, omega 6 fatty acids, oleic acid and linoleic acid and a significantly lower non-
haem Fe intake than female wine drinkers. 
4.8 Food group intake 
Consumption of 13 major food groups (including vegetables, fruits, grains, dairy, meat, poultry and 
seafood) was examined by alcohol drinking status using ANOVA analyses. 
4.8.1 Food group intake of non-drinkers and current drinkers 
Among men, teetotallers consumed a significantly greater proportion of overall calories (g/1,000 
kcal) from fruits and grains compared to ex-drinkers and drinkers after adjustment of confounders 
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(Table 4.35).  Male ex-drinkers consumed more poultry, processed meat, dairy and non-alcoholic 
beverages than other male drinking groups.  Male moderate alcohol drinkers had significantly 
higher consumption of vegetables then other groups.  Male heavy drinkers had significantly lower 
intakes of vegetables, fruits, grains, dairy, non-alcoholic beverages and higher consumption of 
seafood, meat and animal fat than male non-drinkers and male moderate drinkers.   
Female teetotallers had higher consumption of vegetables, fruits, grains and lower consumption of 
meat, processed meat and non-alcoholic beverages than female ex-drinkers and female current 
drinkers (Table 4.36).  Female ex-drinkers consumed more calories from meat, poultry, processed 
meat and non-alcoholic beverages than other groups.  Female moderate drinkers had higher 
intake of dairy then female non-drinkers and female heavy drinkers.  Female heavy drinkers had 
higher consumption of nuts and legumes, seafood and vegetarian meat substitutes and lower 
consumption of vegetables, fruits and grains, poultry and dairy than non-drinkers and moderate 
drinkers. 
4.8.2 Food group intake of current drinkers 
Pattern of alcohol intake: Among male drinkers, those who consumed alcohol on 13-14 days of 
14 days had significantly higher intakes of seafood and lower intakes of vegetables, fruits, grains, 
vegetarian meat substitutes and dairy than those who drank alcohol on 1-6 days, 7-9 days or 10-12 
days (Table 4.37).  Male drinkers who drank on 1-6 days had significantly higher consumption of 
fruits, grains and dairy than other male drinkers.  There was no significant difference in nuts and 
legumes, poultry, processed meat and oils intake among different strata of male current drinkers. 
Female drinkers who drank on 1-6 days had higher consumption of fruits, grains and dairy and 
lower vegetarian meat substitutes than other strata of current drinkers (Table 4.38).  Female 
drinkers consumed alcohol on 7-9 days had a greater proportion of calories from animal fat 
compared to those who drank on 1-6 days, 10-12 days or 13-14 days.  There was no significant 
difference in consumption of nuts and legumes, poultry, processed meat, oils and non-alcoholic 
beverages among different strata of female current drinkers. 
Type of alcoholic beverage: Male beer drinkers had a higher intake of meat and non-alcoholic 
beverages and a lower consumption of fruits compared to wine drinkers, spirits drinkers and mixed 
drinkers (Table 4.39).   Male wine drinkers had higher consumption of grains and lower intake of 
processed meat compared to other male drinkers.  Male spirits drinkers consumed more calories 
from fruits, seafood and animal fat compared to other strata of male drinkers. 
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Among female drinkers, those who drank mostly beer had a lower intake of fruits, grains and 
vegetarian meat substitutes and higher consumption of processed meat than other female drinkers 
(Table 4.40).  Female mixed drinkers had a higher consumption of nuts and legumes and non-
alcoholic beverages compared to other strata of drinkers.  There was no significant difference in 
consumption of meat, processed meat, oils and animal fat among different strata of female current 
drinkers. 
4.9  Alcohol, nutrient/food group intake and blood pressure 
The INTERMAP Study has reported inverse relations to BP of dietary vegetable protein, glutamic 
acid, omega 3 PFA and linolenic fatty acid, omega 6 PFA and linoleic fatty acid, starch, P, Ca, Mg, 
total Fe and non-haem Fe.  Effect of these 12 dietary factors and a selection of food groups 
(considered separately and collectively) on the relation of alcohol intake to BP is described here. 
Partial correlation coefficient between dietary factors 
The sex-age-country partial Pearson correlation coefficients (r) for these 12 nutrients are given in 
Table 4.41.  Most of these dietary factors are highly inter-correlated.  
Vegetable protein intake was positively correlated with intakes of starch (r=0.58), Mg (r=0.56), Fe 
(r=0.42) and non-haem Fe (r=0.47).  Omega 3 PFA was highly correlated with Omega 6 PFA 
(r=0.48) and linoleic fatty acid (r=0.48).  Linolenic fatty acid was positively correlated with omega 6 
PFA (r=0.62) and linoleic fatty acid (r=0.62).  P intake was positively correlated with glutamic acid 
(r=0.59), Ca (r=0.71), Fe (0.49) and non-haem Fe (0.47).  Mg intake was highly correlated with Ca 
(r=0.46), P (r=0.68), Fe (r=0.57) and non-haem Fe (r=0.58).  Non-haem Fe was positively 
correlated with Ca (r=0.42).  7-day alcohol intake (g/day) was inversely correlated with starch (r=-
0.29) and vegetable protein intake (r=-0.20).  Dietary alcohol intake from recalls (%kcal) was 
inversely correlated with starch (r=-0.34), vegetable protein intake (r=-0.23).  
To avoid multi-colinearity, only non-correlated dietary factors were considered together in the linear 
regression analyses. 
4.9.1 Effect of specific dietary factors on relation of alcohol to BP 
Table 4.42 shows that inclusion in linear regression models of all the specific nutrients (considered 
separately) except starch (row D) modestly decreased the size of alcohol-SBP coefficients of male 
drinkers; the positive association between alcohol intake and SBP remained similar in size and 
statistically significant in all models.  The coefficients for the alcohol-SBP relation were altered only 
slightly by separate inclusion in the model of Mg (row J), P (row K), omega 3 fatty acid (row E) or 
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vegetable protein (row B).  Non-haem Fe (row M) accounted for the largest reduction in coefficient 
at 3.5%.  Combinations of nutrients lowered the coefficients slightly more; the biggest reduction 
was 4.9% with non-haem Fe and omega 3 fatty acid (row N). 
Linolenic acid (row F), Mg (row J), P (row K), Fe (row L) and non-haem Fe (row M) modestly 
reduced the alcohol-SBP coefficient in regression analyses of female drinkers (Table 4.43).  
Adjusted for both linolenic acid and Mg, the alcohol-SBP coefficient reduced by 8.1%. In contrast to 
the findings for male drinkers, inclusion singly of vegetable protein, omega 3 PFA, omega 6 PFA or 
linoleic acid resulted in increases in the coefficient.  Alcohol-SBP coefficients were not statistically 
significant in any of these models. 
For male drinkers, the alcohol-DBP coefficients were statistically significant in all models listed in 
Table 4.44.  With each nutrient considered singly, inclusion of non-haem Fe had the biggest 
reduction in coefficient at -7.0% (row M); total Fe (row L), Mg (row J) and P (row K) also decreased 
the alcohol-DBP coefficients modestly and were significant in these models.  Non-haem Fe and 
linoleic acid collectively had the biggest effect on alcohol-DBP relationship (-8.1%); non-haem Fe 
was significantly inversely related to DBP in this regression model. 
For female drinkers, none of the alcohol-DBP coefficients were sizably reduced by adding dietary 
factors to the regression models; the association of alcohol intake and DBP among female drinkers 
remained significant in all models (Table 4.45).  Inclusion singly of starch (row D), linolenic fatty 
acid (row F) and Mg (row J) modestly reduced the coefficient; combined adjustment for linolenic 
acid and Mg account for the largest reduction at 3.7% (row N). 
4.9.2 Effect of specific food groups on the relation of alcohol to BP 
Compared with Model 1, inclusion of grains (row D) increased the alcohol-SBP coefficient among 
male drinkers by 10.9% (Table 4.46).  Food groups vegetables (row B), processed meats (row J) 
or oils (row L) considered separately in the regression models modestly decreased the coefficients; 
the positive association between alcohol intake and SBP remained statistically significant in all 
models. 
For female current drinkers, the food group fruits (row C) produced the biggest reduction (2.5%) in 
alcohol-SBP coefficient; grains (row D) increased the coefficient the most at 8.1% (Table 4.47).  
Inclusion of seafood (row F), poultry (row H) and processed meat (row J) individually produced 
modest increases in the alcohol-SBP coefficients.   
In the regression models of DBP for male drinkers, the positive association between alcohol intake 
and DBP remained statistically significant with adjustment for food groups (Table 4.48).  Among 
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food groups, oils (row L) produced the largest reduction in DBP coefficient (3.9%), then grains (row 
D), vegetables (row B), processed meats (row J), oils (row L) and animal fat (row M).  Adjustment 
for seafood (row F) or dairy (row K) modestly increased the alcohol-DBP coefficients.  
Table 4.49 shows that oils produced the biggest reduction (5.1%) in alcohol-DBP coefficient for 
female drinkers.  The alcohol-DBP associations were significant in all models.  Among food groups 
considered singly, poultry (row H), seafood (row F), grains (row D) and non-alcoholic beverage 
(row N) increased the coefficients modestly.  
In summary, there was a small modification of alcohol-BP relationship by nutrients/foods.  P, Mg 
and non-haem Fe were consistently having a reductive effect on the alcohol-BP association. 
4.10 Urinary amino acid excretion  
Differences in mean excretion of 22 urinary amino acids between non-drinkers and current drinkers 
were reported using ANOVA analyses. 
4.10.1 Urinary amino acid excretion of non-drinkers and current drinkers  
Among men, heavy drinkers had significant lower adjusted mean excretion of urinary alanine, 
glutamine, glycine and serine and significant higher excretion of urinary 3-methylhistidine and 
taurine compared to non-drinkers and moderate drinkers (Table 4.50).  Male teetotallers had 
higher excretion of urinary alanine, glutamine, phenylalanine, serine and threonine compared to 
male ex-drinkers, male moderate and heavy drinkers.  There were no significant differences in 
excretion of urinary asparagine, cystine, histidine, leucine, lysine, methionine, 1-methylhistidine, 
tyrosine or valine. 
Compared to female non-drinkers and moderate drinkers, Table 4.51 shows that female heavy 
drinkers had lower excretion of urinary alanine, glycine and serine after adjustment for 
confounders.  Female teetotallers had higher excretion of urinary alanine, cystine and isoleucine 
compared to other strata.  There were no significant differences in excretion of urinary arginine, 
asparagine, carnosine, ethanolalanine, lysine, methionine, 1-methylhistidine, phenylalanine, 
taurine, threonine or tyrosine among different strata of female participants. 
4.10.2 Urinary amino acid excretion of current drinkers  
Pattern of alcohol intake: Male drinkers who drank on 1- 6 days of 14 days had higher mean 
excretion of urinary alanine, ethanolalanine, glycine and serine and lower excretion of urinary 3-
methylhistidine compared to male drinkers who drank on 7-9 days, 10-12 days and 13-14 days 
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(Table 4.52).  Male drinkers who drank 13-14 days had significantly higher excretion of urinary 
arginine, 3-methylhistidine and taurine and lower excretion of urinary glycine compared to other 
male drinkers.  There was no significant difference in excretion of urinary asparagine, glutamine, 
isoleucine, methionine, 1-methylhistidine, phenylalanine, threonine, tryptophan or valine among 
different groups of male drinkers. 
Table 4.53 shows that female drinkers who drank on 1-6 days had higher mean excretion of 
urinary alanine and glycine compared to other female drinkers.  There were no other significant 
differences in excretion of urinary amino acids among female drinkers by their alcohol drinking 
pattern. 
Type of alcoholic beverage: Male drinkers who consumed mostly wine had higher mean 
excretion of urinary asparagine, glutamine, phenylalanine, serine and tyrosine and lower excretion 
of urinary leucine, methionine and taurine compared to male drinkers who consumed mostly beer 
or spirits or mixed type of alcoholic beverages (Table 4.54).  Male beer drinkers had higher 
excretion of urinary arginine and methionine compared to other male drinkers.  Men who drank 
mostly spirits had a higher excretion of urinary leucine and lower excretion of urinary asparagine, 
glutamine, phenylalanine, serine and tyrosine compared to beer drinkers, wine drinkers and mixed 
drinkers. 
Among women, beer drinkers had higher mean excretion of urinary arginine, leucine and 
methionine and lower excretion of urinary 1-methylhistidine and tryptophan compared to wine 
drinkers and spirits drinkers (Table 4.55).  Female wine drinkers had a higher excretion of urinary 
serine and lower excretion of urinary carnosine, methionine and 3-methylhistidine compared to 
other female drinkers.  Female spirits drinkers had higher excretion of urinary carnosine and 3-
methylhistidine than other female drinkers.   
4.11  Urinary metabolite profiling by 1H-NMR spectroscopy of the INTERMAP urine 
specimens 
The INTERMAP Study previously reported that different patterns of urinary metabolite excretion 
between East Asian and Western population samples based on 1H NMR spectroscopy (Holmes et 
al. 2008).  In this report here, the aim was to identify urinary metabolites that discriminate drinking 
groups, i.e., obtain further insight into factors related to lifestyle, environment, endogenous 
metabolism and gut microbial influences that may explain the alcohol-BP association. 
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4.11.1  Descriptive summary of quantified 1H NMR metabolites  
Male heavy drinkers had significantly lower levels of alanine and hippurate compared to male 
teetotallers, ex-drinkers and moderate drinkers (Table 4.56).  Male ex-drinkers had higher levels of 
alanine, formate and hippurate compared to other strata.  Female ex-drinkers had a lower level of 
hippurate compared to female teetotallers, moderate and heavy drinkers (Table 4.57).  Female 
heavy drinkers had higher NMNA excretion than other female strata. 
Pattern of alcohol intake: Male drinker who drank on 1-6 days of the 14 had higher excretion of 
alanine, formate and hippurate than male drinkers who had alcohol intake on 7-9 days, 10-12 days 
and 13-14 days (Table 4.58).  Female drinkers who drank on 1-6 days had higher excretion of 
alanine and formate than other female strata (Table 4.59). 
Type of alcoholic beverage: Male spirits drinkers had a significantly lower excretion of alanine 
than male wine drinkers or beer drinkers (Table 4.60).  Male wine drinkers had a noteworthily 
higher level of formate compared to other drinking groups.  Female drinkers who consumed more 
than 70% of alcohol from spirits had higher excretion of alanine and lower excretion of NMNA 
compared to other female drinkers (Table 4.61). 
Alcohol, NMR metabolites and blood pressure 
Both SBP and DBP were inversely correlated with urinary formate, hippurate and NMNA and 
positively correlated with urinary alanine; alcohol intake was inversely correlated with urinary 
alanine, formate and hippurate and positively correlated with urinary NMNA; none of these partial 
correlation coefficients were statistically significant.  Urinary formate was positively correlated with 
alanine (r=0.36), hippurate (r=0.36) and NMNA (r=0.41). Urinary hippurate was highly correlated 
with NMNA (r=0.50). 
The coefficients between urinary metabolites and SBP in the regression models for both men and 
women showed that formate and hippurate were inversely related to SBP; alanine and NMNA were 
positively related to SBP; none of these coefficients were statistically significant (Table 4.62 and 
Table 4.63).  All four NMR metabolites were inversely related to DBP for male drinkers; formate 
and hippurate were significantly related to DBP in the regression models (Table 4.64).  Urinary 
formate was inversely related to DBP for female drinkers and alanine, hippurate and NMNA were 
positively associated with DBP and only NMNA-DBP coefficient was significant (Table 4.65). 
Urinary hippurate and NMNA modestly decreased size of alcohol-SBP coefficients of male drinkers 
while alanine and formate increased the coefficients; the positive association between alcohol 
intake and SBP remained similar in the regression models (Table 4.62).  For female current 
drinkers, formate produced the biggest increment (43.1%) in alcohol-SBP coefficient and alanine 
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increased the coefficient by 24.7%; the positive association between alcohol and SBP was 
significant in these two models (Table 4.63).  Inclusion of hippurate and NMNA individually 
modestly reduced the alcohol-SBP coefficients of female drinkers; the association between alcohol 
and SBP became statistically insignificant.  
Table 4.64 shows that the alcohol-DBP associations were significant in all models; formate 
increased the coefficient the most at 11.2%.  Hippurate and NMNA modestly reduced the alcohol-
DBP coefficient in regression analyses of female drinkers; formate increased the coefficient by 
24.4% and alanine increased it by 8.9% (Table 4.65).  Alcohol-DBP coefficients were statistically 
significant in these models. 
In summary, there was a small modification of the alcohol-BP relationship by urinary metabolites in 
models for male drinkers.  For female drinkers, formate has the biggest effect on both alcohol-SBP 
and alcohol-DBP coefficients. 
4.11.2  Urinary metabolite profiling by 1H NMR spectroscopy of drinkers and non-
drinkers 
The median urinary 600 MHz 1H NMR spectrum of current alcohol drinkers from the first urine (in 
blue) and repeat urine (in green) collection are shown in Figure 4.13 for men and Figure 4.14 for 
women.  The median urinary 600 MHz 1H NMR spectrum of non-drinkers from the first urine (in 
blue) and repeat urine (in green) collection are shown in Figure 4.15 for men and Figure 4.16 for 
women.  There was no significant difference in the median spectrum between first and repeat urine 
collection of drinkers or non-drinkers; results from the first urine collection are presented in this 
report. 
Unsupervised multivariate PCA was applied in preliminary analyse of 1H NMR data, there were 
some degree of separations among different drinking groups (results not shown in this report).  
Supervised pattern recognition method PLS-DA yielded partial separation of male non-drinkers, 
moderate drinkers and heavy drinkers (Figure 4.17).  Female drinking groups were partly 
separated (Figure 4.18, observations associated with heavy drinkers on the left, non-drinkers on 
the right). 
OPLS-DA of urinary metabolic profiles using full resolution 1H NMR data of first urine specimens 
were used in this report.  Assignment of metabolites and metabolite identifications were made on 
the basis of extant literature (Beckonert et al. 2007; Lindon et al. 1999; Bohus et al. 2008).  
The median urinary 1D 1H NMR spectra of moderate drinkers and heavy drinkers from the first 
urine collection is shown in Figure 4.19 for men and Figure 4.20 for women.  Table 4.66, the NMR 
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resonance assignment table showed the list of discriminatory metabolites (and 1H chemical shift) 
observed in all the models in this report.   
Spectral differences between alcohol drinkers (moderate and heavy drinkers who had drunk 
alcohol from their 7-day alcohol records during data collection) and non-drinkers (teetotallers and 
non-drinkers) for men and women are shown in Figure 4.21 and Figure 4.22.   The OPLS-DA 
models demonstrated a weak correlation between these two groups; the discriminatory metabolites 
between drinkers and non-drinkers were ethanol and ethyl glucoside.   Apart from these two 
metabolites, male drinkers also had higher levels of acetate and NAG than male non-drinkers; 
female drinkers had higher levels of NMNA and unknown 3 (δ2.78, singlet) than female non-
drinkers.  
Discriminatory metabolites between alcohol drinkers and non-drinkers in Japan, PRC, UK and USA 
was summarised in Table 4.67.  OPLS-DA plots comparing drinkers and non-drinkers by country 
and gender demonstrated several metabolites of statistical importance.  Japanese male and 
female drinkers, Chinese male drinkers and US female drinkers had higher level of N-
acetylglycoprotein (NAG) to non-drinkers.  Excretion of 4-cresyl sulphate, citrate, dimethylamine, 
creatinine and hippurate were higher in male Japanese non-drinkers compared to drinkers.  UK 
male non-drinkers had higher levels of acetaminophen metabolites, citrate, creatinine, hippurate 
and NMNA compared to drinkers. 
4.11.3  Urinary metabolite profiling by 1H NMR spectroscopy by drinking status 
Discriminatory metabolites obtained by OPLS-DA among alcohol drinking groups was summarised 
in Table 4.68.  Compared to male ex-drinkers, male teetotallers had higher levels of NAG, 
glutamine, dimethylglycine (DMG), N,N,N-trimethyllysine and unknown 6 (δ7.67, singlet); lower 
levels of hippurate and NMNA.  Spectral differences showed that levels of urinary alanine, 
glutamine, S-methyl-L-cysteine sulphoxide, unknown 3 (δ2.78, singlet), N,N,N-trimethyllysine, 
unknown 6 and formate were higher and lower urinary 4-cresyl sulphate and hippurate levels in 
female teetotallers compared to female ex-drinkers.  
Male moderate drinkers had significantly higher level of ethyl glycoside and NMNA compared to 
male teetotallers; male teetotallers had higher levels of 2-methyl etythritol, alanine, NAG, 
glutamine, S-methyl-L-cysteine sulphoxide, unknown 3, DMG, N,N,N-trimethyllysine and unknown 
6 compared to male moderate drinkers.  Female teetotallers had higher levels of alanine, NAG, S-
methyl-L-cysteine sulphoxide, creatinine, proline betaine, unknown 3 and unknown 6 compared to 
female moderate drinkers. 
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Male heavy drinkers had higher level of unknown 1 (δ0.88, doublet) and unknown 2 (δ1.08, 
singlet), ethyl glucoside, acetate, NAG and S-methyl-L-cysteine sulphoxide compared to male 
teetotallers.  Female heavy drinkers had higher levels of unknown 1, ethyl glucoside and NMNA 
and lower level of alanine compared to female teetotallers.   Heavy drinkers had higher levels of 
ethanol, ethyl glucoside and NAG (also acetate for men) compared to moderate drinkers for men 
and for women. 
4.11.4  Urinary metabolite profiling by 1H NMR spectroscopy by alcohol drinking 
patterns  
The OPLS-DA coefficients plots indicated that male drinkers who drank alcohol on 1-6 days and 
those drank on 13-14 days of the 14 had higher levels of ethanol, ethyl glucoside, NAG and 
acetate (Figure C17) compared to those who drank only on 1-6 days.  Female drinkers who drank 
on 13-14 days had higher levels of ethanol, ethyl glucoside and NAG compared to female drinkers 
only drank on 1-6 days (Figure C18). 
4.11.5  Urinary metabolite profiling by 1H NMR spectroscopy by type of alcoholic beverage 
consumed 
Discriminatory metabolites from spectral differences among drinking groups (beer vs. wine; beer 
vs. spirits; wine vs. spirits) for men and women were shown in Table 4.69.   
Female wine drinkers had higher excretion of hippurate and lower levels of taurine and 
guanidinoacetate compared to female beer drinkers.  Male spirits drinkers had higher levels of 
urinary lactate, glutamine, S-methyl-L-cysteine sulphoxide, unknown 3 and unknown 6 to male 
beer drinkers.   Female beer drinkers had significantly higher levels of urinary guanidinoacetate 
and lower level of citrate and scyllo-inositol, compared to female spirits drinkers.   Male spirits 
drinkers had higher levels of lactate and NAG compared to male wine drinkers; female spirits 
drinkers reported significantly higher levels of 2-hydroxyisoburtyrate, alanine, NAG, dimethylamine, 
S-methyl-L-cysteine sulphoxide, dimethylglycine, NNN-trimethyllysine, NMNA, unknown 3 and 
unknown 6 compared to female wine drinkers. 
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Table 4.1 Summary descriptive statistics, mean (sd) or percentage, by country, INTERMAP 
Study, men 
 
 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
¶  Including self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
  
Variable Japan PRC UK US ALL 
N 574 416 266 1,103 2,359 
Age (years) 49.5 (5.3) 49.0 (6.0) 49.6 (5.6) 49.1 (5.4) 49.2 (5.5) 
Education (years) 12.3 (2.1) 6.5 (2.4) 13.1 (3.2) 15.4 (3.1) 12.8 (4.2) 
Employed (%)  98.8 94.7 85.3 90.8 92.8 
Married (%) 96.2 96.4 78.2 76.8 85.1 
Body Mass Index (kg/m2) 23.7 (2.7) 22.4 (2.5) 27.7 (3.9) 29.1 (5.1) 25.4 (5.0) 
Moderate/heavy physical activity (hours/day) 2.5 (3.6) 6.2 (3.8) 2.3 (2.7) 3.5 (3.3) 3.6 (3.6) 
On special diet∂ (%) 5.4 3.1 20.3 14.1 10.8 
Taking dietary supplements (%) 20.6 3.6 29.0 47.0 30.9 
Cigarette smoker (%) 51.7 68.3 16.9 19.1 35.5 
Family history of hypertension in any first degree relative 
    Yes (%) 47.7 33.9 45.1 62.4 51.8 
    Unknown (%) 34.8 24.3 39.9 26.5 29.6 
CVD-DMΩ diagnosis (%) 6.4 4.8 12.4 15.9 13.7 
Antihypertensive medication (%) 5.9 5.3 13.9 21.6 14.0 
Systolic blood pressure (mmHg) 120.4 (12.9) 120.9 (17.2) 123.7 (14.4) 120.4 (12.7) 120.8 (13.9) 
Diastolic blood pressure (mmHg) 76.8 (10.0) 73.7 (10.3) 80.7 (9.2) 75.7 (9.6) 76.2 (10.0) 
Current drinkers¶ (%) 97.2 72.6 91.7 76.1 82.4 
Mean 24-hour dietary alcohol intake (g/day) 27.8 (25.6) 17.7 (28.8) 17.9 (23.0) 10.3 (19.1) 16.7 (24.2) 
Mean daily alcohol intake from two 7-day 
records for current drinkers¶ only (g/day) 
30.9 (24.6) 23.3 (30.4) 22.1 (22.8) 13.8 (18.5) 21.2 (24.1) 
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Table 4.2 Summary descriptive statistics, mean (sd) or percentage, by country, INTERMAP 
Study, women 
 
 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
¶  Including self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Variable Japan PRC UK US ALL 
N 571 423 235 1,092 2,321 
Age (years) 49.2 (5.3) 48.9 (5.6) 48.6 (5.6) 49.2 (5.4) 49.1 (5.4) 
Education (years) 11.6 (2.0) 4.3 (2.9) 12.2 (2.9) 14.5 (2.9) 11.7 (4.6) 
Employed (%)  80.9 47.5 84.3 84.0 76.6 
Married (%) 87.9 89.6 74.5 61.6 74.5 
Body Mass Index (kg/m2) 23.2 (3.1) 23.9 (3.7) 27.3 (5.3) 28.7 (6.6) 26.3 (5.9) 
Moderate/heavy physical activity (hours/day) 2.6 (3.5) 5.8 (3.7) 2.0 (2.1) 3.0 (3.0) 3.3 (3.4) 
On special diet∂ (%) 7.9 7.6 22.1 22.4 16.1 
Taking dietary supplements (%) 21.9 4.5 48.5 56.6 37.7 
Cigarette smoker (%) 8.6 5.0 17.9 14.5 11.6 
Family history of hypertension in any first degree relative 
    Yes (%) 44.5 37.1 51.9 73.5 57.6 
    Unknown (%) 36.1 20.6 34.9 18.0 24.6 
CVD-DMΩ diagnosis (%) 6.5 9.2 8.9 15.4 11.4 
Antihypertensive medication (%) 6.8 9.7 12.3 22.4 15.3 
Systolic blood pressure (mmHg) 114.1 (13.9) 121.6 (17.7) 116.6 (13.8) 116.8 (14.8) 117.0 (15.3) 
Diastolic blood pressure (mmHg) 70.5 (9.6) 72.7 (10.1) 73.4 (9.3) 71.1 (9.2) 71.5 (9.5) 
Current drinkers¶ (%) 84.2 18.9 85.1 63.6 62.7 
Mean 24-hour dietary alcohol intake (g/day) 4.0 (8.3) 0.4 (2.2) 8.4 (12.9) 3.4 (9.0) 3.5 (8.8) 
Mean daily alcohol intake from two 7-day 
records for current drinkers¶ only (g/day) 
4.7 (8.6) 2.4 (4.4) 10.0 (11.9) 5.3 (8.6) 5.6 (9.2) 
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Table 4.3 Coefficient of intra-individual variation CV (%) in alcohol intake by methods of 
measurement, current drinkers§ only 
 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
 
 
 
 
Table 4.4 Pearson partial correlation coefficient between mean 24-hour dietary alcohol intake 
(g/day) from four dietary recalls and from two 7-day records (g/day) for current 
drinkers§ only 
 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
*  Adjusted for country and sex 
‡  Adjusted for country 
  
Drinking status  N  24-hour dietary recalls CV (%)  7-day records CV (%)  
   
 
Current drinker
§
  2,866  80.0  65.5  
Male drinker
§
  1,773  73.8  56.4  
Female drinker
§
  1,093  91.2  80.1  
   
 
 
Drinking status  N  Pearson partial correlation coefficient  
   
Current drinker
§
  2,866  0.86 *  
Male current drinker
§
  1,773  0.87 
‡
  
Female current drinker
§
  1,093  0.83 
‡
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Table 4.5 Number (percentage) of non-drinkers (teetotallers and ex-drinkers) and current alcohol 
drinkers (occasional drinkers∞, moderate drinkers and heavy drinkersΨ) by country, 
INTERMAP Study, men and women 
 
 
 Including teetotallers and ex-drinkers 
∞
 Occasional drinkers with no alcoholic beverages during data collection 
Ψ 
Heavy drinkers
 
with mean daily alcohol intake from two 7-day records >26 g/day for men and >13 g/day for women 
§ 
Including occasional drinkers with no alcoholic beverages during data collection 
  
Variable Japan  PRC  UK  US  ALL 
 Men Women  Men Women  Men Women  Men Women  Men Women 
N 574 571  416 423  266 235  1,103 1,092  2,359 2,321 
                         
Teetotaler 12 (02.1) 68 (11.9)  84 (20.2) 332 (78.5)  10 (03.8) 23 (09.8)  60 (05.4) 175 (16.0)  166 (07.0) 598 (25.8) 
Ex-drinker 4 (00.7) 22 (03.9)  30 (07.2) 11 (02.6)  12 (04.5) 12 (05.1)  204 (18.5) 223 (20.4)  250 (10.6) 268 (11.5) 
Non-drinker 16 (02.8) 90 (15.8)  114 (27.4) 343 (81.1)  22 (08.3) 35 (14.9)  264 (23.9) 398 (36.4)  416 (17.6) 866 (37.3) 
                         
Occasional drinker∞ 30 (05.2) 128 (22.4)  7 (01.7) 7 (01.7)  25 (09.4) 33 (14.0)  108 (09.8) 194 (17.8)  170 (07.2) 362 (15.6) 
Moderate drinker 245 (42.7) 298 (52.2)  202 (48.6) 69 (16.3)  137 (51.5) 115 (48.9)  590 (53.5) 415 (38.0)  1,174 (49.8) 897 (38.6) 
Heavy drinkerΨ 283 (49.3) 55 (09.6)  93 (22.4) 4 (00.9)  82 (30.8) 52 (22.1)  141 (12.8) 85 (07.8)  599 (25.4) 196 (08.4) 
Current drinker§ 558 (97.2) 481 (84.2)  302 (72.6) 80 (18.9)  244 (91.7) 200 (85.1)  839 (76.1) 694 (63.6)  1,943 (82.4) 1,455 (62.7) 
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Table 4.6 Mean (SD) alcohol intake from four 24-hour dietary recalls and two 7-day records by 
alcohol drinking status (teetotallers, ex-drinkers, moderate drinkers¶ and heavy 
drinkersΨ), INTERMAP Study, men 
 
 
¶  Including self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, men: mean daily alcohol intake from two 7-day records >26 g/day 
  
Drinking status N 
Alcohol intake (g/day) from 
four 24-hour dietary recalls 
Alcohol intake (g/day) from 
two 7-day records 
  mean (SD) mean (SD) 
    
All men      
Teetotaller 166 0.2 (0.6) - - 
Ex-drinker 250 0.2 (1.0) - - 
Moderate drinker¶ 1,344 8.2 (10.6) 8.3 (7.6) 
Heavy drinkerΨ 599 47.3 (27.5) 50.3 (23.1) 
      
Japan male drinkers only      
Moderate drinker¶ 275 9.8 (10.5) 10.7 (8.1) 
Heavy drinkerΨ 283 46.9 (24.4) 50.6 (18.5) 
      
PRC male drinkers only      
Moderate drinker¶ 209 8.5 (10.2) 7.6 (7.5) 
Heavy drinkerΨ  93 59.6 (34.0) 58.6 (33.0) 
      
UK male drinkers only      
Moderate drinker¶ 162 9.0 (10.8) 9.6 (8.0) 
Heavy drinkerΨ 82 40.2 (27.5) 46.8 (22.3) 
      
US male drinkers only      
Moderate drinker¶ 698 7.2 (10.7) 7.3 (7.0) 
Heavy drinkerΨ 141 44.3 (29.9) 46.4 (22.7) 
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Table 4.7 Mean (SD) alcohol intake from four 24-hour dietary recalls and two 7-day records by 
alcohol drinking status (teetotallers, ex-drinkers, moderate drinkers¶ and heavy 
drinkersΨ), INTERMAP Study, women 
 
 
¶  Including self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, women: mean daily alcohol intake from two 7-day records >13 g/day 
Drinking status N 
Alcohol intake (g/day) from 
four 24-hour dietary recalls 
Alcohol intake (g/day) from 
two 7-day records 
  mean (SD) mean (SD) 
    
All women      
Teetotaller 598 0.1 (0.2) - - 
Ex-drinkers 268 0.1 (0.2) - - 
Moderate drinker¶ 1,259 2.6 (4.6) 2.6 (3.3) 
Heavy drinkerΨ 196 24.3 (17.0) 24.5 (11.8) 
      
Japan female drinkers only      
Moderate drinker¶ 426 2.3 (3.9) 2.1 (2.9) 
Heavy drinkerΨ 55 23.9 (12.2) 24.5 (11.8) 
      
PRC female drinkers only      
Moderate drinker¶ 76 1.2 (2.1) 1.6 (2.2) 
Heavy drinkerΨ 4 19.1 (10.0) 18.3 (6.2) 
      
UK female drinkers only      
Moderate drinker§ 148 4.4 (5.8) 4.2 (4.0) 
Heavy drinkerΨ 52 25.3 (16.9) 26.2 (11.8) 
      
US female drinkers only      
Moderate drinker§ 609 2.5 (4.8) 2.7 (3.3) 
Heavy drinkerΨ  85 24.3 (19.9) 23.7 (11.9) 
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Table 4.8 Characteristics‡ (mean values or percentage) by alcohol drinking status (teetotallers, 
ex-drinkers, moderate drinkers¶ and heavy drinkersΨ), INTERMAP Study, men 
 
 
‡  Adjusted for country 
¶  Including self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, men: mean daily alcohol intake from two 7-day records >26 g/day 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
∞  Family history of hypertension: known hypertension in any first degree relatives 
∆  F-test in analysis of variance  
  
 Drinking status  
 Teetotaller Ex-drinker 
Moderate 
drinker§ 
Heavy 
drinkerΨ  
Variable                                                    N 166 250 1,344 599 p-value∆ 
(%) (7.0) (10.6) (57.0) (25.4)   
      
Age (years) 49.4 49.3 49.1 49.6 0.3 
Education (years) 12.0 11.0 12.0 11.7 <0.0001 
Employed (yes, %) 92.8 85.2 93.4 94.8 0.0008 
Married (yes, %) 90.4 78.0 84.3 88.5 0.7 
BMI (kg/m2) 25.6 26.3 25.7 25.5 0.1 
Moderate or heavy physical activity (hrs/day) 3.0 3.8 3.5 3.9 0.02 
On special diet∂ (yes, %) 9.0 20.4 11.2 6.2 <0.0001 
Taking dietary supplements (yes, %) 17.5 44.0 33.0 24.4 0.2 
Cigarette Smoker (yes, %) 34.9 21.2 31.3 50.9 <0.0001 
CVD-DM diagnosisΩ (yes, %) 9.6 19.2 13.0 13.9 0.1 
Antihypertensive medication (yes, %) 12.1 23.2 14.1 10.5 0.2 
Family history of hypertension∞ (yes, %)  47.6 55.2 54.0 46.7 0.4 
Urinary sodium (mmol/24hr) 201.6 204.2 200.9 195.9 0.4 
Urinary potassium (mmol/24hr) 53.8 55.5 57.5 56.4 0.06 
Urinary Na to urinary K ratio 4.4 4.3 4.2 4.1 0.2 
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Table 4.9 Characteristics‡ (mean values or percentage) by alcohol drinking status (teetotallers, 
ex-drinkers, moderate drinkers¶ and heavy drinkersΨ), INTERMAP Study, women 
 
 
‡  Adjusted for country 
¶  Including self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, men: mean daily alcohol intake from two 7-day records >26 g/day 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
∞  Family history of hypertension: known hypertension in any first degree relatives 
∆  F-test in analysis of variance  
  
 Drinking status  
 Teetotaller Ex-drinker 
Moderate 
drinker§ 
Heavy 
drinkerΨ  
Variable                                                    N 598 268 1,259 196 p-value∆ 
(%) (25.8) (11.6) (54.2) (8.4)   
      
Age (years) 49.3 49.0 49.0 47.9 0.05 
Education (years) 10.5 10.4 10.7 11.1 0.02 
Employed (yes, %) 59.9 80.6 82.2 86.2 0.008 
Married (yes, %) 81.8 62.3 74.3 69.9 0.3 
BMI (kg/m2) 26.6 26.2 25.5 24.6 <0.0001 
Moderate or heavy physical activity (hrs/day) 3.2 3.6 3.4 3.4 0.4 
On special diet∂ (yes, %) 13.9 23.5 16.0 13.3 0.07 
Taking dietary supplements (yes, %) 20.4 47.8 42.9 43.9 0.02 
Cigarette Smoker (yes, %) 5.9 11.6 11.4 30.6 <0.0001 
CVD-DM diagnosisΩ (yes, %) 11.4 19.8 10.3 7.1 0.003 
Antihypertensive medication (yes, %) 15.7 24.3 13.7 11.2 0.003 
Family history of hypertension∞ (yes, %)  52.7 72.4 56.2 61.2 0.007 
Urinary sodium (mmol/24hr) 169.0 165.1 165.8 163.9 0.7 
Urinary potassium (mmol/24hr) 47.4 47.5 50.8 51.2 0.0002 
Urinary Na to urinary K ratio 4.1 3.9 3.7 3.8 0.001 
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Table 4.10 Number (percentage) of moderate drinkers§ and heavy drinkersΨ by daily alcohol 
drinking pattern (number of days alcohol was consumed) from two 7-day alcohol 
records, by country, INTERMAP Study, men and women 
 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day; women, mean daily alcohol intake from two 7-
day records >13 g/day  
  
Variable Japan PRC UK US Total 
      
Number of days (of 14) alcohol was consumed, men 
Moderate drinkers§      
1-6 days 128 (52.2) 165 (81.7) 105 (76.6)   487 (82.5) 885 (75.4) 
7-9 days 30 (12.2) 15 (07.4) 17 (12.4) 60 (10.2) 122 (10.4) 
10-12 days 41 (16.7) 17 (08.4) 11 (08.0) 32 (05.4) 101 (08.6) 
13-14 days 46 (18.8) 5 (02.5) 4 (02.9) 11 (01.9) 66 (05.6) 
Heavy drinkers Ψ      
1-6 days 6 (02.1) 2 (02.2) 17 (20.7) 17 (12.1) 42 (07.0) 
7-9 days 19 (06.7) 10 (10.8) 30 (36.6) 31 (22.0) 90 (15.0) 
10-12 days 38 (13.4) 51 (54.8) 18 (22.0) 34 (24.1) 141 (23.5) 
13-14 days 220 (77.7) 30 (32.3) 17 (20.7) 59 (41.8) 326 (54.4) 
      
Number of days (of 14) alcohol was consumed, women 
Moderate drinkers§      
1-6 days 230 (77.2) 57 (82.6) 99 (86.1) 391 (94.2) 777 (86.6) 
7-9 days 38 (12.8) 6 (08.7) 9 (07.8) 22 (05.3) 75 (08.4) 
10-12 days 19 (06.4) 4 (05.8) 5 (04.3) 2 (00.5) 30 (03.3) 
13-14 days 11 (03.7) 2 (02.9) 2(01.7) 0 (00.0) 15 (01.7) 
Heavy drinkers Ψ      
1-6 days 1 (01.8) 0 (00.0) 12 (23.1) 24 (28.2) 37 (18.9) 
7-9 days 10 (18.2) 0 (00.0) 22 (42.3) 24 (28.2) 56 (28.6) 
10-12 days 14 (25.5) 2 (50.0) 7 (13.5) 23 (27.1) 46 (23.5) 
13-14 days 30 (54.5) 2 (50.0) 11 (21.2) 14 (16.5) 57 (29.1) 
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Table 4.11 Mean‡ (standard error), daily alcohol intake (g/day) from two 7-day alcohol records by 
alcohol drinking pattern (number of days of 14 alcohol was consumed) and amount of 
alcohol (moderate drinkers§ and heavy drinkersΨ), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, men: mean daily alcohol intake from two 7-day records >26 g/day 
γ  F-test in analysis of variance  
  
Number of days (of 14)  
alcohol was consumed 
Moderate drinkers§ 
(N=1,174) 
Heavy drinkersΨ 
(N=599) 
mean (SE) mean (SE) 
   
Mean daily alcohol intake (g/day) over all 14 days  
1-6 days 6.7 (0.5) 39.6 (4.6) 
7-9 days 15.1 (0.7) 45.4 (3.5) 
10-12 days 17.9 (0.8) 56.2 (3.3) 
13-14 days 20.2 (0.9) 61.7 (3.1) 
p-value γ <0.0001 <0.0001 
   
Mean daily alcohol intake (g/day) on drinking days only 
1-6 days 33.0 (1.9) 115.0 (6.1) 
7-9 days 30.3 (2.6) 75.8 (4.7) 
10-12 days 26.2 (2.7) 70.4 (4.4) 
13-14 days 23.4 (3.2) 65.8 (4.2) 
p-value γ 0.0004 <0.0001 
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Table 4.12 Mean‡ (standard error), daily alcohol intake (g/day) from two 7-day alcohol records by 
alcohol drinking pattern (number of days of 14 alcohol was consumed) and amount of 
alcohol (moderate drinkers§ and heavy drinkersΨ), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, women: mean daily alcohol intake from two 7-day records >13 g/day 
γ  F-test in analysis of variance  
  
Number of days (of 14)  
alcohol was consumed 
Moderate drinkers§ 
(N=897) 
Heavy drinkersΨ 
(N=196) 
mean (SE) mean (SE) 
   
Mean daily alcohol intake (g/day) over all 14 days  
1-6 days∆ 2.8 (0.3) 11.2 (2.9) 
7-9 days∆ 7.5 (0.4) 15.1 (2.7) 
10-12 days∆ 8.9 (0.6) 22.2 (2.7) 
13-14 days∆ 8.5 (0.8) 28.8 (2.7) 
p-value γ <0.0001 <0.0001 
   
Mean daily alcohol intake (g/day) on drinking days only 
1-6 days∆ 15.5 (1.3) 41.8 (3.7) 
7-9 days∆ 14.7 (2.0) 27.8 (3.5) 
10-12 days∆ 14.3 (2.8) 25.2 (3.5) 
13-14 days∆ 13.2 (3.7) 27.2 (3.5) 
p-value γ 0.8 <0.0001 
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Table 4.13 Characteristics‡ (mean values or percentage) of current drinkers§ by alcohol drinking 
pattern (number of days of alcohol consumption of 14) from two 7-day records), men 
 
 
‡  Adjusted for country 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
∞  Family history of hypertension: known hypertension in any first degree relatives 
∆ F-test in analysis of variance  
  
Number of days of alcohol consumption
Variable 1-6 days 7-9 days 10-12 days 13,14 days
N 927 212 242 392 p-value∆
(%) (52.3) (12.0) (13.7) (22.1)
Age (years) 48.8 48.8 50.1 50.0 0.0002
Education (years) 11.8 12.4 11.8 11.9 0.08
Employed (yes, %) 92.9 91.5 95.0 96.7 0.9
Married (yes, %) 83.3 85.4 90.5 91.1 0.8
BMI (kg/m2) 26.0 25.2 25.4 25.1 0.0006
Moderate or heavy physical activity (hrs/day) 3.6 3.4 4.0 4.0 0.1
On special diet∂ (yes, %) 11.7 9.4 7.4 4.9 0.1
Taking dietary supplements (yes, %) 31.9 35.9 24.0 25.3 0.4
Cigarette Smoker (yes, %) 31.5 29.3 45.9 55.1 <0.0001
CVD-DM diagnosisΩ (yes, %) 13.2 11.8 12.4 14.3 0.9
Antihypertensive medication (yes, %) 14.4 13.7 10.7 7.4 0.8
Family history of hypertension∞ (yes, %) 56.0 48.1 45.9 44.4 0.03
Urinary sodium (mmol/24hr) 202.1 202.3 194.7 190.7 0.07
Urinary potassium (mmol/24hr) 56.3 59.1 57.0 57.1 0.2
Urinary Na to urinary K ratio 4.3 4.1 4.1 3.9 0.02
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Table 4.14 Characteristics‡ (mean values or percentage) of current drinkers§ by alcohol drinking 
pattern (number of days of alcohol consumption of 14) from two 7-day records), women 
 
 
‡  Adjusted for country 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
∞  Family history of hypertension: known hypertension in any first degree relatives 
∆  F-test in analysis of variance  
  
Number of days of alcohol consumption
Variable 1-6 days 7-9 days 10-12 days 13,14 days
N 814 131 76 72 p-value∆
(%) (74.5) (12.0) (7.0) (6.6)
Age (years) 48.9 48.9 48.8 49.0 1.0
Education (years) 10.7 11.4 10.8 11.1 0.01
Employed (yes, %) 82.6 87.0 76.3 84.7 0.3
Married (yes, %) 73.1 75.6 76.3 84.7 0.8
BMI (kg/m2) 25.7 23.9 24.5 24.8 0.0007
Moderate or heavy physical activity (hrs/day) 3.7 3.2 3.4 3.6 0.4
On special diet∂ (yes, %) 15.4 15.3 11.8 9.7 0.9
Taking dietary supplements (yes, %) 42.5 45.8 36.8 31.9 0.5
Cigarette Smoker (yes, %) 14.5 16.0 18.4 25.0 0.02
CVD-DM diagnosisΩ (yes, %) 9.0 4.6 7.9 2.8 0.2
Antihypertensive medication (yes, %) 12.3 12.2 7.9 12.5 0.7
Family history of hypertension∞ (yes, %) 57.4 51.9 59.2 50.0 0.7
Urinary sodium (mmol/24hr) 166.3 159.7 154.0 158.5 0.1
Urinary potassium (mmol/24hr) 50.8 54.1 48.5 52.0 0.08
Urinary Na to urinary K ratio 3.7 3.4 3.7 3.5 0.1
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Table 4.15 Number (percentage) of moderate drinkers§ and heavy drinkersΨ by alcoholic beverage 
type consumed, from two 7-day records, by country, men 
 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, men: mean daily alcohol intake from two 7-day records >26 g/day 
∆  Combination of alcoholic beverages: beer, wine and spirits 
  
Alcoholic Beverage Type  Japan PRC UK US ALL 
      
Moderate drinkers§      
>70% beer 106 (43.3) 28 (13.9) 66 (48.2) 291 (49.3) 491 (41.8) 
>70% wine 48 (19.6) 0 (00.0) 26 (19.0) 88 (14.9) 162 (13.8) 
>70% spirits 15 (06.1) 160 (79.2) 10 (07.3) 80 (13.6) 265 (22.6) 
Mixed∆ 76 (31.0) 14 (06.9) 35 (25.6) 131 (22.2) 256 (21.8) 
      
Beer & wine 29 (38.2) 0 (000.0) 7 (20.0) 38 (29.0) 74 (28.9) 
Beer & spirits 15 (19.7) 14 (100.0) 5 (14.3) 29 (22.1) 63 (24.6) 
Wine & spirits 1 (01.3) 0 (000.0) 5 (14.3) 12 (09.2) 18 (07.0) 
Beer, wine & spirits 31 (40.8) 0 (000.0) 18 (51.4) 52 (39.7) 101 (39.5) 
      
Heavy drinkers Ψ      
>70% beer 59 (20.9) 0 (00.0) 37 (45.1) 75 (53.2) 171 (28.6) 
>70% wine 69 (24.4) 0 (00.0) 5 (06.1) 15 (10.6) 89 (14.9) 
>70% spirits 28 (09.9) 89 (95.7) 6 (07.3) 21 (14.9) 144 (24.0) 
Mixed∆ 127 (44.9) 4 (04.3) 34 (41.5) 30 (21.3) 195 (32.6) 
      
Beer & wine 21 (16.5) 0 (000.0) 3 (08.8) 2 (06.7) 26 (13.3) 
Beer & spirits 18 (14.2) 4 (100.0) 6 (17.7) 9 (30.0) 37 (19.0) 
Wine & spirits 3 (02.4) 0 (000.0) 1 (02.9) 1 (03.3) 5 (02.6) 
Beer, wine & spirits 85 (66.9) 0 (000.0) 24 (70.6) 18 (60.0) 127 (65.1) 
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Table 4.16 Number (percentage) of moderate drinkers§ and heavy drinkersΨ by alcoholic beverage 
type consumed, from two 7-day records, by country, women 
 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, women: mean daily alcohol intake from two 7-day records >13 g/day 
∆  Combination of alcoholic beverages: beer, wine and spirits 
  
Alcoholic Beverage Type  Japan PRC UK US ALL 
      
Moderate drinkers§      
>70% beer 145 (48.7) 14 (20.3) 19 (16.5) 63 (15.2) 241 (26.9) 
>70% wine 45 (15.1) 1 (01.5) 52 (45.2) 170 (41.0) 268 (29.9) 
>70% spirits 45 (15.1) 51 (73.9) 20 (17.4) 102 (24.6) 218 (24.3) 
Mixed∆ 63 (21.1) 3 (04.4) 24 (20.9) 80 (19.3) 170 (19.0) 
      
Beer & wine 26 (41.3) 0 (000.0) 4 (16.7) 19 (23.8) 49 (28.8) 
Beer & spirits 13 (20.6) 3 (100.0) 1 (04.2) 11 (13.8) 28 (16.5) 
Wine & spirits 5 (07.9) 0 (000.0) 13 (54.2) 30 (37.5) 48 (28.2) 
Beer, wine & spirits 19 (30.2) 0 (000.0) 6 (25.0) 20 (25.0) 45 (26.5) 
      
Heavy drinkers Ψ      
>70% beer 36 (65.5) 0 (00.0) 3 (05.8) 17 (20.0) 56 (28.6) 
>70% wine 4 (07.3) 0 (00.0) 19 (36.5) 31 (36.5) 54 (27.6) 
>70% spirits 2 (  3.6) 3 (75.0) 9 (17.3) 11 (12.9) 25 (12.8) 
Mixed∆ 13 (23.6) 1 (25.0) 21 (40.4) 26 (30.6) 61 (31.1) 
      
Beer & wine 0 (00.0) 0 (000.0) 0 (00.0) 3 (11.5) 3 (04.9) 
Beer & spirits 4 (30.8) 1 (100.0) 2 (09.5) 4 (15.4) 11 (18.0) 
Wine & spirits 0 (00.0) 0 (000.0) 4 (19.1) 7 (26.9) 11 (18.0) 
Beer, wine & spirits 9 (69.2) 0 (00.00) 15 (71.4) 12 (46.2) 36 (59.0) 
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Table 4.17 Mean‡ (standard error), daily alcohol intake (g/day) by alcoholic beverage type, 
moderate drinkers§ and heavy drinkersΨ, men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, men: mean daily alcohol intake from two 7-day records >26 g/day 
∆  F-test in analysis of variance  
  
Alcoholic Beverage Type  
Moderate drinkers§ 
(N=1,174) 
Heavy drinkersΨ 
(N=599) 
 Mean (SE) Mean (SE) 
   
Mean daily alcohol intake (g/day) over all 14 days 
>70% alcohol intake from beer 8.9 (0.7) 52.0 (3.6) 
>70% alcohol intake from wine 7.2 (0.8) 51.2 (4.0) 
>70% alcohol intake from spirits 9.2 (0.8) 59.3 (3.6) 
Combination of beer, wine and spirits 11.0 (0.8) 52.2 (3.5) 
p-value∆ <0.0001 0.1 
   
Mean daily alcohol intake (g/day) on drinking days only 
>70% alcohol intake from beer 29.5 (2.0) 63.9 (5.0) 
>70% alcohol intake from wine 26.3 (2.4) 62.6 (5.5) 
>70% alcohol intake from spirits 34.8 (2.2) 80.1 (4.9) 
Combination of beer, wine and spirits 33.8 (2.2) 68.2 (4.8) 
p-value∆ 0.0002 0.003 
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Table 4.18 Mean‡ (standard error), daily alcohol intake (g/day) by alcoholic beverage type, 
moderate drinkers§ and heavy drinkersΨ, women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: women, mean daily alcohol intake from two 7-day records >13 g/day 
∆  F-test in analysis of variance  
  
Alcoholic Beverage Type 
Moderate drinkers§ 
(N=897) 
Heavy drinkersΨ 
 (N=196) 
 Mean (SE) Mean (SE) 
   
Mean daily alcohol intake (g/day) over all 14 days 
>70% alcohol intake from beer 3.5 (0.4) 22.4 (3.4) 
>70% alcohol intake from wine 2.9 (0.4) 18.4 (3.1) 
>70% alcohol intake from spirits 3.3 (0.4) 22.8 (3.6) 
Combination of beer, wine and spirits 5.1 (0.4) 18.9 (3.1) 
p-value∆ <0.0001 0.3 
   
Mean daily alcohol intake (g/day) on drinking days only 
>70% alcohol intake from beer 14.0 (1.5) 28.9 (4.1) 
>70% alcohol intake from wine 13.4 (1.6) 27.1 (3.7) 
>70% alcohol intake from spirits 17.4 (1.6) 35.8 (4.4) 
Combination of beer, wine and spirits 16.4 (1.6) 30.4 (3.7) 
p-value∆ 0.006 0.1 
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Table 4.19 Characteristics‡ (mean values or percentage) of current drinkers§ by alcoholic beverage 
type consumed (beer, wine, spirits and mixed∆), men 
 
 
‡  Adjusted for country 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
∞  Family history of hypertension: known hypertension in any first degree relatives 
γ  F-test in analysis of variance  
∆  Combination of alcoholic beverages: beer, wine and spirits 
 
  
Alcoholic beverage type consumed
Variable
>70% 
Beer
>70% 
Wine
>70% 
Spirits
Mixed
N 662 251 409 451 p-valueγ
(%) (37.3) (14.2) (23.1) (25.4)
Age (years) 48.7 50.0 49.6 49.2 0.005
Education (years) 11.5 12.6 11.6 12.6 <0.0001
Employed (yes, %) 92.0 96.0 93.2 96.0 0.006
Married (yes, %) 82.5 88.8 88.5 88.3 0.08
BMI (kg/m2) 25.6 25.0 25.9 25.7 0.06
Moderate or heavy physical activity (hrs/day) 4.0 3.8 3.6 3.2 0.002
On special diet∂ (yes, %) 8.8 10.0 7.8 11.1 0.2
Taking dietary supplements (yes, %) 32.2 37.9 17.4 33.3 0.004
Cigarette Smoker (yes, %) 31.7 35.9 57.7 32.2 0.0006
CVD-DM diagnosisΩ (yes, %) 13.8 15.1 9.5 14.4 0.3
Antihypertensive medication (yes, %) 14.4 10.4 7.1 14.9 0.3
Family history of hypertension∞ (yes, %) 57.0 50.6 42.3 50.8 0.1
Urinary sodium (mmol/24hr) 200.5 197.3 194.4 201.8 0.6
Urinary potassium (mmol/24hr) 55.6 61.2 53.5 60.5 <0.0001
Urinary Na to urinary K ratio 4.2 4.0 4.3 4.0 0.1
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Table 4.20 Characteristics‡ (mean values or percentage) of current drinkers§ by alcoholic beverage 
type consumed (beer, wine, spirits and mixed∆), women 
 
 
‡  Adjusted for country 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
∞  Family history of hypertension: known hypertension in any first degree relatives 
γ  F-test in analysis of variance  
∆  Combination of alcoholic beverages: beer, wine and spirits 
 
  
Alcoholic beverage type consumed
Variable
>70% 
Beer
>70% 
Wine
>70% 
Spirits
Mixed
N 297 322 243 231 p-valueγ
(%) (27.2) (29.5) (22.2) (21.1)
Age (years) 48.6 49.2 49.1 48.5 0.4
Education (years) 10.5 11.6 10.1 11.4 <0.0001
Employed (yes, %) 78.1 84.8 83.1 85.7 0.0007
Married (yes, %) 77.8 75.8 70.0 72.7 0.01
BMI (kg/m2) 25.7 24.2 25.9 25.4 0.0002
Moderate or heavy physical activity (hrs/day) 3.2 3.6 4.0 3.4 0.1
On special diet∂ (yes, %) 11.1 18.1 14.0 15.6 0.8
Taking dietary supplements (yes, %) 28.3 53.1 37.9 47.6 0.004
Cigarette Smoker (yes, %) 21.9 10.6 14.8 15.6 <0.0001
CVD-DM diagnosisΩ (yes, %) 7.4 7.5 9.1 8.2 0.8
Antihypertensive medication (yes, %) 10.8 11.8 14.4 11.3 0.08
Family history of hypertension∞ (yes, %) 53.2 59.3 53.5 59.3 0.8
Urinary sodium (mmol/24hr) 168.2 159.5 165.2 162.5 0.3
Urinary potassium (mmol/24hr) 47.8 53.2 50.8 53.4 0.0002
Urinary Na to urinary K ratio 4.0 3.4 3.7 3.5 <0.0001
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Table 4.21 Mean systolic and diastolic blood pressure‡ by alcohol drinking status, men and women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
¶ Self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day; women, mean daily alcohol intake from two 7-
day records >13 g/day  
∆  F-test in analysis of variance  
a  p<0.01 for heavy drinkers vs. teetotallers 
b  p<0.01 for heavy drinkers vs. ex-drinkers 
c  p<0.01 for heavy drinkers vs. occasional drinkers 
d  p<0.01 for heavy drinkers vs. moderate drinkers 
Drinking status  
Systolic BP Diastolic BP 
N mean (SE)  mean (SE)  
    
 
  
 
Men 
   
 
  
 
Teetotaller 166 122.7 (1.3) a 76.0 (0.9)  
Ex-drinker 250 122.1 (1.1) b 74.6 (0.8) b 
Occasional drinker¶ 170 120.3 (1.2) c 74.7 (0.9) c 
Moderate drinker 1,174 122.3 (0.8) d 76.2 (0.6) d 
Heavy drinkerΨ 599 125.7 (0.9)  77.8 (0.7)  
p-value∆ 
 
<0.0001  <0.0001  
    
 
  
 
Women 
   
 
  
 
Teetotaller 598 118.9 (0.9)  70.7 (0.6) a 
Ex-drinker 268 118.6 (1.1)  70.8 (0.7) b 
Occasional drinker¶ 362 118.7 (1.0)  70.9 (0.7) c 
Moderate drinker 897 118.3 (0.8) d 71.4 (0.5) d 
Heavy drinkerΨ 196 121.4 (1.2)  73.5 (0.8)  
p-value∆ 
 
0.09  0.01  
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Table 4.22 Mean systolic and diastolic blood pressure‡ of non-alcohol drinkers (teetotallers and ex-
drinkers), occasional¶ drinkers and current drinkers by alcohol drinking pattern, men 
and women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
¶ Self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
∆  F-test in analysis of variance  
a  p<0.01 for drinkers drank on 13,14 days vs. teetotallers 
b  p<0.01 for drinkers drank on 1-6 days vs. drinkers drank on 13,14 days 
c  p<0.01 for drinkers drank on 1-6 days vs. drinkers drank on 7-9 days 
d  p<0.01 for drinkers drank on 13,14 days vs. ex-drinkers 
e  p<0.01 for drinkers drank on 7-9 days vs. ex-drinkers 
f  p<0.01 for drinkers drank on 10-12 days vs. ex-drinkers 
g  p<0.01 for drinkers drank on 13,14 days vs. occasional drinkers 
  
Drinking status  
Systolic BP Diastolic BP 
N mean (SE)  mean (SE)  
    
 
  
 
Men 
   
 
  
 
Teetotaller 166 122.6 (1.3) a 75.9 (0.9)  
Ex-drinker 250 121.9 (1.1)  74.5 (0.8)  
Occasional drinker¶ 170 120.3 (1.2) g 74.7 (0.9) g 
Current drinker 
   
 
  
 
Drank alcohol on 1-6 days 927 121.9 (0.8) b 75.9 (0.6) b 
Drank alcohol on 7-9 days 212 124.6 (1.1) c 78.2 (0.8) c  
Drank alcohol on 10-12 days 242 124.2 (1.1)  77.0 (0.8) f 
Drank alcohol on 13, 14 days 392 126.2 (1.0) d 78.0 (0.7) d 
p-value∆ 
 
<0.0001  <0.0001  
    
 
  
 
Women 
   
 
  
 
Teetotaller 598 118.9 (0.9)  70.8 (0.6) a 
Ex-drinker 268 118.5 (1.1)  70.7 (0.7)  
Occasional drinker¶ 362 118.7 (1.0)  71.0 (0.7) g 
Current drinker 
   
 
  
 
Drank alcohol on 1-6 days 814 118.1 (0.8) b 71.3 (0.6)  
Drank alcohol on 7-9 days 131 120.6 (1.4)  72.9 (0.9)  
Drank alcohol on 10-12 days 76 120.3 (1.7)  72.6 (1.1)  
Drank alcohol on 13, 14 days 72 122.8 (1.7)  74.1 (1.1) d 
p-value∆ 
 
0.08  0.02  
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Table 4.23 Mean systolic and diastolic blood pressure‡ of non-alcohol drinkers (teetotallers and ex-
drinkers), occasional¶ drinkers and current drinkers by alcoholic beverage type 
consumed, from two 7-day records, men and women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
¶ Self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
γ  F-test in analysis of variance  
 
  
Drinking status  
Systolic BP Diastolic BP 
N mean (SE)  mean (SE)  
    
 
  
 
Men 
   
 
  
 
Teetotaller 166 123.0 (1.3)  76.2 (0.9)  
Ex-drinker 250 122.3 (1.1)  74.7 (0.8)  
Occasional drinker¶ 170 120.3 (1.2)  74.6 (0.9)  
Current drinker 
   
 
  
 
„Beer‟ drinker 662 123.2 (0.9)  76.2 (0.7)  
„Wine‟ drinker 251 122.8 (1.1)  76.7 (0.8)  
„Spirits‟ drinker 409 124.1 (1.0)  77.3 (0.7)  
„Mixed‟ drinker∆ 451 123.0 (1.0)  76.8 (0.7)  
p-valueγ 
  
0.1  
 
0.009  
    
 
  
 
Women 
   
 
  
 
Teetotaller 598 119.1 (0.9)  70.9 (0.6)  
Ex-drinker 268 118.7 (1.1)  70.9 (0.7)  
Occasional drinker¶ 362 118.8 (1.0)  71.0 (0.7)  
Current drinker 
   
 
  
 
„Beer‟ drinker 297 119.5 (1.0)  71.7 (0.7)  
„Wine‟ drinker 322 118.1 (1.1)  71.6 (0.7)  
„Spirits‟ drinker 243 118.8 (1.1)  72.1 (0.7)  
„Mixed‟ drinker∆ 231 119.5 (1.1)  72.1 (0.7)  
p-valueγ 
  
0.9  
 
0.5  
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Table 4.24  Blood pressure difference‡ for alcohol intake higher by 1 unit (13 g/day) among current 
alcohol drinkers§, men and women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
∆  F-test in analysis of variance  
  
Current alcohol 
drinkers 
 
Systolic BP 
 
Diastolic BP 
 
Difference (SE)  P value∆  Difference (SE)  P value∆ 
       
Men  1.13 (0.17) <0.0001  0.52 (0.12) <0.0001 
       
Women  1.85 (0.52) 0.0004  1.51 (0.36) <0.0001 
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Table 4.25 Mean systolic and diastolic blood pressure‡ of current alcohol drinkers§ by alcohol 
drinking pattern from two 7-day records, men and women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, and mean daily alcohol intake (from two 7-day records) 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
∆  F-test in analysis of variance   
Alcohol drinking pattern  
Systolic BP Diastolic BP 
N mean (SE)  mean (SE)  
    
 
  
 
Men 
   
 
  
 
Drank alcohol on 1-6 days 927 122.9 (1.0)  76.6 (0.7)  
Drank alcohol on 7-9 days 212 124.3 (1.2)  78.5 (0.9)  
Drank alcohol on 10-12 days 242 123.1 (1.2)  76.9 (0.9)  
Drank alcohol on 13, 14 days 392 124.0 (1.2)  77.4 (0.9)  
p-value∆ 
  
0.5  
 
0.1  
    
 
  
 
Women 
   
 
  
 
Drank alcohol on 1-6 days 814 117.4 (1.2)  71.8 (0.8)  
Drank alcohol on 7-9 days 131 118.7 (1.5)  72.4 (1.1)  
Drank alcohol on 10-12 days 76 118.0 (1.9)  71.6 (1.3)  
Drank alcohol on 13, 14 days 72 119.4 (2.1)  72.2 (1.5)  
p-value∆ 
  
0.7  
 
0.9  
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Table 4.26 Mean systolic and diastolic blood pressure‡ of current alcohol drinkers§ by type of 
alcoholic beverage consumed from two 7-day records, men and women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, and mean daily alcohol intake (from two 7-day records) 
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
γ  F-test in analysis of variance  
  
Drinking status  
Systolic BP Diastolic BP 
N mean (SE)  mean (SE)  
    
 
  
 
Men 
   
 
  
 
„Beer‟ drinker 662 123.2 (1.0)  76.6 (0.8)  
„Wine‟ drinker 251 122.5 (1.2)  76.9 (0.9)  
„Spirits‟ drinker 409 124.5 (1.1)  77.7 (0.8)  
„Mixed‟ drinker∆ 451 122.3 (1.1)  76.8 (0.8)  
p-valueγ 
  
0.2  
 
0.5  
    
 
  
 
Women 
   
 
  
 
„Beer‟ drinker 297 118.3 (1.3)  71.6 (0.9)  
„Wine‟ drinker 322 116.8 (1.3)  71.6 (0.9)  
„Spirits‟ drinker 243 118.2 (1.3)  72.4 (0.9)  
„Mixed‟ drinker∆ 231 117.7 (1.3)  71.8 (0.9)  
p-valueγ 
  
0.6  
 
0.7  
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Table 4.27 Regression coefficient and standard error for model covariates in regression of systolic 
blood pressure on alcohol intake of current alcohol drinkers§, men and women 
 
 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
δ Categorical variable 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
∞  Family history of hypertension: known hypertension in any first degree relatives 
∆ Combination of alcoholic beverages: beer, wine and spirits 
Φ  Variable tested statistically significant to BP in stepwise regression model 
 
  
Variable
Men Women
Coefficient SE t value P value Coefficient SE t value P value
Age (years) 0.35 0.06 6.22 <0.0001 Φ 0.56 0.07 7.57 <0.0001 Φ
δ Country (Japan, PRC, UK, US) -0.84 0.35 -2.37 0.02 -0.54 0.42 -1.28 0.20
Education (years) -0.23 0.10 -2.36 0.02 Φ -0.34 0.13 -2.67 0.01 Φ
δ Marital status (yes/no) -1.00 0.92 -1.09 0.27 1.64 0.93 1.77 0.08
δ Employment status (yes/no) 0.42 1.30 0.32 0.75 -0.38 1.04 -0.37 0.71
δ Cigarette smoker (yes/no) 0.91 0.70 1.29 0.20 0.65 1.12 0.58 0.56
δ Taking supplements (yes/no) -1.57 0.70 -2.24 0.02 -0.50 0.86 -0.58 0.56
δ On special diet∂ (yes/no) 2.60 1.06 2.45 0.01 -0.84 1.11 -0.76 0.45
δ CVD-DM diagnosisΩ (yes/no) 0.36 0.91 0.39 0.70 3.10 1.43 2.17 0.03
δ Family history of hypertension∞ (yes/no) 5.13 0.83 6.14 <0.0001 Φ 5.39 1.09 4.94 <0.0001 Φ
Moderate to heavy physical activity (hrs/day) 0.03 0.09 0.37 0.71 -0.05 0.12 -0.42 0.67
Body Mass Index (kg/m2) 0.95 0.08 11.77 <0.0001 Φ 0.79 0.08 9.81 <0.0001 Φ
Urinary sodium excretion (mmol/day) 0.00 0.00 -0.30 0.76 0.01 0.01 1.71 0.09
Urinary potassium excretion (mmol/day) -0.05 0.02 -2.76 0.01 Φ -0.01 0.02 -0.58 0.56
Mean daily alcohol intake (g/day) 0.09 0.02 4.87 <0.0001 Φ 0.10 0.06 1.73 0.08
δ Alcohol drinking pattern 
(1-6 days, 7-9 days, 10-12 days, 13-14 days)
0.04 0.37 0.11 0.91 0.64 0.64 1.00 0.32 Φ
δ Type of alcoholic beverage consumed (beer, 
wine, spirits, mixed∆)
-0.09 0.25 -0.36 0.72 0.16 0.36 0.45 0.66
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Table 4.28 Regression coefficient and standard error for model covariates in regression of diastolic 
blood pressure on alcohol intake of current alcohol drinkers§, men and women 
 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
δ Categorical variable 
∂  Special diet: weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet 
Ω CVD-DM: history of heart attack, other heart disease, stroke, or diabetes 
∞  Family history of hypertension: known hypertension in any first degree relatives 
∆ Combination of alcoholic beverages: beer, wine and spirits 
Φ  Variable tested statistically significant to BP in stepwise regression model 
  
Variable
Men Women
Coefficient SE t value P value Coefficient SE t value P value
Age (years) 0.10 0.04 2.33 0.02 0.22 0.05 4.34 <0.0001 Φ
δ Country (Japan, PRC, UK, US) -1.38 0.26 -5.29 <0.0001 Φ -0.45 0.29 -1.55 0.12
Education (years) -0.01 0.07 -0.17 0.86 -0.17 0.09 -2.02 0.04
δ Marital status (yes/no) -0.89 0.68 -1.32 0.19 1.02 0.63 1.61 0.11
δ Employment status (yes/no) 0.75 0.96 0.79 0.43 -0.56 0.71 -0.80 0.43
δ Cigarette smoker (yes/no) -0.45 0.52 -0.86 0.39 -0.03 0.76 -0.04 0.96
δ Taking supplements (yes/no) -0.79 0.51 -1.53 0.13 -0.21 0.59 -0.35 0.72
δ On special diet∂ (yes/no) 0.84 0.78 1.08 0.28 -0.19 0.76 -0.25 0.80
δ CVD-DM diagnosisΩ (yes/no) -0.89 0.67 -1.33 0.18 -0.30 0.98 -0.30 0.76
δ Family history of hypertension∞ (yes/no) 3.49 0.61 5.68 <0.0001 Φ 2.91 0.75 3.91 <0.0001 Φ
Moderate to heavy physical activity (hrs/day) -0.10 0.07 -1.56 0.12 -0.15 0.08 -1.78 0.07
Body Mass Index (kg/m2) 0.73 0.06 12.22 <0.0001 Φ 0.41 0.06 7.43 <0.0001 Φ
Urinary sodium excretion (mmol/day) 0.00 0.00 -0.25 0.80 0.01 0.01 1.19 0.23 Φ
Urinary potassium excretion (mmol/day) -0.01 0.01 -0.54 0.59 0.01 0.02 0.36 0.72
Mean daily alcohol intake (g/day) 0.04 0.01 3.02 <0.0001 Φ 0.11 0.04 2.81 0.01 Φ
δ Alcohol drinking pattern 
(1-6 days, 7-9 days, 10-12 days, 13-14 days)
0.02 0.27 0.08 0.94 0.06 0.44 0.13 0.90
δ Type of alcoholic beverage consumed (beer, 
wine, spirits, mixed∆)
0.07 0.18 0.40 0.69 0.22 0.25 0.91 0.36
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Table 4.29  Mean nutrient intakes‡ (%kcal or amount/1000kcal) for total energy by drinking status 
(teetotallers, ex-drinkers, moderate drinkers§ and heavy drinkersΨ), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
f  p<0.05 for ex-drinkers vs. moderate drinkers 
  
 Drinking status 
 
 
Variable Teetotaller 
 
Ex-drinker 
 Moderate 
drinker§ 
 Heavy 
drinkerΨ 
 
p-value∆ 
N 166  250  1,344  599   
(%) (7.0)  (10.6)  (57.0)  (25.4)    
  
 
 
 
 
 
   
Total energy (kcal/day) 2204.9 
a d 
2282.7 
b 
2306.0 
c 
2489.4  <0.0001 
Food-derived energy (kcal/day) 2202.0 
 
2269.4 
b 
2240.2 
c 
2156.4  0.02 
Alcohol-derived energy (kcal/day) 2.9 
a d 
13.3 
b 
65.8 
c f 
333.0  <0.0001 
Total protein (%kcal) 14.9 
 
15.2 
 
15.3 
c 
15.0  0.09 
Vegetable protein (%kcal) 7.7 
a d 
7.3 
b e 
7.4 
c 
6.7  <0.0001 
Animal protein (%kcal) 7.2 
a d 
7.8 
e 
7.9 
 
8.2  0.005 
Starch (%kcal) 38.4 
a d 
35.3 
b e 
35.5 
c 
29.6  <0.0001 
Carbohydrate (%kcal) 57.9 
a d 
55.3 
b e 
53.6 
c f 
45.1  <0.0001 
Total Fat (%kcal) 26.3 
d 
27.9 
b e 
27.5 
c 
26.0  <0.0001 
SFA (%kcal) 8.1 
 
8.6 
b e 
8.4 
c 
7.9  0.0002 
PUFA (%kcal) 5.9 
d 
6.5 
b e 
6.4 
c 
6.1  0.0003 
MUFA (%kcal) 9.7 
 
10.2 
b 
10.0 
c 
9.5  0.0002 
Omega 3 (%kcal) 0.86 
 
0.86 
 
0.88 
c 
0.83  0.01 
Omega 6 (%kcal) 5.1 
d 
5.6 
b e 
5.6 
c 
5.3  0.0006 
Oleic acid (%kcal) 8.6 
d 
9.1 
b e 
9.0 
c 
8.6  0.0007 
Linoleic acid (%kcal) 5.0 
d 
5.6 
b e 
5.5 
c 
5.2  0.0006 
Linolenic acid (%kcal) 0.65 
a 
0.65 
b 
0.66 
c 
0.59  <0.0001 
Arachidonic acid (%kcal) 0.055 
a 
0.057 
 
0.059 
 
0.061  0.1 
EPA (%kcal) 0.070 
 
0.069 
b 
0.073 
c 
0.080  0.1 
DPA (%kcal) 0.024 
 
0.024 
b 
0.025 
c 
0.027  0.09 
DHA (%kcal) 0.11 
 
0.11 
 
0.11 
 
0.12  0.3 
Sum of EPA, DPA, DHA (%kcal) 0.20 
 
0.20 
 
0.21 
c 
0.23  0.2 
Cholesterol (g/1000kcal) 129.5 
a d 
139.3 
 
141.0 
 
145.2  0.07 
Fibre (g/1000kcal) 11.5 
a 
11.2 
b 
11.3 
c 
10.1  <0.0001 
Calcium (mg/1000kcal) 305.7 
 
321.5 
b 
319.9 
c 
298.9  0.0006 
Magnesium (mg/1000kcal) 152.6 
 
149.8 
 
153.1 
 
150.0  0.2 
Phosphorus (mg/1000kcal)  568.7 
 
576.5 
b 
577.2 
c 
557.2  0.002 
Iron (mg/1000kcal) 7.0 
 
7.1 
 
7.1 
c 
6.8  0.04 
Non-haem iron (mg/1000kcal) 6.6 
a 
6.7 
b 
6.7 
c 
6.3  0.001 
Haem iron (mg/1000kcal) 0.36 
a 
0.40 
b 
0.41 
c 
0.51  <0.0001 
Copper (mg/1000kcal) 0.83 
a 
0.81 
b 
0.81 
c 
0.77  <0.0001 
Beta-Carotene (mcg/1000kcal) 1364.9 
 
1229.2 
 
1384.9 
 
1285.7  0.2 
Retinol (mcg/1000kcal) 145.0 
 
163.1 
 
154.0 
 
161.4  0.8 
Vitamin C (mg/1000kcal) 52.4 
a 
47.2 
 
50.7 
c 
45.6  0.003 
Vitamin E (mg/1000kcal) 4.7 
 
4.8 
b 
4.8 
c 
4.5  0.001 
Folacin (mcg/1000kcal) 151.2 
 
154.2 
 
157.2 
 
152.6  0.2 
Niacin (mg/1000kcal) 9.5 
a 
9.7 
b 
9.7 
c 
10.3  0.0005 
Pantothenic Acid (mg/1000kcal) 2.4 
 
2.4 
 
2.4 
c 
2.3  0.002 
Thiamin (mg/1000kcal) 0.73 
 
0.74 
 
0.75 
 
0.74  1.0 
Vitamin B6 (mg/1000kcal) 0.83 
 
0.81 
 
0.84 
 
0.84  0.4 
Vitamin B12 (mcg/1000kcal) 2.1 
a 
2.3 
b 
2.3 
c 
2.7  0.0003 
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Table 4.29  (continued) 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
f  p<0.05 for ex-drinkers vs. moderate drinkers 
 
 Drinking status   
Variable Teetotaller 
 
Ex-drinker 
 Moderate 
drinker§ 
 Heavy 
drinkerΨ 
 
p-value∆ 
N 166  250  1,344  599   
(%) (7.0)  (10.6)  (57.0)  (25.4)    
  
 
 
 
 
 
   
Glutamic acid (%kcal) 3.1 a 3.0 b 3.1 c 2.9  <0.0001 
Cystine (%kcal) 0.24 a 0.24 b 0.24 c 0.23  <0.0001 
Proline (%kcal) 0.95 a 0.94 b 0.96 c 0.91  <0.0001 
Phenyalanine (%kcal) 0.67  0.69 b 0.69 c 0.66  0.0002 
Serine (%kcal) 0.68  0.69 b 0.69 c 0.66  <0.0001 
Tryptophan (%kcal) 0.19  0.19 b 0.19 c 0.18  <0.0001 
Leucine (%kcal) 1.2  1.2  1.2 c 1.1  0.002 
Arginine (%kcal) 0.83  0.86  0.86  0.86  0.3 
Valine (%kcal) 0.77  0.79  0.79 c 0.77  0.005 
Aspartic acid (%kcal) 1.3  1.3  1.3  1.3  0.2 
Tyrosine (%kcal) 0.51  0.52  0.53 c 0.51  0.05 
Glycine (%kcal) 0.63  0.65  0.65  0.65  0.4 
Isoleucine (%kcal) 0.66 d 0.67  0.68 c 0.66  0.007 
Alanine (%kcal) 0.72  0.73  0.74  0.74  0.3 
Histidine (%kcal) 0.41  0.42  0.42  0.42  0.3 
Threonine (%kcal) 0.56 d 0.58  0.59  0.57  0.07 
Methionine (%kcal) 0.32  0.33  0.33  0.32  0.05 
Lysine (%kcal) 0.88 a d 0.93  0.94  0.94  0.06 
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Table 4.30 Mean nutrient intakes‡ (%kcal or amount/1000kcal) for total energy by drinking status 
(teetotallers, ex-drinkers, moderate drinkers§ and heavy drinkersΨ), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: women, mean daily alcohol intake from two 7-day records >13 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
  
 Drinking status 
 
 
Variable Teetotaller 
 
Ex-drinker 
 Moderate 
drinker§ 
 Heavy 
drinkerΨ 
 
p-value∆ 
N 598  268  1,259  196   
(%) (25.8)  (11.6)  (54.2)  (8.4)    
  
 
 
 
 
 
   
Total energy (kcal/day) 1719.6 
 
1769.4 
 
1764.7 
 
1787.2  0.2 
Food-derived energy (kcal/day) 1710.9 
a 
1762.3 
b 
1741.8 
c 
1616.5  0.0004 
Alcohol-derived energy (kcal/day) 8.6 
a d 
7.1 
b 
22.9 
c 
170.7  <0.0001 
Total protein (%kcal) 15.3 
 
15.3 
 
15.3 
 
15.0  0.7 
Vegetable protein (%kcal) 7.3 
a d 
7.1 
e 
7.1 
c 
6.8  0.0006 
Animal protein (%kcal) 7.9 
 
8.1 
 
8.1 
 
8.1  0.7 
Starch (%kcal) 35.7 
a d 
33.8 
b e 
34.5 
c 
31.5  <0.0001 
Carbohydrate (%kcal) 55.2 
a d 
54.7 
b 
54.2 
c 
48.0  <0.0001 
Total Fat (%kcal) 28.2 
a 
28.8 
b 
28.5 
c 
27.0  0.01 
SFA (%kcal) 8.7 
d 
9.0 
b 
9.1 
c 
8.3  0.0004 
PUFA (%kcal) 6.5 
a 
6.5 
b 
6.3 
c 
6.0  0.04 
MUFA (%kcal) 10.3 
 
10.5 
b 
10.4 
 
10.0  0.2 
Omega 3 (%kcal) 0.93 
a d 
0.86 
e 
0.86 
 
0.85  0.01 
Omega 6 (%kcal) 5.6 
a 
5.6 
b 
5.5 
c 
5.2  0.05 
Oleic acid (%kcal) 9.0 
 
9.4 
b 
9.2 
 
8.9  0.1 
Linoleic acid (%kcal) 5.5 
a 
5.6 
b 
5.4 
c 
5.1  0.04 
Linolenic acid (%kcal) 0.74 
a d 
0.68 
e 
0.68 
 
0.66  0.008 
Arachidonic acid (%kcal) 0.058 
 
0.059 
 
0.056 
 
0.061  0.3 
EPA (%kcal) 0.059 
 
0.057 
 
0.056 
 
0.061  0.6 
DPA (%kcal) 0.024 
 
0.023 
 
0.023 
 
0.023  0.8 
DHA (%kcal) 0.101 
 
0.097 
 
0.094 
 
0.098  0.7 
Sum of EPA, DPA, DHA (%kcal) 0.18 
 
0.18 
 
0.17 
 
0.18  0.7 
Cholesterol (g/1000kcal) 141.0 
a 
147.2 
 
140.3 
c 
158.0  0.003 
Fibre (g/1000kcal) 11.9 
a d 
11.5 
b 
11.5 
c 
10.9  0.007 
Calcium (mg/1000kcal) 340.3 
 
330.9 
 
348.7 
 
336.0  0.08 
Magnesium (mg/1000kcal) 155.9 
 
155.0 
 
155.6 
 
159.5  0.5 
Phosphorus (mg/1000kcal)  578.8 
 
581.3 
 
588.6 
 
581.6  0.4 
Iron (mg/1000kcal) 7.0 
 
6.9 
 
6.9 
 
6.8  0.9 
Non-haem iron (mg/1000kcal) 6.6 
 
6.5 
 
6.6 
 
6.4  0.8 
Haem iron (mg/1000kcal) 0.36 
 
0.40 
 
0.38 
 
0.40  0.2 
Copper (mg/1000kcal) 0.81 
 
0.82 
 
0.82 
 
0.82  0.6 
Beta-Carotene (mcg/1000kcal) 1499.0 
a 
1590.0 
b 
1488.1 
c 
1107.4  0.01 
Retinol (mcg/1000kcal) 172.9 
 
209.9 
 
181.7 
 
190.7  0.2 
Vitamin C (mg/1000kcal) 58.9 
a d 
58.4 
b 
55.0 
c 
49.4  0.008 
Vitamin E (mg/1000kcal) 5.3 
 
5.0 
 
5.2 
 
5.1  0.3 
Folacin (mcg/1000kcal) 161.6 
d 
154.2 
 
155.3 
 
156.8  0.2 
Niacin (mg/1000kcal) 9.0 
 
9.2 
 
9.2 
 
9.5  0.2 
Pantothenic Acid (mg/1000kcal) 2.5 
 
2.4 
 
2.4 
 
2.4  0.7 
Thiamin (mg/1000kcal) 0.77 
a 
0.72 
 
0.76 
c 
0.68  0.02 
Vitamin B6 (mg/1000kcal) 0.85 
 
0.84 
 
0.83 
 
0.83  0.8 
Vitamin B12 (mcg/1000kcal) 2.2 
a 
2.5 
 
2.4 
c 
2.8  0.01 
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Table 4.30 (continued) 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: women, mean daily alcohol intake from two 7-day records >13 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
  
 Drinking status   
Variable Teetotaller 
 
Ex-drinker 
 Moderate 
drinker§ 
 Heavy 
drinkerΨ 
 
p-value∆ 
N 598  268  1,259  196   
(%) (25.8)  (11.6)  (54.2)  (8.4)    
  
 
 
 
 
 
   
Glutamic acid (%kcal) 3.1 a 3.0 e 3.1 c 3.0  0.003 
Cystine (%kcal) 0.24 a 0.24 b 0.24 c 0.23  0.06 
Proline (%kcal) 0.99  0.95 e 0.99  0.98  0.008 
Phenyalanine (%kcal) 0.69  0.69  0.69 c 0.68  0.1 
Serine (%kcal) 0.70  0.69  0.69 c 0.67  0.2 
Tryptophan (%kcal) 0.19 a 0.19 b 0.19 c 0.18  0.07 
Leucine (%kcal) 1.19  1.18  1.19 c 1.15  0.2 
Arginine (%kcal) 0.84  0.86 b 0.84 c 0.82  0.1 
Valine (%kcal) 0.79 a 0.79 b 0.79 c 0.77  0.2 
Aspartic acid (%kcal) 1.3 a 1.3 b 1.3 c 1.3  0.1 
Tyrosine (%kcal) 0.52  0.52  0.53  0.51  0.4 
Glycine (%kcal) 0.64  0.64  0.63  0.62  0.6 
Isoleucine (%kcal) 0.68  0.68  0.68 c 0.66  0.3 
Alanine (%kcal) 0.73  0.74  0.73  0.71  0.4 
Histidine (%kcal) 0.42  0.42  0.42  0.41  0.4 
Threonine (%kcal) 0.58  0.59  0.58  0.56  0.3 
Methionine (%kcal) 0.33  0.33  0.33  0.32  0.4 
Lysine (%kcal) 0.93  0.94  0.93  0.91  0.6 
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Table 4.31 Mean nutrient intakes‡ (%kcal or amount/1000kcal) for total energy of current drinkers§ 
by alcohol drinking pattern (number of days alcohol was consumed from two 7-day 
records), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆  F-test in analysis of variance  
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
f  p<0.05 for drinkers drunk on 10-12 days vs. 13,14 days 
  
 Number of days alcohol consumed 
 
 
Variable 1-6 days  7-9 days  10-12 days  13,14 days  p-value∆ 
N 927  212  242  392   
(%) (52.3)  (12.0)  (13.7)  (22.1)    
          
Total energy (kcal/day) 2287.2 
 
2320.9 
b c 
2438.5 
d 
2442.1 
e 
<0.0001 
Food-derived energy (kcal/day) 2229.5 
a 
2129.3 
 
2166.2 
 
2091.1 
e 
0.0006 
Alcohol-derived energy (kcal/day) 57.7 
a 
191.6 
b c 
272.3 
d f 
351.0 
e 
<0.0001 
Total protein (%kcal) 15.4 
a 
15.1 
b c 
14.9 
d 
15.0 
e 
0.02 
Vegetable protein (%kcal) 7.4 
 
7.1 
 
6.8 
d 
6.7 
e 
<0.0001 
Animal protein (%kcal) 8.0 
 
7.9 
 
8.0 
 
8.2 
 
0.7 
Starch (%kcal) 35.6 
a 
33.6 
b c 
30.9 
d f 
29.3 
e 
<0.0001 
Carbohydrate (%kcal) 54.1 
a 
49.8 
b c 
47.1 
d f 
44.6 
e 
<0.0001 
Total Fat (%kcal) 27.2 
 
26.7 
c 
26.5 
f 
25.4 
e 
<0.0001 
SFA (%kcal) 8.2 
 
8.0 
 
8.1 
f 
7.6 
e 
0.003 
PUFA (%kcal) 6.4 
 
6.2 
 
6.2 
 
5.9 
e 
0.003 
MUFA (%kcal) 9.9 
 
9.8 
c 
9.6 
 
9.3 
e 
0.002 
Omega 3 (%kcal) 0.88 
 
0.85 
 
0.83 
d 
0.82 
e 
0.04 
Omega 6 (%kcal) 5.6 
 
5.4 
 
5.4 
 
5.1 
e 
0.006 
Oleic acid (%kcal) 8.9 
 
8.8 
c 
8.7 
 
8.4 
e 
0.006 
Linoleic acid (%kcal) 5.5 
 
5.3 
 
5.3 
 
5.1 
e 
0.005 
Linolenic acid (%kcal) 0.66 
 
0.65 
c 
0.61 
d 
0.57 
e 
<0.0001 
Arachidonic acid (%kcal) 0.063 
 
0.062 
 
0.060 
 
0.064 
 
0.5 
EPA (%kcal) 0.076 
 
0.071 
c 
0.076 
 
0.085 
 
0.2 
DPA (%kcal) 0.026 
 
0.025 
 
0.026 
 
0.027 
 
0.7 
DHA (%kcal) 0.11 
 
0.10 
c 
0.11 
 
0.12 
e 
0.06 
Sum of EPA, DPA, DHA (%kcal) 0.21 
 
0.20 
c 
0.21 
 
0.23 
e 
0.01 
Cholesterol (g/1000kcal) 145.4 
 
141.9 
 
143.5 
 
143.7 
 
0.9 
Fibre (g/1000kcal) 11.3 
a 
10.8 
c 
10.3 
d 
10.1 
e 
<0.0001 
Calcium (mg/1000kcal) 323.4 
a 
299.4 
 
317.6 
f 
297.5 
e 
0.0002 
Magnesium (mg/1000kcal) 152.9 
 
150.9 
 
149.4 
 
151.1 
 
0.4 
Phosphorus (mg/1000kcal)  581.3 
a 
557.7 
 
563.4 
d 
557.9 
e 
0.0003 
Iron (mg/1000kcal) 7.2 
 
6.9 
 
6.7 
d 
6.9 
e 
0.01 
Non-haem iron (mg/1000kcal) 6.8 
a 
6.4 
 
6.3 
d 
6.3 
e 
0.0007 
Haem iron (mg/1000kcal) 0.41 
a 
0.47 
 
0.45 
 
0.53 
e 
<0.0001 
Copper (mg/1000kcal) 0.82 
 
0.79 
b c 
0.76 
d 
0.75 
e 
<0.0001 
Beta-Carotene (mcg/1000kcal) 1442.0 
 
1510.8 
c 
1287.8 
 
1273.3 
e 
0.07 
Retinol (mcg/1000kcal) 164.2 
 
139.2 
 
160.8 
 
166.3 
 
0.6 
Vitamin C (mg/1000kcal) 50.6 
 
48.4 
c 
48.6 
f 
40.8 
e 
<0.0001 
Vitamin E (mg/1000kcal) 4.9 
a 
4.6 
 
4.5 
d 
4.6 
e 
<0.0001 
Folacin (mcg/1000kcal) 159.9 
 
157.8 
 
155.7 
 
152.5 
e 
0.2 
Niacin (mg/1000kcal) 9.9 
 
9.9 
c 
10.4 
d 
10.6 
e 
0.004 
Pantothenic Acid (mg 2.5 
a 
2.4 
 
2.3 
d 
2.3 
e 
0.0007 
Thiamin (mg/1000kcal) 0.76 
 
0.86 
 
0.74 
 
0.77 
 
0.3 
Vitamin B6 (mg/1000kcal) 0.85 
 
0.83 
 
0.84 
 
0.86 
 
0.4 
Vitamin B12 (mcg/1000kcal) 2.3 
 
2.5 
 
2.5 
 
2.8 
e 
0.003 
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Table 4.31 (continued) 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆  F-test in analysis of variance  
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
f  p<0.05 for drinkers drunk on 10-12 days vs. 13,14 days 
 Number of days alcohol consumed 
 
 
Variable 1-6 days  7-9 days  10-12 days  13,14 days  p-value∆ 
N 927  212  242  392   
(%) (52.3)  (12.0)  (13.7)  (22.1)    
          
Glutamic acid (%kcal) 3.1 
a 
3.0 
c 
2.9 
d 
2.9 
e 
<0.0001 
Cystine (%kcal) 0.24 
a 
0.23 
c 
0.23 
d 
0.23 
e 
<0.0001 
Proline (%kcal) 0.96 
a 
0.92 
 
0.91 
d 
0.90 
e 
<0.0001 
Phenyalanine (%kcal) 0.70 
a 
0.68 
 
0.67 
d 
0.66 
e 
<0.0001 
Serine (%kcal) 0.70 
a 
0.68 
 
0.67 
d 
0.66 
e 
<0.0001 
Tryptophan (%kcal) 0.19 
a 
0.19 
 
0.18 
d 
0.18 
e 
<0.0001 
Leucine (%kcal) 1.2 
a 
1.2 
 
1.1 
d 
1.1 
e 
<0.0001 
Arginine (%kcal) 0.87 
 
0.86 
 
0.86 
 
0.85 
 
0.4 
Valine (%kcal) 0.80 
a 
0.78 
 
0.77 
d 
0.76 
e 
0.0005 
Aspartic acid (%kcal) 1.4 
 
1.3 
 
1.3 
 
1.3 
e 
0.1 
Tyrosine (%kcal) 0.53 
 
0.52 
 
0.51 
d 
0.51 
e 
0.01 
Glycine (%kcal) 0.66 
 
0.65 
 
0.65 
 
0.65 
 
0.7 
Isoleucine (%kcal) 0.68 
a 
0.66 
 
0.65 
d 
0.65 
e 
0.0005 
Alanine (%kcal) 0.75 
 
0.74 
 
0.73 
 
0.73 
 
0.3 
Histidine (%kcal) 0.43 
 
0.42 
 
0.42 
 
0.42 
 
0.2 
Threonine (%kcal) 0.59 
 
0.58 
 
0.57 
d 
0.57 
e 
0.02 
Methionine (%kcal) 0.33 
 
0.33 
 
0.32 
d 
0.32 
e 
0.006 
Lysine (%kcal) 0.95 
 
0.93 
 
0.93 
 
0.93 
 
0.7 
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Table 4.32 Mean nutrient intakes‡ (%kcal or amount/1000kcal) for total energy of current drinkers§ 
by alcohol drinking pattern (number of days alcohol was consumed from two 7-day 
records), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆  F-test in analysis of variance  
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
f  p<0.05 for drinkers drunk on 10-12 days vs. 13,14 days 
  
 Number of days alcohol consumed 
 
 
Variable 1-6 days  7-9 days  10-12 days  13,14 days  p-value∆ 
N 814  131  76  72   
(%) (74.5)  (12.0)  (7.0)  (6.6)   
          
Total energy (kcal/day) 1755.9 
 
1814.7 
 
1804.6 
 
1868.3 
e 
0.07 
Food-derived energy (kcal/day) 1726.4 
 
1716.7 
 
1648.6 
 
1669.3 
 
0.3 
Alcohol-derived energy (kcal/day) 29.6 
a 
98.0 
b c 
156.0 
d f 
199.0 
e 
<0.0001 
Total protein (%kcal) 15.4 
 
15.1 
 
14.9 
 
14.6 
e 
0.1 
Vegetable protein (%kcal) 6.9 
 
6.8 
 
6.6 
d 
6.4 
e 
0.001 
Animal protein (%kcal) 8.4 
 
8.3 
 
8.2 
 
8.1 
 
0.8 
Starch (%kcal) 33.1 
a 
31.6 
c 
30.2 
d 
28.8 
e 
<0.0001 
Carbohydrate (%kcal) 53.6 
a 
50.1 
b c 
47.4 
d 
47.1 
e 
<0.0001 
Total Fat (%kcal) 28.5 
 
28.6 
 
28.0 
 
27.2 
 
0.3 
SFA (%kcal) 9.2 
 
9.1 
 
8.9 
 
8.6 
 
0.2 
PUFA (%kcal) 6.2 
 
6.2 
 
6.0 
 
5.9 
 
0.7 
MUFA (%kcal) 10.4 
 
10.6 
 
10.4 
 
10.1 
 
0.7 
Omega 3 (%kcal) 0.78 
 
0.80 
 
0.71 
 
0.78 
 
0.3 
Omega 6 (%kcal) 5.4 
 
5.4 
 
5.3 
 
5.1 
 
0.7 
Oleic acid (%kcal) 9.5 
 
9.6 
 
9.5 
 
9.2 
 
0.8 
Linoleic acid (%kcal) 5.3 
 
5.3 
 
5.3 
 
5.1 
 
0.7 
Linolenic acid (%kcal) 0.62 
 
0.63 
 
0.58 
 
0.61 
 
0.6 
Arachidonic acid (%kcal) 0.057 
a 
0.064 
 
0.056 
 
0.057 
 
0.1 
EPA (%kcal) 0.048 
 
0.052 
 
0.040 
 
0.048 
 
0.8 
DPA (%kcal) 0.022 
 
0.024 
 
0.020 
 
0.020 
 
0.5 
DHA (%kcal) 0.09 
 
0.09 
 
0.07 
 
0.09 
 
0.6 
Sum of EPA, DPA, DHA (%kcal) 0.16 
 
0.17 
 
0.13 
 
0.16 
 
0.7 
Cholesterol (g/1000kcal) 137.5 
 
146.8 
 
148.8 
 
148.0 
 
0.1 
Fibre (g/1000kcal) 11.6 
a 
11.0 
c 
10.6 
d 
10.2 
e 
<0.0001 
Calcium (mg/1000kcal) 360.2 
 
349.4 
 
332.6 
d 
353.4 
 
0.2 
Magnesium (mg/1000kcal) 159.2 
 
161.9 
 
160.2 
 
158.2 
 
0.8 
Phosphorus (mg/1000kcal)  608.3 
 
596.7 
 
585.1 
 
599.3 
 
0.2 
Iron (mg/1000kcal) 7.0 
 
6.7 
 
6.6 
 
6.7 
 
0.1 
Non-haem iron (mg/1000kcal) 6.6 
 
6.2 
 
6.2 
 
6.3 
 
0.1 
Haem iron (mg/1000kcal) 0.41 
 
0.42 
 
0.44 
 
0.43 
 
0.6 
Copper (mg/1000kcal) 0.82 
 
0.85 
c 
0.83 
 
0.78 
 
0.06 
Beta-Carotene (mcg/1000kcal) 1688.8 
 
1482.1 
 
1427.8 
 
1519.4 
 
0.4 
Retinol (mcg/1000kcal) 189.9 
 
196.3 
 
197.4 
 
206.9 
 
0.9 
Vitamin C (mg/1000kcal) 59.9 
 
59.9 
c 
53.4 
f 
40.1 
e 
<0.0001 
Vitamin E (mg/1000kcal) 5.1 
 
5.0 
 
5.0 
 
4.7 
 
0.4 
Folacin (mcg/1000kcal) 159.1 
 
154.1 
 
147.3 
 
156.8 
 
0.2 
Niacin (mg/1000kcal) 9.6 
 
9.6 
 
9.7 
 
9.8 
 
0.9 
Pantothenic Acid (mg 2.6 
 
2.6 
 
2.5 
 
2.4 
 
0.2 
Thiamin (mg/1000kcal) 0.78 
a 
0.69 
 
0.72 
 
0.72 
 
0.06 
Vitamin B6 (mg/1000kcal) 0.87 
 
0.85 
 
0.84 
 
0.85 
 
0.7 
Vitamin B12 (mcg/1000kcal) 2.4 
 
2.5 
 
2.8 
 
3.0 
e 
0.2 
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Table 4.32 (continued) 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆  F-test in analysis of variance  
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
f  p<0.05 for drinkers drunk on 10-12 days vs. 13,14 days 
  
 Number of days alcohol consumed 
 
 
Variable 1-6 days  7-9 days  10-12 days  13,14 days  p-value∆ 
N 814  131  76  72   
(%) (74.5)  (12.0)  (7.0)  (6.6)   
          
Glutamic acid (%kcal) 3.1  3.0  3.0  2.9 e 0.01 
Cystine (%kcal) 0.24  0.23 c 0.23 d 0.22 e 0.0005 
Proline (%kcal) 0.97  0.94  0.95  0.93  0.3 
Phenyalanine (%kcal) 0.69  0.68  0.66 d 0.65 e 0.004 
Serine (%kcal) 0.70  0.68  0.66 d 0.66 e 0.003 
Tryptophan (%kcal) 0.19  0.19  0.18 d 0.18 e 0.005 
Leucine (%kcal) 1.2  1.2  1.1 d 1.1 e 0.01 
Arginine (%kcal) 0.85  0.84  0.82  0.79 e 0.03 
Valine (%kcal) 0.80  0.79  0.77 d 0.75 e 0.01 
Aspartic acid (%kcal) 1.3  1.3 c 1.3  1.2 e 0.02 
Tyrosine (%kcal) 0.53  0.52  0.51  0.50 e 0.05 
Glycine (%kcal) 0.65  0.64  0.62  0.61 e 0.2 
Isoleucine (%kcal) 0.68  0.67  0.66  0.64 e 0.02 
Alanine (%kcal) 0.74  0.73  0.71  0.69 e 0.08 
Histidine (%kcal) 0.43  0.42  0.41  0.40 e 0.05 
Threonine (%kcal) 0.59  0.58  0.57  0.55 e 0.03 
Methionine (%kcal) 0.33  0.33  0.32  0.31 e 0.06 
Lysine (%kcal) 0.96  0.94  0.92  0.90 e 0.1 
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Table 4.33 Mean nutrient intakes‡ (%kcal or amount/1000kcal) for total energy of current drinkers§ 
by alcoholic beverage type consumed (beer, wine, spirits and mixed∆), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
γ  F-test in analysis of variance  
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
  
 Alcoholic beverage type consumed 
 
 
Variable 
>70% 
Beer 
 >70% 
Wine 
 >70% 
Spirits 
 
Mixed 
 
 
N 662  251  409  451  p-valueγ 
(%) (37.3)  (14.2)  (23.1)  (25.4)    
          
Total energy (kcal/day) 2328.0 
 
2349.0 
 
2330.3 
 
2358.4 
 
0.8 
Food-derived energy (kcal/day) 2196.0 
 
2206.6 
 
2154.6 
 
2192.6 
 
0.7 
Alcohol-derived energy (kcal/day) 132.0 
a d 
142.5 
e 
175.8 
 
165.8 
 
0.001 
Total protein (%kcal) 15.5 
 
15.1 
 
15.1 
 
15.3 
 
0.2 
Vegetable protein (%kcal) 7.3 
a d 
7.4 
b e 
7.0 
 
7.1 
 
0.001 
Animal protein (%kcal) 8.1 
 
7.7 
b 
8.1 
 
8.2 
 
0.2 
Starch (%kcal) 34.4 
a d f 
35.8 
b e 
32.6 
 
33.0 
 
<0.0001 
Carbohydrate (%kcal) 51.3 
f 
52.5 
b e 
50.3 
 
50.5 
 
0.01 
Total Fat (%kcal) 27.3 
f 
26.0 
 
26.5 
 
26.9 
 
0.02 
SFA (%kcal) 8.2 
f 
7.8 
 
8.0 
 
8.1 
 
0.1 
PUFA (%kcal) 6.4 
d 
6.4 
 
6.1 
 
6.3 
 
0.2 
MUFA (%kcal) 9.9 
f 
9.3 
b 
9.7 
 
9.8 
 
0.01 
Omega 3 (%kcal) 0.86 
 
0.85 
 
0.86 
 
0.85 
 
1.0 
Omega 6 (%kcal) 5.6 
d 
5.5 
 
5.3 
 
5.5 
 
0.1 
Oleic acid (%kcal) 9.0 
f 
8.4 
b 
8.7 
 
8.9 
 
0.001 
Linoleic acid (%kcal) 5.5 
d 
5.5 
 
5.2 
 
5.4 
 
0.1 
Linolenic acid (%kcal) 0.65 
 
0.64 
 
0.62 
 
0.63 
 
0.5 
Arachidonic acid (%kcal) 0.064 
 
0.060 
 
0.062 
 
0.063 
 
0.5 
EPA (%kcal) 0.074 
 
0.072 
 
0.082 
 
0.076 
 
0.5 
DPA (%kcal) 0.025 
d 
0.024 
 
0.028 
 
0.026 
 
0.1 
DHA (%kcal) 0.10 
d 
0.10 
 
0.12 
 
0.11 
 
0.2 
Sum of EPA, DPA, DHA (%kcal) 0.20 
 
0.20 
 
0.23 
 
0.21 
 
0.3 
Cholesterol (g/1000kcal) 145.9 
 
138.3 
b 
139.5 
c 
151.9 
 
0.02 
Fibre (g/1000kcal) 11.2 
d 
11.2 
e 
10.6 
 
10.9 
 
0.02 
Calcium (mg/1000kcal) 319.2 
 
316.3 
 
311.0 
 
313.6 
 
0.7 
Magnesium (mg/1000kcal) 155.2 
a f 
148.8 
 
151.9 
 
149.7 
 
0.009 
Phosphorus (mg/1000kcal)  577.6 
 
564.6 
 
569.0 
 
570.1 
 
0.3 
Iron (mg/1000kcal) 7.0 
f 
7.4 
b e 
6.8 
 
7.1 
 
0.009 
Non-heme iron (mg/1000kcal) 6.5 
f 
7.0 
b e 
6.4 
 
6.7 
 
0.002 
Heme iron (mg/1000kcal) 0.5 
 
0.4 
 
0.5 
 
0.4 
 
0.4 
Copper (mg/1000kcal) 0.80 
f 
0.82 
b 
0.79 
 
0.79 
 
0.4 
Vitamin C (mg/1000kcal) 46.7 
 
46.4 
 
49.1 
 
49.8 
 
0.2 
Vitamin E (mg/1000kcal) 4.8 
 
4.8 
 
4.6 
c 
4.9 
 
0.2 
Beta-Carotene (mcg/1000kcal) 1367.7 
 
1464.6 
 
1379.9 
 
1437.1 
 
0.7 
Retinol (mcg/1000kcal) 143.1 
a 
144.8 
b 
158.7 
 
188.9 
 
0.03 
Thiamin (mg/1000kcal) 0.76 
 
0.72 
 
0.80 
 
0.78 
 
0.7 
Folacin (mcg/1000kcal) 161.3 
 
157.8 
 
153.5 
 
159.6 
 
0.3 
Niacin (mg/1000kcal) 10.3 
d f 
9.7 
b 
9.8 
c 
10.6 
 
0.0005 
Pantothenic Acid (mg 2.5 
d f 
2.4 
 
2.4 
 
2.4 
 
0.0004 
Vitamin B6 (mg/1000kcal) 0.87 
d 
0.85 
 
0.82 
c 
0.86 
 
0.07 
Vitamin B12 (mcg/1000kcal) 2.4 
 
2.3 
 
2.5 
 
2.5 
 
0.4 
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Table 4.33 (continued) 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
γ  F-test in analysis of variance  
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
  
 Alcoholic beverage type consumed 
 
 
Variable 
>70% 
Beer 
 >70% 
Wine 
 >70% 
Spirits 
 
Mixed 
 
 
N 662  251  409  451  p-valueγ 
(%) (37.3)  (14.2)  (23.1)  (25.4)    
          
Glutamic acid (%kcal) 3.1 
d 
3.0 
 
2.9 
c 
3.0 
 
0.003 
Cystine (%kcal) 0.24 
 
0.24 
 
0.24 
 
0.24 
 
0.6 
Proline (%kcal) 0.96 
d f 
0.94 
 
0.91 
c 
0.95 
 
0.0003 
Phenyalanine (%kcal) 0.69 
 
0.68 
 
0.68 
 
0.68 
 
0.4 
Serine (%kcal) 0.69 
 
0.68 
 
0.68 
 
0.69 
 
0.5 
Tryptophan (%kcal) 0.19 
 
0.19 
 
0.19 
 
0.19 
 
0.7 
Leucine (%kcal) 1.2 
 
1.2 
 
1.2 
 
1.2 
 
0.6 
Arginine (%kcal) 0.87 
 
0.86 
 
0.86 
 
0.86 
 
0.6 
Valine (%kcal) 0.79 
 
0.78 
 
0.79 
 
0.78 
 
0.5 
Aspartic acid (%kcal) 1.4 
 
1.3 
 
1.3 
 
1.3 
 
0.2 
Tyrosine (%kcal) 0.53 
 
0.52 
 
0.52 
 
0.52 
 
0.2 
Glycine (%kcal) 0.66 
 
0.64 
 
0.65 
 
0.65 
 
0.2 
Isoleucine (%kcal) 0.68 
 
0.67 
 
0.67 
 
0.67 
 
0.6 
Alanine (%kcal) 0.75 
 
0.73 
 
0.75 
 
0.74 
 
0.5 
Histidine (%kcal) 0.43 
 
0.42 
 
0.42 
 
0.42 
 
0.7 
Threonine (%kcal) 0.59 
 
0.57 
 
0.58 
 
0.58 
 
0.5 
Methionine (%kcal) 0.33 
 
0.32 
 
0.33 
 
0.33 
 
0.7 
Lysine (%kcal) 0.95 
 
0.92 
 
0.94 
 
0.94 
 
0.4 
  
 
 
 
 
 
 
 
 
 1 
123 
 
Table 4.34 Mean nutrient intakes‡ (%kcal or amount/1000kcal) for total energy of current drinkers§ 
by alcoholic beverage type consumed (beer, wine, spirits and mixed∆), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
γ  F-test in analysis of variance  
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
  
 Alcoholic beverage type consumed 
 
 
Variable 
>70% 
Beer 
 >70% 
Wine 
 >70% 
Spirits 
 
Mixed 
 
 
N 297  322  243  231  p-valueγ 
(%) (27.2)  (29.5)  (22.2)  (21.1)   
          
Total energy (kcal/day) 1817.4 
f 
1721.3 
 
1769.9 
 
1786.6 
 
0.06 
Food-derived energy (kcal/day) 1745.4 
f 
1667.6 
 
1720.6 
 
1705.9 
 
0.2 
Alcohol-derived energy (kcal/day) 72.0 
d f 
53.7 
b 
49.3 
c 
80.7 
 
<0.0001 
Total protein (%kcal) 15.3 
 
15.1 
 
15.3 
 
15.2 
 
0.7 
Vegetable protein (%kcal) 6.8 
 
7.0 
 
6.8 
 
6.8 
 
0.4 
Animal protein (%kcal) 8.4 
 
8.1 
 
8.5 
 
8.2 
 
0.4 
Starch (%kcal) 31.5 
d f 
33.2 
b 
32.9 
c 
31.7 
 
0.001 
Carbohydrate (%kcal) 51.2 
d f 
53.6 
b 
52.5 
 
51.2 
 
0.0001 
Total Fat (%kcal) 28.9 
f 
27.4 
e 
28.6 
 
28.4 
 
0.05 
SFA (%kcal) 9.2 
 
8.9 
 
9.3 
 
8.9 
 
0.4 
PUFA (%kcal) 6.2 
f 
5.8 
b 
6.1 
 
6.3 
 
0.04 
MUFA (%kcal) 10.6 
f 
10.0 
b e 
10.5 
 
10.4 
 
0.03 
Omega 3 (%kcal) 0.81 
d f 
0.75 
 
0.75 
 
0.80 
 
0.06 
Omega 6 (%kcal) 5.4 
f 
5.1 
b 
5.4 
 
5.5 
 
0.04 
Oleic acid (%kcal) 9.6 
f 
9.0 
b e 
9.6 
 
9.5 
 
0.03 
Linoleic acid (%kcal) 5.4 
f 
5.0 
b 
5.3 
 
5.4 
 
0.04 
Linolenic acid (%kcal) 0.62 
 
0.59 
 
0.60 
 
0.64 
 
0.3 
Arachidonic acid (%kcal) 0.060 
 
0.057 
 
0.056 
 
0.060 
 
0.6 
EPA (%kcal) 0.055 
d 
0.044 
 
0.041 
 
0.050 
 
0.2 
DPA (%kcal) 0.023 
 
0.021 
 
0.020 
 
0.023 
 
0.3 
DHA (%kcal) 0.10 
d 
0.08 
 
0.08 
 
0.09 
 
0.1 
Sum of EPA, DPA, DHA (%kcal) 0.18 
d 
0.15 
 
0.14 
 
0.16 
 
0.1 
Cholesterol (g/1000kcal) 144.5 
 
138.0 
 
139.2 
 
139.8 
 
0.7 
Fibre (g/1000kcal) 11.1 
 
11.4 
 
11.4 
 
11.4 
 
0.5 
Calcium (mg/1000kcal) 350.9 
 
360.7 
 
361.2 
 
351.1 
 
0.6 
Magnesium (mg/1000kcal) 157.5 
 
161.0 
 
160.6 
 
159.8 
 
0.6 
Phosphorus (mg/1000kcal)  601.4 
 
601.0 
 
612.8 
 
599.5 
 
0.5 
Iron (mg/1000kcal) 6.7 
d f 
7.0 
 
7.0 
 
6.8 
 
0.1 
Non-heme iron (mg/1000kcal) 6.3 
d f 
6.6 
 
6.6 
 
6.4 
 
0.06 
Heme iron (mg/1000kcal) 0.4 
 
0.4 
 
0.4 
 
0.4 
 
0.5 
Copper (mg/1000kcal) 0.81 
 
0.83 
 
0.83 
 
0.82 
 
0.7 
Beta-Carotene (mcg/1000kcal) 1673.7 
 
1616.7 
 
1671.9 
 
1507.6 
 
0.7 
Retinol (mcg/1000kcal) 207.5 
 
182.7 
 
207.2 
 
166.1 
 
0.2 
Vitamin C (mg/1000kcal) 55.6 
f 
62.8 
e 
55.8 
 
57.8 
 
0.05 
Vitamin E (mg/1000kcal) 5.0 
 
4.9 
e 
5.2 
 
5.1 
 
0.1 
Folacin (mcg/1000kcal) 155.7 
 
159.2 
 
158.3 
 
156.1 
 
0.8 
Niacin (mg/1000kcal) 9.5 
 
9.6 
 
9.8 
 
9.6 
 
0.7 
Pantothenic Acid (mg 2.5 
 
2.5 
 
2.6 
 
2.5 
 
0.3 
Thiamin (mg/1000kcal) 0.76 
 
0.77 
 
0.79 
 
0.72 
 
0.3 
Vitamin B6 (mg/1000kcal) 0.85 
 
0.86 
 
0.88 
 
0.85 
 
0.5 
Vitamin B12 (mcg/1000kcal) 2.7 
 
2.4 
 
2.5 
 
2.4 
 
0.5 
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Table 4.34 (continued) 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
γ  F-test in analysis of variance  
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
 
 
 
 
 
  
 Alcoholic beverage type consumed 
 
 
Variable 
>70% 
Beer 
 >70% 
Wine 
 >70% 
Spirits 
 
Mixed 
 
 
N 297  322  243  231  p-valueγ 
(%) (27.2)  (29.5)  (22.2)  (21.1)   
          
Glutamic acid (%kcal) 3.0 
 
3.0 
 
3.1 
 
3.0 
 
0.8 
Cystine (%kcal) 0.23 
 
0.23 
 
0.24 
 
0.23 
 
0.5 
Proline (%kcal) 0.98 
a 
0.95 
 
0.95 
 
0.95 
 
0.2 
Phenyalanine (%kcal) 0.68 
 
0.68 
 
0.69 
 
0.68 
 
0.5 
Serine (%kcal) 0.69 
 
0.68 
 
0.70 
 
0.68 
 
0.7 
Tryptophan (%kcal) 0.19 
 
0.19 
 
0.19 
 
0.19 
 
0.5 
Leucine (%kcal) 1.2 
 
1.2 
 
1.2 
 
1.2 
 
0.5 
Arginine (%kcal) 0.84 
 
0.84 
 
0.85 
 
0.84 
 
0.8 
Valine (%kcal) 0.79 
 
0.79 
 
0.81 
 
0.79 
 
0.5 
Aspartic acid (%kcal) 1.3 
 
1.3 
 
1.3 
 
1.3 
 
0.8 
Tyrosine (%kcal) 0.53 
 
0.52 
 
0.53 
 
0.52 
 
0.6 
Glycine (%kcal) 0.65 
 
0.63 
 
0.64 
 
0.63 
 
0.3 
Isoleucine (%kcal) 0.68 
 
0.67 
 
0.68 
 
0.67 
 
0.6 
Alanine (%kcal) 0.73 
 
0.72 
 
0.74 
 
0.72 
 
0.5 
Histidine (%kcal) 0.42 
 
0.42 
 
0.43 
 
0.42 
 
0.5 
Threonine (%kcal) 0.58 
 
0.58 
 
0.59 
 
0.58 
 
0.5 
Methionine (%kcal) 0.33 
 
0.33 
 
0.34 
 
0.33 
 
0.6 
Lysine (%kcal) 0.95 
 
0.93 
 
0.96 
 
0.94 
 
0.6 
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Table 4.35 Mean food group consumption‡ (g/1000kcal) by drinking status (teetotallers, ex-
drinkers, moderate drinkers§ and heavy drinkersΨ), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
 
  
 
Drinking status  
 
Variable 
Teetotaller 
 
Ex-drinker 
 
Moderate 
drinker§ 
 
Heavy 
drinkerΨ 
 p-value∆ 
N 166 
 
250 
 
1,344 
 
599  
 (%) (7.0) 
 
(10.6) 
 
(57.0) 
 
(25.4)  
 
  
 
 
 
 
 
 
 
 Total vegetables (g/1000kcal) 176.8
 174.6  182.0 c 168.7  0.002 
Total fruits (g/1000kcal) 117.1 
a 108.8 b 108.9 c 87.2  <0.0001 
Total grains (g/1000kcal) 299.1 
a d e  261.5 b 258.2 c 208.8  <0.0001 
Nuts and legumes (g/1000kcal) 11.6 
a d 13.1  14.7  14.9  0.1 
Seafood (g/1000kcal) 18.4 
a 19.5 b 20.0 c 23.9  <0.0001 
Meat (g/1000kcal) 19.5 
 18.6 b 20.1 c 22.6  0.04 
Poultry (g/1000kcal) 11.4 
d e 15.3 b 13.9  12.8  0.06 
Vegetarian meat substitutes(g/1000kcal) 15.2 
 16.8  15.5  15.5  0.90 
Processed meat (g/1000kcal) 6.9 
 8.8  8.1  8.2  0.30 
Dairy (g/1000kcal) 72.6 
a 79.0 b 76.5 c 60.2  <0.0001 
Oil (g/1000kcal) 5.2 
 5.4  5.6 c 5.1  0.03 
Animal fat (g/1000kcal) 1.6 
a 1.7  1.9 c 2.2  0.08 
Non-alcoholic beverages (g/1000kcal) 311.2 
e 376.8 b 321.4  292.2  0.003 
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Table 4.36 Mean food group consumption‡ (g/1000kcal) by drinking status (teetotallers, ex-
drinkers, moderate drinkers§ and heavy drinkersΨ), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
 
Drinking status  
 
Variable 
Teetotaller 
 
Ex-drinker 
 
Moderate 
drinker§ 
 
Heavy 
drinkerΨ 
 p-value∆ 
N 598 
 
268 
 
1,259 
 
196  
 (%) (25.8) 
 
(11.6) 
 
(54.2) 
 
(8.4)  
 
  
 
 
 
 
 
 
 
 Total vegetables (g/1000kcal) 193.2
d 191.4  185.8  185.2  0.3 
Total fruits (g/1000kcal) 116.9 
a 116.6 b 115.0 c 91.9  0.04 
Total grains (g/1000kcal) 265.8 
a d e 250.7 b 252.0 c 234.6  <0.0001 
Nuts and legumes (g/1000kcal) 13.6 
 14.2  13.6  15.0  0.8 
Seafood (g/1000kcal) 18.2 
 17.7  18.0  19.3  0.8 
Meat (g/1000kcal) 20.2 
 22.5  20.9  21.1  0.5 
Poultry (g/1000kcal) 11.2 
 11.9  11.7  10.9  0.9 
Vegetarian meat substitutes(g/1000kcal) 17.5 
d 19.0  15.5 c 19.2  0.04 
Processed meat (g/1000kcal) 6.9 
 8.0  7.0  7.6  0.3 
Dairy (g/1000kcal) 95.5 
 86.3  100.9 c 83.5  0.004 
Oil (g/1000kcal) 5.4 
d 4.9  4.9  5.0  0.06 
Animal fat (g/1000kcal) 1.7 
 1.4  1.7  1.8  0.5 
Non-alcoholic beverages (g/1000kcal) 336.0 
e 445.2  362.2  390.0  0.001 
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Table 4.37 Mean food group consumption‡ (g/1000kcal) of current drinkers§ by alcohol drinking 
pattern (number of days alcohol was consumed from two 7-day records), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
f  p<0.05 for drinkers drunk on 10-12 days vs. 13,14 days 
 
  
 
Number of days alcohol consumed  
 
Variable 
1-6 days 
 
7-9 days 
 
10-12 
days 
 
13,14 
days 
 p-value∆ 
N 927 
 
212 
 
242 
 
392  
 (%) (52.3) 
 
(12.0) 
 
(13.7) 
 
(22.1)  
 
  
 
 
 
 
 
 
 
 Total vegetables (g/1000kcal) 179.8
e 180.2 c 174.2 f 159.6  <0.0001
Total fruits (g/1000kcal) 110.5 
a e 93.9 c 90.4 d 78.1  <0.0001 
Total grains (g/1000kcal) 259.0 
a e 240.5 c 211.2 b d 207.3  <0.0001 
Nuts and legumes (g/1000kcal) 14.8 
 14.7  14.2  14.6  1.0 
Seafood (g/1000kcal) 19.7 
e 20.5 c 22.4  24.8  0.001 
Meat (g/1000kcal) 21.3 
 23.3  22.6  22.1  0.5 
Poultry (g/1000kcal) 14.3 
 14.1  12.9  13.4  0.6 
Vegetarian meat substitutes(g/1000kcal) 13.5 
e 15.8 c 16.1 f 9.6  0.006 
Processed meat (g/1000kcal) 7.7 
 7.5  7.3  7.5  0.9 
Dairy (g/1000kcal) 79.1 
a e 62.8  68.7 d 58.8  <0.0001 
Oil (g/1000kcal) 5.7 
 5.4  5.2  5.4  0.2 
Animal fat (g/1000kcal) 1.7 
 2.1  2.2  2.0  0.09 
Non-alcoholic beverages (g/1000kcal) 287.4 
e 273.2  238.4 d 249.1  0.04 
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Table 4.38 Mean food group consumption‡ (g/1000kcal) of current drinkers§ by alcohol drinking 
pattern (number of days alcohol was consumed from two 7-day records), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
 
 
 
  
 
Number of days alcohol consumed  
 
Variable 
1-6 days 
 
7-9 days 
 
10-12 
days 
 
13,14 
days 
 p-value∆ 
N 814 
 
131 
 
76 
 
72  
 (%) (74.5) 
 
(12.0) 
 
(7.0) 
 
(6.6)  
 
  
 
 
 
 
 
 
 
 Total vegetables (g/1000kcal) 185.2
 183.1  183.9  170.9  0.4
Total fruits (g/1000kcal) 134.0 
a e 115.2  123.4  103.9  0.03 
Total grains (g/1000kcal) 239.6 
e 231.4 c 219.1 d 212.3  <0.0001 
Nuts and legumes (g/1000kcal) 13.5 
 11.8  11.5  12.4  0.5 
Seafood (g/1000kcal) 17.9 
 16.7  15.7  21.1  0.3 
Meat (g/1000kcal) 22.4 
 24.3  24.7  18.7  0.2 
Poultry (g/1000kcal) 13.1 
 13.0  12.9  11.2  0.8 
Vegetarian meat substitutes(g/1000kcal) 12.5 
a 16.7  17.0  13.5  0.08 
Processed meat (g/1000kcal) 6.9 
 7.7  7.3  7.4  0.8 
Dairy (g/1000kcal) 110.1 
 102.0  88.1 d 99.5  0.08 
Oil (g/1000kcal) 5.0 
 5.3  5.1  5.4  0.5 
Animal fat (g/1000kcal) 1.9 
a 2.5 c 1.9  1.6  0.09 
Non-alcoholic beverages (g/1000kcal) 332.6 
 348.3  339.4  301.3  0.8 
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Table 4.39 Mean food group consumption‡ (g/1000kcal) of current drinkers§ by alcoholic beverage 
type consumed (beer, wine, spirits and mixed∆), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
 
  
 
Alcoholic beverage type consumed  
 
Variable 
>70% 
Beer 
 
>70% 
Wine 
 
>70% 
Spirits 
 
Mixed  p-value∆ 
N 662 
 
251 
 
409 
 
451  
 (%) (37.3) 
 
(14.2) 
 
(23.1) 
 
(25.4)  
 
  
 
 
 
 
 
 
 
 Total vegetables (g/1000kcal) 180.1 
 174.1  172.1  175.8  0.4 
Total fruits (g/1000kcal) 93.7 
 97.7  105.1  100.1  0.4 
Total grains (g/1000kcal) 237.3 
f 258.6 b 243.7  232.8  0.001 
Nuts and legumes (g/1000kcal) 16.1 
d 14.2  12.4 c 16.4  0.009 
Seafood (g/1000kcal) 19.3 
d 18.8 e 23.4  21.0  0.03 
Meat (g/1000kcal) 24.3 
a d f 20.7 e 20.5  21.8  0.01 
Poultry (g/1000kcal) 13.8 
 13.6  13.6  14.8  0.7 
Vegetarian meat substitutes(g/1000kcal) 14.1 
 11.9  14.0  12.8  0.6 
Processed meat (g/1000kcal) 7.3 
d 6.4 e 8.8 c 6.9  0.05 
Dairy (g/1000kcal) 72.0 
 70.8  73.3  70.1  0.9 
Oil (g/1000kcal) 5.8 
 5.6  5.3  5.6  0.3 
Animal fat (g/1000kcal) 1.6 
d 1.6 e 2.1  2.0  0.09 
Non-alcoholic beverages (g/1000kcal) 288.0 
a f 239.5  285.3  253.5  0.04 
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Table 4.40 Mean foods consumption‡ (g/1000kcal) of current drinkers§ by alcoholic beverage type 
consumed (beer, wine, spirits and mixed∆), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
 
 
Alcoholic beverage type consumed  
 
Variable 
>70% 
Beer 
 
>70% 
Wine 
 
>70% 
Spirits 
 
Mixed  p-value∆ 
N 297 
 
322 
 
243 
 
231  
 (%) (27.2) 
 
(29.5) 
 
(22.2) 
 
(21.1)  
 
  
 
 
 
 
 
 
 
 Total vegetables (g/1000kcal) 183.8
 187.2  177.3  187.6  0.4
Total fruits (g/1000kcal) 122.7 
 139.3  126.8  125.8  0.2 
Total grains (g/1000kcal) 226.3 
d f 241.8 b 242.9 c 228.1  0.001 
Nuts and legumes (g/1000kcal) 13.4 
 12.3  12.0  14.3  0.4 
Seafood (g/1000kcal) 18.3 
 17.5  16.1  19.6  0.2 
Meat (g/1000kcal) 23.4 
 20.3  23.7  22.1  0.2 
Poultry (g/1000kcal) 12.4 
 13.2  13.5  12.5  0.9 
Vegetarian meat substitutes(g/1000kcal) 15.6 
 13.2  10.7  14.5  0.09 
Processed meat (g/1000kcal) 8.1 
f 5.9 b 6.5  7.6  0.02 
Dairy (g/1000kcal) 103.7 
 106.3  112.5  102.1  0.5 
Oil (g/1000kcal) 5.0 
 4.9 b 4.9  5.6  0.02 
Animal fat (g/1000kcal) 1.8 
 2.2 b 2.0  1.7  0.02 
Non-alcoholic beverages (g/1000kcal) 341.1 
 286.5 b 315.2  384.8  0.009 
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Table 4.41  Partial‡ Pearson correlation for selected nutrients (%kcal or amount/1000kcal) 
 
 
 
‡ Adjusted for age and population samples, then pooled by 4 countries 
  
Nutrient 
Vegetable 
protein 
Glutamic 
acid 
Starch 
Omega 
3 PFA 
Linolenic 
acid 
Omega 
6 PFA 
Linoleic 
acid 
Ca Mg P Fe 
Glutamic acid (%kcal) 0.33 
          
Starch (%kcal) 0.58 0.12 
         
Omega 3 PFA (%kcal) -0.02 0.06 -0.17 
        
Linolenic fatty acid (%kcal) 0.03 -0.04 -0.13 0.83 
       
Omega 6 PFA (%kcal) 0.02 -0.04 -0.18 0.48 0.62 
      
Linoleic fatty acid (%kcal) 0.03 -0.05 -0.17 0.48 0.62 1.00 
     
Calcium (mg/1000kcal) 0.17 0.36 -0.11 0.03 0.00 -0.06 -0.06 
    
Magnesium (mg/1000kcal) 0.56 0.33 0.11 0.07 0.00 -0.02 -0.02 0.46 
   
Phosphorous (mg/1000kcal) 0.26 0.59 -0.02 0.08 -0.05 -0.09 -0.09 0.71 0.68 
  
Iron (mg/1000kcal) 0.42 0.35 0.11 0.05 0.01 0.01 0.01 0.39 0.57 0.49 
 
Non-haem Fe (mg/1000kcal) 0.47 0.31 0.15 0.04 0.02 0.02 0.02 0.42 0.58 0.47 0.99 
            
7-day alcohol intake (g/day) -0.20 -0.13 -0.29 -0.04 -0.08 -0.08 -0.08 -0.07 -0.02 -0.08 -0.08 
24-hr dietary alcohol (%kcal) -0.23 -0.16 -0.34 -0.05 -0.09 -0.11 -0.11 -0.09 -0.02 -0.11 -0.08 
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Table 4.42  Effect of nutrient variables on alcohol-SBP relationship, male current drinkers  
 
 
* Coefficient for alcohol-SBP relation in multiple linear regression model 
‡
 Percent change in alcohol-SBP coefficient compared to Model 1 
  
Row Model Coefficient* % change‡ 
p-value, 
alcohol 
p-value 
A 
Model 1: age, country, years of 
education, marital status, 
employment, cigarette smoking, 
supplement intake, special diet, 
CVD-DM diagnosis, family 
history of hypertension, hours of 
moderate to heavy physical 
activity per day, BMI, urinary Na 
and K, alcohol drinking pattern 
and type of alcoholic beverage 
0.086 
 
<0.0001  
B Model 1 + vegetable protein 0.085 -1.02 <0.0001  
C Model 1 +  glutamic acid 0.085 -0.63 <0.0001  
D Model 1 + starch 0.096 + 11.76 <0.0001 0.06 (starch) 
E Model 1 + omega 3 fatty acid 0.085 -1.02 <0.0001  
F Model 1 + linolenic acid 0.085 -0.93 <0.0001  
G Model 1 + omega 6 fatty acid 0.085 -0.80 <0.0001  
H Model 1 + linoleic acid 0.085 -0.84 <0.0001  
I Model 1 + calicum 0.085 -0.77 <0.0001  
J Model 1 + magnesium 0.084 -1.94 <0.0001 0.003 (Mg) 
K Model 1 + phosphorous 0.084 -1.77 <0.0001 0.005 (P) 
L Model 1 + iron 0.083 -3.11 <0.0001 0.01 (Fe) 
M Model 1 + non-haem iron 0.083 -3.46 <0.0001 0.03 (Non-haem Fe) 
N 
Model 1 + non-haem iron and 
omega 3 fatty acid 
0.082 -4.91 <0.0001 0.02 (Non-haem Fe) 
O 
Model 1 + non-haem iron and  
linolenic acid 
0.082 -4.70 <0.0001 0.02 (Non-haem Fe) 
P 
Model 1 + non-haem iron and 
omega 3 fatty acid 
0.082 -4.23 <0.0001 0.03 (Non-haem Fe) 
Q 
Model 1 + non-haem iron and 
linoleic acid 
0.082 -4.26 <0.0001 0.03 (Non-haem Fe) 
R 
Model 1 + omega 3 fatty acid 
and magnesium 
0.083 -3.10 <0.0001 0.002 (Mg) 
S 
Model 1 + omega 3 fatty acid 
and vegetable protein 
0.083 -3.05 <0.0001  
T 
Model 1 + omega 3 fatty acid 
and phosphorous 
0.084 -2.56 <0.0001 0.007 (P) 
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Table 4.43  Effect of nutrient variables on alcohol-SBP relationship, female current drinkers 
 
 
* Coefficient for alcohol-SBP relation in multiple linear regression model 
‡
 Percent change in alcohol-SBP coefficient compared to Model 1 
  
Row Model Coefficient* % change‡ 
p-value, 
alcohol 
p-value 
A 
Model 1: age, country, years of 
education, marital status, 
employment, cigarette 
smoking, supplement intake, 
special diet, CVD-DM 
diagnosis, family history of 
hypertension, hours of 
moderate to heavy physical 
activity per day, BMI, urinary 
Na and K, alcohol drinking 
pattern and type of alcoholic 
beverage 
0.100 
 
0.08  
B Model 1 + vegetable protein 0.102 +2.52 0.08  
C Model 1 +  glutamic acid 0.100 +0.32 0.08  
D Model 1 + starch 0.100 +0.79 0.09  
E Model 1 + omega 3 fatty acid 0.102 +2.61 0.08 0.01 (Omega 3) 
F Model 1 + linolenic acid 0.095 -5.08 0.1 0.05 (PFA18:3) 
G Model 1 + omega 6 fatty acid 0.102 +2.73 0.08  
H Model 1 + linoleic acid 0.102 +2.73 0.08  
I Model 1 + calicum 0.100 +0.15 0.08  
J Model 1 + magnesium 0.096 -4.04 0.1  
K Model 1 + phosphorous 0.099 -1.09 0.09  
L Model 1 + iron 0.099 -0.15 0.09  
M Model 1 + non-haem iron 0.099 -0.26 0.09  
N 
Model 1 + linolenic acid and 
magnesium 
0.091 -8.12 0.1 0.07 (Mg) 
O 
Model 1 + linolenic acid and 
phosphorous 
0.094 -5.57 0.1 0.05 (P) 
P 
Model 1 + linolenic acid and 
non-hame iron 
0.094 -5.70 0.1 0.04 (Non-haem Fe) 
Q Model 1 + linolenic and iron 0.094 -5.56 0.1 0.04 (Non-haem Fe) 
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Table 4.44  Effect of nutrient variables on alcohol-DBP relationship, male current drinkers  
 
 
* Coefficient for alcohol-DBP relation in multiple linear regression model 
‡
 Percent change in alcohol-DBP coefficient compared to Model 1 
 
 
 
  
Row Model Coefficient* % change‡ 
p-value, 
alcohol 
p-value 
A 
Model 1: age, country, years of 
education, marital status, 
employment, cigarette smoking, 
supplement intake, special diet, 
CVD-DM diagnosis, family 
history of hypertension, hours of 
moderate to heavy physical 
activity per day, BMI, urinary Na 
and K, alcohol drinking pattern 
and type of alcoholic beverage 
0.039 
 
0.004  
B Model 1 + vegetable protein 0.038 -4.27 0.004  
C Model 1 +  glutamic acid 0.039 -0.55 0.003  
D Model 1 + starch 0.039 -0.74 0.004  
E Model 1 + omega 3 fatty acid 0.039 -0.54 0.003  
F Model 1 + linolenic acid 0.040 +1.20 0.002  
G Model 1 + omega 6 fatty acid 0.039 -0.58 0.003  
H Model 1 + linoleic acid 0.039 -0.59 0.003  
I Model 1 + calicum 0.039 +0.08 0.003  
J Model 1 + magnesium 0.037 -4.36 0.004 <0.0001 (Mg) 
K Model 1 + phosphorous 0.038 -2.85 0.003 0.005 (P) 
L Model 1 + iron 0.037 -6.25 0.005 0.002 (Fe) 
M Model 1 + non-haem iron 0.036 -6.98 0.005 0.005 (Non-haem Fe) 
N 
Model 1 + non-haem iron and 
omega 3 fatty acid 
0.037 -6.16 0.005 0.006 
O 
Model 1 + non-haem iron and  
linolenic acid 
0.036 -7.54 0.005 0.005 (Non-haem Fe) 
P 
Model 1 + non-haem iron and 
omega 3 fatty acid 
0.036 -7.53 0.005 0.005 (Non-haem Fe) 
Q 
Model 1 + non-haem iron and 
linoleic acid 
0.036 -8.06 0.006 0.004 (Non-haem Fe) 
R 
Model 1 + omega 3 fatty acid 
and magnesium 
0.037 -4.44 0.004 <0.0001 (Mg) 
S 
Model 1 + omega 3 fatty acid 
and vegetable protein 
0.037 -5.08 0.005  
T 
Model 1 + omega 3 fatty acid 
and phosphorous 
0.038 -2.37 0.004 0.005 (P) 
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Table 4.45  Effect of nutrient variables on alcohol-DBP relationship, female current drinkers  
 
 
* Coefficient for alcohol-DBP relation in multiple linear regression model 
‡
 Percent change in alcohol-DBP coefficient compared to Model 1 
 
Row Model Coefficient* % change‡ 
p-value, 
alcohol 
p-value 
A 
Model 1: age, country, years of 
education, marital status, 
employment, cigarette 
smoking, supplement intake, 
special diet, CVD-DM 
diagnosis, family history of 
hypertension, hours of 
moderate to heavy physical 
activity per day, BMI, urinary 
Na and K, alcohol drinking 
pattern and type of alcoholic 
beverage 
0.111 
 
0.005 
 
B Model 1 + vegetable protein 0.112 +1.37 0.005  
C Model 1 +  glutamic acid 0.111 +0.53 0.005  
D Model 1 + starch 0.108 -2.45 0.007  
E Model 1 + omega 3 fatty acid 0.112 +1.39 0.004 0.03 (Omega 3) 
F Model 1 + linolenic acid 0.108 -2.58 0.006  
G Model 1 + omega 6 fatty acid 0.110 -0.56 0.005  
H Model 1 + linoleic acid 0.110 -0.64 0.006  
I Model 1 + calicum 0.110 -0.33 0.005  
J Model 1 + magnesium 0.109 -1.61 0.006  
K Model 1 + phosphorous 0.110 -0.82 0.006  
L Model 1 + iron 0.110 -0.56 0.005  
M Model 1 + non-haem iron 0.110 -0.52 0.005  
N 
Model 1 + linolenic acid and 
magnesium 0.106 -3.73 0.007  
O 
Model 1 + linolenic acid and 
phosphorous 0.107 -3.06 0.007  
P 
Model 1 + linolenic acid and 
non-hame iron 0.107 -3.31 0.007  
Q Model 1 + linolenic and iron 0.107 -3.35 0.0007  
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Table 4.46  Effect of food groups on alcohol-SBP relationship, male current drinkers 
 
 
* Coefficient for alcohol-SBP relation in multiple linear regression model 
‡
 Percent change in alcohol-SBP coefficient compared to Model 1 
  
Row Model Coefficient* % change‡ 
p-value, 
alcohol 
p-value 
A 
Model 1: age, country, years of 
education, marital status, 
employment, cigarette 
smoking, supplement intake, 
special diet, CVD-DM 
diagnosis, family history of 
hypertension, hours of 
moderate to heavy physical 
activity per day, BMI, urinary 
Na and K, alcohol drinking 
pattern and type of alcoholic 
beverage 
0.086 
 
<0.0001 
 
B 
Model 1 + Vegetables 
(g/1000kcal) 
0.084 -1.79 <0.0001 
 
C Model 1 + Fruits (g/1000kcal) 0.086 +0.30 <0.0001 
 
D Model 1 + Grains (g/1000kcal) 0.095 +10.88 <0.0001 
0.01 
E Model 1 + Nuts (g/1000kcal) 0.086 -0.24 <0.0001 
 
F 
Model 1 + Seafood 
(g/1000kcal) 
0.088 +2.40 <0.0001 
0.04 
G Model 1 + Meat (g/1000kcal) 0.086 +0.17 <0.0001 
 
H Model 1 + Poultr y(g/1000kcal) 0.086 -0.18 <0.0001 
 
I 
Model 1 + Vegetarian meat 
substitutes (g/1000kcal) 
0.086 +0.57 <0.0001 
0.02 
J 
Model 1 + Processed meat 
(g/1000kcal) 
0.085 -1.42 <0.0001 
 
K Model 1 + Dairy (g/1000kcal) 0.085 -0.79 <0.0001 
 
L Model 1 + Oil (g/1000kcal) 0.085 -1.57 <0.0001 
 
M 
Model 1 + Animal fat 
(g/1000kcal) 
0.086 +0.20 <0.0001 
 
N 
Model 1 + Non-alcoholic 
beverages (g/1000kcal) 
0.086 +0.00 <0.0001 
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Table 4.47  Effect of food groups on alcohol-SBP relationship, female current drinkers 
 
 
* Coefficient for alcohol-SBP relation in multiple linear regression model 
‡
 Percent change in alcohol-SBP coefficient compared to Model 1 
  
Row Model Coefficient* % change‡ 
p-value, 
alcohol 
p-value 
A 
Model 1: age, country, years of 
education, marital status, 
employment, cigarette 
smoking, supplement intake, 
special diet, CVD-DM 
diagnosis, family history of 
hypertension, hours of 
moderate to heavy physical 
activity per day, BMI, urinary 
Na and K, alcohol drinking 
pattern and type of alcoholic 
beverage 
0.100 
 
0.08  
B 
Model 1 + Vegetables 
(g/1000kcal) 
0.100 0.02 0.08  
C Model 1 + Fruits (g/1000kcal) 0.097 -2.54 0.09  
D Model 1 + Grains (g/1000kcal) 0.108 8.09 0.06  
E Model 1 + Nuts (g/1000kcal) 0.098 -1.49 0.09  
F 
Model 1 + Seafood 
(g/1000kcal) 
0.102 2.42 0.08  
G Model 1 + Meat (g/1000kcal) 0.098 -1.14 0.09  
H Model 1 + Poultr y(g/1000kcal) 0.102 3.19 0.08 0.02 
I 
Model 1 + Vegetarian meat 
substitutes (g/1000kcal) 
0.100 0.42 0.08  
J 
Model 1 + Processed meat 
(g/1000kcal) 
0.103 3.43 0.07  
K Model 1 + Dairy (g/1000kcal) 0.098 -1.24 0.09  
L Model 1 + Oil (g/1000kcal) 0.098 -2.08 0.09  
M 
Model 1 + Animal fat 
(g/1000kcal) 
0.099 -0.88 0.09  
N 
Model 1 + Non-alcoholic 
beverages (g/1000kcal) 
0.100 0.83 0.08  
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Table 4.48  Effect of food groups on alcohol-DBP relationship, male current drinkers 
 
 
* Coefficient for alcohol-DBP relation in multiple linear regression model 
‡
 Percent change in alcohol-DBP coefficient compared to Model 1 
 
  
Row Model Coefficient* % change‡ 
p-value, 
alcohol 
p-value 
A 
Model 1: age, country, years of 
education, marital status, 
employment, cigarette 
smoking, supplement intake, 
special diet, CVD-DM 
diagnosis, family history of 
hypertension, hours of 
moderate to heavy physical 
activity per day, BMI, urinary 
Na and K, alcohol drinking 
pattern and type of alcoholic 
beverage 
0.039 
 
0.003  
B 
Model 1 + Vegetables 
(g/1000kcal) 
0.038 -2.55 0.003  
C Model 1 + Fruits (g/1000kcal) 0.039 -0.10 0.003  
D Model 1 + Grains (g/1000kcal) 0.038 -2.90 0.004  
E Model 1 + Nuts (g/1000kcal) 0.039 -0.30 0.003  
F 
Model 1 + Seafood 
(g/1000kcal) 
0.041 3.82 0.002 0.04 
G Model 1 + Meat (g/1000kcal) 0.039 -0.03 0.003  
H Model 1 + Poultr y(g/1000kcal) 0.039 0.04 0.003  
I 
Model 1 + Vegetarian meat 
substitutes (g/1000kcal) 
0.040 1.12 0.002 0.005 
J 
Model 1 + Processed meat 
(g/1000kcal) 
0.039 -1.22 0.003  
K Model 1 + Dairy (g/1000kcal) 0.040 1.25 0.002  
L Model 1 + Oil (g/1000kcal) 0.038 -3.94 0.004  
M 
Model 1 + Animal fat 
(g/1000kcal) 
0.039 -1.51 0.003  
N 
Model 1 + Non-alcoholic 
beverages (g/1000kcal) 
0.039 -0.99 0.003  
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Table 4.49  Effect of food groups on alcohol-DBP relationship, female current drinkers 
 
 
* Coefficient for alcohol-DBP relation in multiple linear regression model 
‡
 Percent change in alcohol-DBP coefficient compared to Model 1 
  
Row Model Coefficient* % change‡ 
p-value, 
alcohol 
p-value 
A 
Model 1: age, country, years of 
education, marital status, 
employment, cigarette 
smoking, supplement intake, 
special diet, CVD-DM 
diagnosis, family history of 
hypertension, hours of 
moderate to heavy physical 
activity per day, BMI, urinary 
Na and K, alcohol drinking 
pattern and type of alcoholic 
beverage 
0.111 
 
0.005  
B 
Model 1 + Vegetables 
(g/1000kcal) 
0.111 0.09 0.005  
C Model 1 + Fruits (g/1000kcal) 0.108 -2.55 0.006 0.02 
D Model 1 + Grains (g/1000kcal) 0.113 1.88 0.005  
E Model 1 + Nuts (g/1000kcal) 0.110 -0.36 0.005  
F 
Model 1 + Seafood 
(g/1000kcal) 
0.113 2.62 0.004  
G Model 1 + Meat (g/1000kcal) 0.108 -2.50 0.006  
H Model 1 + Poultr y(g/1000kcal) 0.111 3.10 0.005  
I 
Model 1 + Vegetarian meat 
substitutes (g/1000kcal) 
0.111 0.34 0.005  
J 
Model 1 + Processed meat 
(g/1000kcal) 
0.110 -0.43 0.005  
K Model 1 + Dairy (g/1000kcal) 0.110 -0.13 0.005  
L Model 1 + Oil (g/1000kcal) 0.105 -5.08 0.008 0.05 
M 
Model 1 + Animal fat 
(g/1000kcal) 
0.109 -1.03 0.006  
N 
Model 1 + Non-alcoholic 
beverages (g/1000kcal) 
0.113 1.84 0.004  
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Table 4.50  Mean urinary amino acid excretion‡ (mmol/24hour) by drinking status (teetotallers, ex-
drinkers, moderate drinkers§ and heavy drinkersΨ), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: women, mean daily alcohol intake from two 7-day records >13 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
f  p<0.05 for ex-drinkers vs. moderate drinkers 
  
 Drinking status   
Variable Teetotaller 
 
Ex-drinker 
 Moderate 
drinker§ 
 Heavy 
drinkerΨ 
 
p-value∆ 
N 166  250  1,344  599   
(%) (7.0)  (10.6)  (57.0)  (25.4)    
  
 
 
 
 
 
   
Urinary alanine (mmol/24h) 441.1 
a 
433.1 
b 
420.0 
c 
383.4  0.0009 
Urinary arginine (mmol/24h) 36.9 
 
50.0 
f 
36.0 
 
40.3  0.2 
Urinary asparagine (mmol/24h) 253.9 
 
230.7 
 
239.1 
 
232.8  0.3 
Urinary carnosine (mmol/24h) 142.0 
 
141.5 
 
144.2 
c 
151.2  0.2 
Urinary cystine (mmol/24h) 118.0 
 
109.0 
 
108.6 
 
106.8  0.4 
Urinary ethanolalanine (mmol/24h) 378.7 
 
387.5 
 
392.9 
c 
374.1  0.03 
Urinary glutamine (mmol/24h) 532.5 
a 
511.4 
 
510.0 
c 
479.7  0.02 
Urinary glycine (mmol/24h) 1414.3 
a 
1440.8 
b f 
1323.3 
c 
1144.8  <0.0001 
Urinary histidine (mmol/24h) 983.3 
 
953.4 
 
970.6 
 
952.1  0.8 
Urinary isoleucine (mmol/24h) 10.1 
a d 
11.4 
 
11.5 
 
11.6  0.2 
Urinary leucine (mmol/24h) 39.9 
 
41.6 
 
39.2 
 
41.1  0.5 
Urinary lysine (mmol/24h) 476.1 
 
438.9 
 
442.5 
 
447.5  0.9 
Urinary methionine (mmol/24h) 42.6 
 
40.7 
 
44.1 
 
44.5  0.2 
Urinary 1-methylhistidine (mmol/24h) 690.3 
 
759.0 
 
757.7 
 
770.5  0.8 
Urinary 3-methylhistidine (mmol/24h) 275.3 
a 
279.9 
b 
283.1 
c 
294.7  0.02 
Urinary phenylalanine (mmol/24h) 86.1 
a d 
79.0 
 
79.6 
 
76.5  0.1 
Urinary serine (mmol/24h) 464.6 
a 
434.7 
b 
437.1 
c 
399.5  0.0003 
Urinary taurine (mmol/24h) 1073.3 
a 
1081.4 
b 
1063.9 
c 
1359.0  <0.0001 
Urinary threonine (mmol/24h) 218.5 
a 
199.6 
 
203.9 
 
192.5  0.1 
Urinary tryptophan (mmol/24h) 70.2 
 
59.7 
e 
64.1 
 
63.1  0.08 
Urinary tyrosine (mmol/24h) 133.0 
 
136.3 
 
128.9 
 
125.4  0.3 
Urinary valine (mmol/24h) 47.8 
 
50.9 
 
48.7 
 
49.1  0.5 
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Table 4.51  Mean urinary amino acid excretion (mmol/24hour) by drinking status (teetotallers, ex-
drinkers, moderate drinkers§ and heavy drinkersΨ), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: women, mean daily alcohol intake from two 7-day records >13 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
f  p<0.05 for ex-drinkers vs. moderate drinkers 
  
 Drinking status   
Variable Teetotaller 
 
Ex-drinker 
 Moderate 
drinker§ 
 Heavy 
drinkerΨ 
 
p-value∆ 
N 598  268  1,259  196   
(%) (25.8)  (11.6)  (54.2)  (8.4)    
          
Urinary alanine (mmol/24h) 371.0 a d 361.1 b 349.7 c 315.7  0.003 
Urinary arginine (mmol/24h) 23.3  23.5  22.0  22.6  0.4 
Urinary asparagine (mmol/24h) 204.1  198.9  198.0  183.2  0.3 
Urinary carnosine (mmol/24h) 107.0  109.7  110.0  110.4  0.7 
Urinary cystine (mmol/24h) 90.5 a d 86.6  82.3  79.4  0.05 
Urinary ethanolalanine (mmol/24h) 326.2  317.6  325.4  313.7  0.2 
Urinary glutamine (mmol/24h) 443.8 a 420.9  432.3  404.7  0.1 
Urinary glycine (mmol/24h) 1429.4 a 1477.2 b 1500.1 c 1189.6  0.0003 
Urinary histidine (mmol/24h) 791.0  716.7 e 758.7  740.3  0.1 
Urinary isoleucine (mmol/24h) 11.1 a d 10.3  9.8  9.6  0.004 
Urinary leucine (mmol/24h) 33.5 d 32.6 f 29.9  30.4  0.003 
Urinary lysine (mmol/24h) 345.2  341.1  320.8  307.5  0.4 
Urinary methionine (mmol/24h) 36.1  38.1  35.9  38.1  0.2 
Urinary 1-methylhistidine (mmol/24h) 616.2  628.1  632.0  593.0  0.9 
Urinary 3-methylhistidine (mmol/24h) 189.5 d 196.6  197.7  193.0  0.1 
Urinary phenylalanine (mmol/24h) 71.1  69.8  68.9  65.1  0.8 
Urinary serine (mmol/24h) 364.5 a 361.2 b 359.0 c 321.1  0.04 
Urinary taurine (mmol/24h) 671.4  765.8  728.8  764.9  0.2 
Urinary threonine (mmol/24h) 178.6  176.4  177.0  162.3  0.5 
Urinary tryptophan (mmol/24h) 55.3  49.3 e 52.3  51.0  0.1 
Urinary tyrosine (mmol/24h) 97.8  92.5  93.1  93.5  0.4 
Urinary valine (mmol/24h) 43.2 a d 43.1  41.0  39.8  0.07 
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Table 4.52 Mean urinary amino acid excretion (mmol/24hour) of current drinkers§ by alcohol 
drinking pattern (number of days alcohol was consumed from two 7-day records), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
f  p<0.05 for drinkers drunk on 10-12 days vs. 13,14 days 
 
  
 Number of days alcohol consumed   
Variable 1-6 days 
 
7-9 days 
 
10-12 days 
 
13,14 days  p-value∆ 
N 927  212  242  392   
(%) (52.3)  (12.0)  (13.7)  (22.1)    
          
Urinary alanine (mmol/24h) 421.7 a 382.1  379.2 d 388.7 e 0.002 
Urinary arginine (mmol/24h) 27.7  26.9  28.6 c 32.9 e 0.02 
Urinary asparagine (mmol/24h) 240.8  230.3  236.3  249.5  0.4 
Urinary carnosine (mmol/24h) 144.8  149.9  148.1  153.6 e 0.2 
Urinary cystine (mmol/24h) 108.6  106.2  103.7  107.7  0.8 
Urinary ethanolalanine (mmol/24h) 393.1 a 372.8  375.4 d 379.2  0.03 
Urinary glutamine (mmol/24h) 517.7  494.2  506.9  510.0  0.5 
Urinary glycine (mmol/24h) 1345.1  1265.7  1229.5 d 1207.2 e 0.02 
Urinary histidine (mmol/24h) 979.4  926.1  957.1 c 1016.5  0.1 
Urinary isoleucine (mmol/24h) 11.2  11.3  11.2  11.4  1.0 
Urinary leucine (mmol/24h) 37.9  39.4  39.7  41.7  0.3 
Urinary lysine (mmol/24h) 445.3  432.8  429.0  480.7  0.6 
Urinary methionine (mmol/24h) 46.2  46.5  44.5  47.0  0.7 
Urinary 1-methylhistidine (mmol/24h) 736.1  845.9  857.8  791.2  0.2 
Urinary 3-methylhistidine (mmol/24h) 281.5  284.6  290.3 c 301.0 e 0.01 
Urinary phenylalanine (mmol/24h) 79.0  76.7  76.6  77.5  0.6 
Urinary serine (mmol/24h) 443.5  426.0  413.7 d 424.5  0.1 
Urinary taurine (mmol/24h) 1101.5  1081.8  1183.3 c 1439.0 e f <0.0001 
Urinary threonine (mmol/24h) 205.8  198.7  193.3  210.4  0.4 
Urinary tryptophan (mmol/24h) 63.6  62.0  63.4  65.1  0.9 
Urinary tyrosine (mmol/24h) 130.2 a 121.3  128.6  131.3  0.2 
Urinary valine (mmol/24h) 48.6  46.4  47.8  49.2  0.4 
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Table 4.53 Mean urinary amino acid excretion (mmol/24hour) of current drinkers§ by alcohol 
drinking pattern (number of days alcohol was consumed from two 7-day records), 
women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
f  p<0.05 for drinkers drunk on 10-12 days vs. 13,14 days 
  
 Number of days alcohol consumed   
Variable 1-6 days 
 
7-9 days 
 
10-12 days 
 
13,14 days  p-value∆ 
N 814  131  76  72   
(%) (74.5)  (12.0)  (7.0)  (6.6)    
          
Urinary alanine (mmol/24h) 329.3  308.3  310.8  283.7 e 0.03 
Urinary arginine (mmol/24h) 22.4  23.2  24.2  21.8  0.7 
Urinary asparagine (mmol/24h) 190.2  179.9  185.9  181.8  0.8 
Urinary carnosine (mmol/24h) 114.0  113.4  117.3  119.6  0.6 
Urinary cystine (mmol/24h) 81.9  80.4  86.4  74.7  0.5 
Urinary ethanolalanine (mmol/24h) 335.6  326.8  323.2  322.7  0.3 
Urinary glutamine (mmol/24h) 427.9  421.3  412.6  423.3  0.9 
Urinary glycine (mmol/24h) 1522.0  1408.7  1328.8  1302.3  0.08 
Urinary histidine (mmol/24h) 759.2  745.0  758.5  728.5  0.9 
Urinary isoleucine (mmol/24h) 9.1  9.6  9.1  9.2  0.8 
Urinary leucine (mmol/24h) 27.8  27.6  29.8  28.3  0.7 
Urinary lysine (mmol/24h) 320.4  345.6  359.2  280.9  0.2 
Urinary methionine (mmol/24h) 34.1  35.3  38.0  38.4  0.1 
Urinary 1-methylhistidine (mmol/24h) 695.9  692.7  670.2  679.3  1.0 
Urinary 3-methylhistidine (mmol/24h) 208.1  208.7  208.8  200.6  0.8 
Urinary phenylalanine (mmol/24h) 63.9  60.2  62.9  61.8  1.0 
Urinary serine (mmol/24h) 353.0  334.7  322.2  326.2  0.2 
Urinary taurine (mmol/24h) 744.7  871.5  841.4  795.2  0.3 
Urinary threonine (mmol/24h) 165.2  161.5  152.1  160.0  0.8 
Urinary tryptophan (mmol/24h) 49.1  47.6  49.7  47.5  0.9 
Urinary tyrosine (mmol/24h) 84.9  86.2  90.2  86.0  0.8 
Urinary valine (mmol/24h) 38.9  38.7  38.5  37.4  0.9 
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Table 4.54 Mean urinary amino acid excretion (mmol/24hour) of current drinkers§ by alcoholic 
beverage type consumed (beer, wine, spirits and mixed∆), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
  
 Alcoholic beverage type consumed   
Variable 
>70% 
Beer 
 >70% 
Wine 
 >70% 
Spirits 
 
Mixed 
 
p-value∆ 
N 662  251  409  451   
(%) (37.3)  (14.2)  (23.1)  (25.4)    
          
Urinary alanine (mmol/24h) 403.3  431.8  395.7  405.6  0.2 
Urinary arginine (mmol/24h) 30.5 d 27.7  26.2  30.1  0.1 
Urinary asparagine (mmol/24h) 244.2  255.5 e 227.7  245.8  0.2 
Urinary carnosine (mmol/24h) 149.4  145.9  145.3  149.3  0.8 
Urinary cystine (mmol/24h) 109.1  109.6  102.1  111.7  0.5 
Urinary ethanolalanine (mmol/24h) 385.8  397.8  380.6  385.7  0.4 
Urinary glutamine (mmol/24h) 505.1 f 538.7 e 495.2  527.6  0.08 
Urinary glycine (mmol/24h) 1293.6  1376.7  1244.7  1321.8  0.3 
Urinary histidine (mmol/24h) 962.0  1015.8  940.9  1017.2  0.1 
Urinary isoleucine (mmol/24h) 11.3  11.3  11.0  11.5  0.8 
Urinary leucine (mmol/24h) 40.1 f 35.0 e 41.0  37.1  0.08 
Urinary lysine (mmol/24h) 452.7  425.0  430.5  475.5  0.5 
Urinary methionine (mmol/24h) 48.6 a f 42.1  46.6  44.7  0.005 
Urinary 1-methylhistidine (mmol/24h) 739.7  761.0  819.9  768.6  0.8 
Urinary 3-methylhistidine (mmol/24h) 281.3  279.4  290.6  290.1  0.2 
Urinary phenylalanine (mmol/24h) 80.0 d 84.0 b e 74.3  78.3  0.006 
Urinary serine (mmol/24h) 439.1  464.0 e 412.0  442.8  0.04 
Urinary taurine (mmol/24h) 1132.1 f 958.3 b e 1213.0  1249.4  0.002 
Urinary threonine (mmol/24h) 203.8  217.4  194.9  210.0  0.3 
Urinary tryptophan (mmol/24h) 65.4  66.1  61.4  63.6  0.5 
Urinary tyrosine (mmol/24h) 129.5 f 139.2 e 123.9  130.2  0.05 
Urinary valine (mmol/24h) 48.7  50.8  47.4  47.9  0.3 
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Table 4.55 Mean urinary amino acid excretion (mmol/24hour) of current drinkers§ by alcoholic 
beverage type consumed (beer, wine, spirits and mixed∆), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
 
 Alcoholic beverage type consumed   
Variable 
>70% 
Beer 
 >70% 
Wine 
 >70% 
Spirits 
 
Mixed 
 
p-value∆ 
N 297  322  243  231   
(%) (27.2)  (29.5)  (22.2)  (21.1)    
          
Urinary alanine (mmol/24h) 314.7  326.2  332.3  311.1  0.3 
Urinary arginine (mmol/24h) 24.1 d 22.2  21.4  22.6  0.2 
Urinary asparagine (mmol/24h) 192.9  191.8  186.7  178.2  0.5 
Urinary carnosine (mmol/24h) 115.5  110.5 e 119.4 c 111.7  0.07 
Urinary cystine (mmol/24h) 83.4  80.3  79.1  82.8  0.7 
Urinary ethanolalanine (mmol/24h) 338.3 f 322.8  334.3  330.4  0.2 
Urinary glutamine (mmol/24h) 426.6  434.1  427.6  412.7  0.6 
Urinary glycine (mmol/24h) 1444.1  1572.7  1467.7  1417.8  0.2 
Urinary histidine (mmol/24h) 749.7  764.4  771.2  732.6  0.7 
Urinary isoleucine (mmol/24h) 9.4  9.0  8.9  9.5  0.5 
Urinary leucine (mmol/24h) 31.1 a d f 26.4  26.5  27.2  0.002 
Urinary lysine (mmol/24h) 333.6  315.0  321.2  322.7  0.9 
Urinary methionine (mmol/24h) 37.2 f 30.9 b e 35.7  34.9  0.002 
Urinary 1-methylhistidine (mmol/24h) 639.9  706.4  710.8  724.2  0.7 
Urinary 3-methylhistidine (mmol/24h) 206.1  202.9 e 213.4  207.1  0.2 
Urinary phenylalanine (mmol/24h) 61.6  71.7  59.7  61.4  0.3 
Urinary serine (mmol/24h) 348.3  359.3 b 346.3  328.4  0.2 
Urinary taurine (mmol/24h) 824.7  754.0  748.2  760.1  0.7 
Urinary threonine (mmol/24h) 161.9  166.3  171.6  152.1  0.3 
Urinary tryptophan (mmol/24h) 46.2 d 48.5  52.1  48.5  0.2 
Urinary tyrosine (mmol/24h) 82.6  86.0  88.4  86.1  0.5 
Urinary valine (mmol/24h) 38.9  38.6  38.9  38.1  0.9 
          
 1 
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Table 4.56 Mean 1H NMR metabolites‡ (mmol/24hr) by alcohol drinking status (teetotallers, ex-
drinkers, moderate drinkers¶ and heavy drinkersΨ), INTERMAP Study, men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
f  p<0.05 for ex-drinkers vs. moderate drinkers 
 
Abbreviation: NMNA, N-methylnicotinate 
 
 
 
Table 4.57 Mean 1H NMR metabolites‡ (mmol/24hr) by alcohol drinking status (teetotallers, ex-
drinkers, moderate drinkers¶ and heavy drinkersΨ), INTERMAP Study, women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day 
∆  F-test in analysis of variance  
a  p<0.05 for teetotallers vs. heavy drinkers 
b  p<0.05 for ex-drinkers vs. heavy drinkers 
c  p<0.05 for moderate drinkers vs. heavy drinkers 
d  p<0.05 for teetotallers vs. moderate drinkers 
e  p<0.05 for ex-drinkers vs. teetotallers 
f  p<0.05 for ex-drinkers vs. moderate drinkers 
 
Abbreviation: NMNA, N-methylnicotinate 
 
  
NMR metabolite Drinking status 
 Teetotaller  Ex-drinker  Moderate drinker  Heavy drinker  p-value 
 N Mean  N Mean  N Mean  N Mean   
Alanine (mmol/24hr) 140 0.38 a 230 0.39 b 1,227 0.38 c 554 0.35  0.002 
Formate (mmol/24hr) 142 0.32  221 0.35 b 1,218 0.34 c 544 0.32  0.01 
Hippurate (mmol/24hr) 141 2.73  218 2.93 b 1,207 2.82 c 514 2.44  0.0002 
NMNA (mmol/24hr) 125 0.20  211 0.24  1,195 0.25  531 0.23  0.2 
              
 
NMR metabolite Drinking status 
 Teetotaller  Ex-drinker  Moderate drinker  Heavy drinker  p-value 
 N Mean  N Mean  N Mean  N Mean   
Alanine (mmol/24hr) 485 0.33 a 243 0.31  1,167 0.32 c 186 0.30  0.1 
Formate (mmol/24hr) 478 0.31  229 0.31  1,137 0.30  176 0.29  0.3 
Hippurate (mmol/24hr) 499 2.46  243 2.66  1,169 2.72 c 189 2.81  0.04 
NMNA (mmol/24hr) 440 0.24 a 234 0.23 b 1,156 0.24 c 189 0.28  0.004 
              
 
147 
 
Table 4.58 Mean 1H NMR metabolites‡ (mmol/24hr) of current drinkers§ by alcohol drinking pattern 
(number of days of alcohol consumption of 14) from two 7-day records, men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
f  p<0.05 for drinkers drunk on 10-12 days vs. 13,14 days 
 
Abbreviation: NMNA, N-methylnicotinate 
 
 
 
Table 4.59 Mean 1H NMR metabolites‡ (mmol/24hr) of current drinkers§ by alcohol drinking pattern 
(number of days of alcohol consumption of 14) from two 7-day records, women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
a  p<0.05 for drinkers drunk only on 1-6 days vs. 7-9 days 
b  p<0.05 for drinkers drunk on 7-9 days vs. 10-12 days 
c  p<0.05 for drinkers drunk on 7-9 days vs. 13,14 days 
d  p<0.05 for drinkers drunk only on 1-6 days vs. 10-12 days 
e  p<0.05 for drinkers drunk only on 1-6 days vs. 13,14 days 
f  p<0.05 for drinkers drunk on 10-12 days vs. 13,14 days 
 
Abbreviation: NMNA, N-methylnicotinate 
  
NMR metabolite Number of days alcohol consumed 
 1-6 days  7-9 days  10-12 days  13,14 days  p-value 
 N Mean  N Mean  N Mean  N Mean   
Alanine (mmol/24hr) 845 0.39 a 198 0.36  225 0.37  362 0.36 e 0.002 
Formate (mmol/24hr) 831 0.34  200 0.33  217 0.33  360 0.33  0.01 
Hippurate (mmol/24hr) 827 2.81  186 2.65  220 2.57  336 2.44 e 0.0002 
NMNA (mmol/24hr) 814 0.24  188 0.23  199 0.25  366 0.24  0.2 
              
 
NMR metabolite Number of days alcohol consumed 
 1-6 days  7-9 days  10-12 days  13,14 days  p-value 
 N Mean  N Mean  N Mean  N Mean   
Alanine (mmol/24hr) 760 0.32 a 121 0.30  69 0.32  70 0.30 e 0.1 
Formate (mmol/24hr) 734 0.32  122 0.29  69 0.27 d 65 0.29  0.008 
Hippurate (mmol/24hr) 764 2.82  123 2.92  70 2.56  69 2.59  0.3 
NMNA (mmol/24hr) 744 0.27  123 0.29  71 0.28  68 0.27  0.5 
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Table 4.60 Mean 1H NMR metabolites‡ (mmol/24hr) of current drinkers§ by alcoholic beverage type 
consumed (beer, wine, spirits and mixed∆), men 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
 
Abbreviation: NMNA, N-methylnicotinate 
 
 
 
 
 
Table 4.61 Mean 1H NMR metabolites‡ (mmol/24hr) of current drinkers§ by alcoholic beverage type 
consumed (beer, wine, spirits and mixed∆), women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
a  p<0.05 for drinkers drunk mostly beer vs. mixed drinkers 
b  p<0.05 for drinkers drunk mostly wine vs. mixed drinkers 
c  p<0.05 for drinkers drunk mostly spirits vs. mixed drinkers 
d  p<0.05 for drinkers drunk mostly beer vs. mostly spirits 
e  p<0.05 for drinkers drunk mostly wine vs. mostly spirits 
f  p<0.05 for drinkers drunk mostly beer vs. mostly wine 
 
Abbreviation: NMNA, N-methylnicotinate 
  
NMR metabolite Alcoholic beverage type consumed 
 >70% Beer  >70% Wine  >70% Spirits  Mixed  p-value 
 N Mean  N Mean  N Mean  N Mean   
Alanine (mmol/24hr) 605 0.38  227 0.39  372 0.37  426 0.38  0.002 
Formate (mmol/24hr) 599 0.33  241 0.37 b e 337 0.33  431 0.32  0.01 
Hippurate (mmol/24hr) 604 2.71  219 2.82  332 2.58  414 2.77  0.0002 
NMNA (mmol/24hr) 611 0.25  238 0.24  289 0.22  429 0.25  0.2 
              
 
NMR metabolite Alcoholic beverage type consumed 
 >70% Beer  >70% Wine  >70% Spirits  Mixed  p-value 
 N Mean  N Mean  N Mean  N Mean   
Alanine (mmol/24hr) 284 0.30  303 0.32 e 218 0.33 c 215 0.31  0.06 
Formate (mmol/24hr) 277 0.30  291 0.31  207 0.32  215 0.31  0.3 
Hippurate (mmol/24hr) 273 2.76  311 2.81  221 2.83  221 2.78  1.0 
NMNA (mmol/24hr) 279 0.28  306 0.28 e 204 0.25 c 217 0.29  0.09 
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Table 4.62 Coefficient for 1H NMR metabolites and SBP and the effect of metabolites on alcohol-
SBP relationship, male current drinkers  
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, mean alcohol intake, alcohol drinking pattern and type of alcoholic beverage 
∆  Coefficient for metabolite-SBP relation in multiple linear regression model 
*  Coefficient for alcohol-SBP relation in multiple linear regression model 
   
Abbreviation: NMNA, N-methylnicotinate 
 
 
 
 
Table 4.63 Coefficient for 1H NMR metabolites and SBP and the effect of metabolites on alcohol-
SBP relationship, female current drinkers  
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, mean alcohol intake, alcohol drinking pattern and type of alcoholic beverage 
∆  Coefficient for metabolite-SBP relation in multiple linear regression model 
*  Coefficient for alcohol-SBP relation in multiple linear regression model 
   
Abbreviation: NMNA, N-methylnicotinate 
  
   
 
   
 
Metabolite-BP 
coefficient∆ 
p-value, 
metabolite 
 
Alcohol-BP 
coefficient* 
Change on 
alcohol-BP 
coefficient 
p-value, 
alcohol 
   
 
   
Model 1‡ 
  
 0.087 
 
<0.0001 
Model 1 + alanine (mmol/24hr) 1.81 0.4  0.089 2.1 % <0.0001 
Model 1 + formate (mmol/24hr) -3.94 0.1  0.088 1.0 % <0.0001 
Model 1 + hippurate (mmol/24hr) -0.27 0.2  0.085 -2.0 % <0.0001 
Model 1 + NMNA (mmol/24hr) 0.41 0.8  0.080 -8.3 % <0.0001 
   
 
   
 
   
 
   
 
Metabolite-BP 
coefficient∆ 
p-value, 
metabolite 
 
Alcohol-BP 
coefficient* 
Change on 
alcohol-BP 
coefficient 
p-value, 
alcohol 
   
 
   
Model 1‡ 
  
 0.097 
 
0.09 
Model 1 + alanine (mmol/24hr) 4.22 0.2  0.121 24.7 % 0.04 
Model 1 + formate (mmol/24hr) -2.43 0.4  0.139 43.1 % 0.02 
Model 1 + hippurate (mmol/24hr) -0.09 0.7  0.089 -8.1 % 0.1 
Model 1 + NMNA (mmol/24hr) 4.15 0.1  0.095 -2.3 % 0.1 
   
 
   
 
150 
 
Table 4.64 Coefficient for 1H NMR metabolites and DBP and the effect of metabolites on alcohol-
DBP relationship, male current drinkers  
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, mean alcohol intake, alcohol drinking pattern and type of alcoholic beverage 
∆  Coefficient for metabolite-DBP relation in multiple linear regression model 
*  Coefficient for alcohol-DBP relation in multiple linear regression model 
 
Abbreviation: NMNA, N-methylnicotinate 
 
 
 
 
Table 4.65 Coefficient for 1H NMR metabolites and DBP and the effect of metabolites on alcohol-
DBP relationship, female current drinkers  
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, mean alcohol intake, alcohol drinking pattern and type of alcoholic beverage 
∆  Coefficient for metabolite-DBP relation in multiple linear regression model 
*  Coefficient for alcohol-DBP relation in multiple linear regression model 
 
Abbreviation: NMNA, N-methylnicotinate 
 
  
   
 
   
 
Metabolite-BP 
coefficient∆ 
p-value, 
metabolite 
 
Alcohol-BP 
coefficient* 
Change on 
alcohol-BP 
coefficient 
p-value, 
alcohol 
   
 
   
Model 1‡ 
  
 0.039 
 
0.003 
Model 1 + alanine (mmol/24hr) -0.71 0.6  0.039 0.1 % 0.003 
Model 1 + formate (mmol/24hr) -4.91 0.006  0.044 11.2 % 0.002 
Model 1 + hippurate (mmol/24hr) -0.34 0.02  0.042 7.0 % 0.003 
Model 1 + NMNA (mmol/24hr) -0.53 0.6  0.040 1.0 % 0.007 
   
 
   
 
   
 
   
 
Metabolite-BP 
coefficient∆ 
p-value, 
metabolite 
 
Alcohol-BP 
coefficient* 
Change on 
alcohol-BP 
coefficient 
p-value, 
alcohol 
   
 
   
Model 1‡ 
  
 0.109 
 
0.006 
Model 1 + alanine (mmol/24hr) 0.39 0.9  0.119 8.9 % 0.004 
Model 1 + formate (mmol/24hr) -2.82 0.2  0.136 24.4 % 0.001 
Model 1 + hippurate (mmol/24hr) 0.01 1.0  0.103 -6.1 % 0.009 
Model 1 + NMNA (mmol/24hr) 3.04 0.07  0.106 -2.9 % 0.009 
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Table 4.66 1H NMR resonance assignment table for discriminatory metabolites from OPLS-DA 
analyses 
 
 
 
s: singlet, d: doublet, t: triplet, q: quartet, m: multiplet 
  
No. 
1H chemical shift  
ppm (multiplicity) 
Metabolite Note 
1 0.88(d) Unknown 1   
2 1.08(s) Unknown 2   
3 1.14(s) 2-methyl etythritol Aromatic herbs consumption 
4 1.18(t), 3.66(t) Ethanol Alcohol consumption 
5 1.20(t) Ethyl glucoside Rice wine/sake consumption 
6 1.33(d), 4.11(q) Lactate Anaerobic respiration & glycolysis 
7 1.36(s) 2-hydroxyisohurtyrate   
8 1.48(d) Alanine Amino acid 
9 1.91(s) Acetate Acetaldehyde metabolite 
10 2.01(s), 2.04(s), 2.06(s) N-acetylglycoprotein Markers of inflammation 
11 2.16(s), 2.17(s), 2.18(s), 
7.17(d), 7.36(d) 
Acetaminophen, acetaminophen 
glucuronide 
Acetaminophen metabolites 
12 2.35(s), 7.20(d), 7.27(d) 4 cresyl sulfate Gut microbial co-metabolite 
13 2.45(m) Glutamate Amino acid 
14 2.54(d), 2.68(d) Citrate Tricarboxylic acid cycle (energy metabolism) 
15 2.72(s) Dimethylamine Gut microbial co-metabolite 
16 2.76(s), 2.83(s) S-methyl-L-cysteine sulphoxide  Cruciferous vegetables consumption 
17 2.78(s) Unknown 3   
18 2.93(s) Dimethylglycine Methylation product of methylglycine 
19 3.04(s), 4.06(s) Creatinine Muscle turn-over 
20 3.11(s), 3.30(s) proline betaine Citrus consumption 
21 3.12(s) N,N,N-trimethyllysine. Methylation product of lysine 
22 3.19 (s) Unknown 4   
23 3.21(s) Unknown 5   
24 3.35(s) Scyllo-inositol Fish consumption, microbial co-metabolite 
25 3.43(t) Taurine Amino acid 
26 3.80(s) Guanidinoacetate Creatine precursor 
27 3.98(d), 7.55(t), 7.64(t), 
7.82(t) 
Hippurate Gut microbial co-metabolite 
28 4.44(s), 8.84(t), 9.12(s) N-methylnicotinate Vitamin B3 metabolism 
29 7.67(s) Unknown 6   
30 8.45(s) Formate Gut microbial & 1 Carbon metabolism 
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Table 4.67 Discriminatory metabolites between drinkers and non-drinkers, OPLS-DA, by country 
and gender  
 
 
Japan PRC UK US 
  Men Women Men Women Men Women Men Women 
Number of  
drinker 
524 352 295 71 218 165 714 494 
Number of  
non-drinker 
46 216 120 344 47 66 366 583 
R
2
Y 0.24 0.31 0.45 0.28 0.54 0.65 0.14 0.23 
Q
2
Y -0.06 -0.02 0.01 -0.21 -0.2 -0.2 0.01 0.08 
p-value  0.01 0.006 0.0005 0.2 0.08 0.07 0.04 <0.0001 
OPLS-DA loading 
coefficient plot 
C1 C2 C3 C4 C5 C6 C7 C8 
       
  
No. Metabolite 
      
  
  5. Ethyl  
      glucoside 
Drinker Drinker Drinker 
 
Drinker 
 
Drinker Drinker 
  7. 2-hydroxy 
      isohurtyrate   
Drinker 
   
  
  9. Acetate 
  
Drinker 
   
  
10. NAG Drinker Drinker Drinker 
   
 Drinker 
11. Acetaminophen  
    
Non-drinker 
 
  
12. 4 cresyl sulfate Non-drinker 
     
  
14. Citrate Non-drinker 
   
Non-drinker 
 
  
15. Dimethyl- 
     amine 
Non-drinker 
     
  
19. Creatinine Non-drinker 
   
Non-drinker 
 
 Non-drinker 
22. Unknown 4 
 
Drinker Drinker 
   
  
27. Hippurate Non-drinker Non-drinker 
 
Drinker Non-drinker 
 
 Non-drinker 
28. NMNA 
    
Non-drinker 
 
 Non-drinker 
 
Drinker: metabolite level higher in drinker than non-drinker 
Non-drinker: metabolite level higher in non-drinker than drinker 
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Table 4.68 Discriminatory metabolites between drinkers and non-drinkers, OPLS-DA, by gender 
and alcohol drinking status  
 
  Men Women Men Women Men Women Men Women 
Number of  
 
Ex-drinker  
(244) 
Ex-drinker 
(266) 
Moderate 
(1157) 
Moderate 
(886) 
Heavy 
(594) 
Heavy 
(196) 
Moderate 
(1157) 
Moderate 
(886) 
Number of  
  
Teetotaller 
(165) 
Teetotaller 
(585) 
Teetotaller 
(165) 
Teetotaller 
(585) 
Teetotaller 
(165) 
Teetotaller 
(585) 
Heavy 
(594) 
Heavy 
(196) 
R
2
Y 0.37 0.35 0.17 0.33 0.43 0.48 0.32 0.35 
Q
2
Y 0.12 0.22 0.03 0.26 0.28 0.38 0.25 0.23 
p-value  <0.0001 <0.0001 0.0002 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
OPLS-DA loading 
coefficient plot 
C9 C10 C11 C12 C13 C14 C15 C16 
         
No. Metabolite 
        
  1. Unknown 1 
   
Moderate Heavy Heavy 
  
  2. Unknown 2 
    
Heavy 
   
  3. 2-methyl          
      etythritol   
Teetotaller 
     
  4. Ethanol 
      
Heavy Heavy 
  5. Ethyl glucoside 
  
Moderate 
 
Heavy Heavy Heavy Heavy 
  8. Alanine 
 
Teetotaller Teetotaller Teetotaller 
 
Teetotaller 
  
  9. Acetate 
    
Heavy 
 
Heavy 
 
10. NAG Teetotaller 
 
Teetotaller Teetotaller Heavy 
 
Heavy Heavy 
12. 4 cresyl sulfate 
 
Ex-drinker 
      
13. Glutamate Teetotaller Teetotaller Teetotaller 
     
16. S-methyl-L-   
      cysteine  
      sulphoxide  
 
Teetotaller Teetotaller Teetotaller Heavy 
   
17. Unknown 3 
 
Teetotaller Teetotaller Teetotaller 
    
18. DMG Teetotaller 
 
Teetotaller 
     
19. Creatinine 
   
Teetotaller 
    
20. Proline betaine 
   
Teetotaller 
    
21. N,N,N- 
      trimethyllysine 
Teetotaller Teetotaller Teetotaller 
     
27. Hippurate Ex-drinker Ex-drinker 
      
28. NMNA Ex-drinker 
 
Moderate 
  
Heavy 
  
29. Unknown 6 Teetotaller Teetotaller Teetotaller Teetotaller 
    
30.  Formate 
 
Teetotaller 
      
          
Teetotaller: metabolite level higher in teetotaller than the other drinker group 
Ex-drinker: metabolite level higher in ex-drinker than the other drinker group 
Moderate: metabolite level higher in moderate drinker than the other drinker group 
Heavy: metabolite level higher in heavy drinker than the other drinker group 
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Table 4.69 Discriminatory metabolites between drinkers and non-drinkers, OPLS-DA, by gender 
and type of alcohol consumed 
 
    Men Women Men Women Men Women 
  Number of  Beer (646) Beer (293) Beer (646) Beer (293) Wine (250) Wine (320) 
  Number of  Wine (250) Wine (320) Spirits (407) Spirits (239) Spirits (407) Spirits (239) 
  R
2
Y 0.24 0.38 0.36 0.34 0.35 0.34 
  Q
2
Y 0.12 0.22 0.26 0.15 0.44 0.06 
  p-value  0.01 <0.0001 <0.0001 0.0006 0.002 <0.0001 
 OPLS-DA loading coefficient 
plot  
C19 C20 C21 C22 C23 C24 
  
      
No. Metabolite       
 
    
4. Ethanol Beer           
5. Ethyl glucoside Wine       Wine   
6. Lactate     Spirits   Spirits   
7. 2-hydroxyisobutyrate           Spirits 
8. Alanine           Spirits 
10. NAG         Spirits Spirits 
13. Glutamate     Spirits       
14. Citrate       Spirits     
15. Dimethylamine           Spirits 
16. S-methyl-L-cysteine 
sulphoxide  
    Spirits     Spirits 
17. Unknown 3     Spirits     Spirits 
18. Dimethylglycine           Spirits 
21. N,N,N-trimethyllysine.           Spirits 
23. Unknown 5         Wine   
24. Scyllo-inositol       Spirits     
25. Taurine   Beer         
26. Guanidinoacetate   Beer   Beer     
27. Hippurate   Wine         
28. NMNA           Spirits 
29. Unknown 6     Spirits     Spirits 
 
Beer: metabolite level higher in beer drinker than the other drinker group 
Wine: metabolite level higher in wine drinker than the other drinker group 
Spirits: metabolite level higher in spirits drinker than the other drinker group 
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Figure 4.1 Histogram for mean daily alcohol intake from two 7-day records (g/day), male 
current drinkers§ 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
  
156 
 
Figure 4.2 Histogram for mean daily alcohol intake from two 7-day records (g/day), female 
current drinkers§ 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
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Figure 4.3 Histogram for number of drinking days from two 7-day records, male current 
drinkers§ 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, men: mean daily alcohol intake from two 7-day records >26 g/day 
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Figure 4.4  Histogram for number of drinkinfg days from two 7-day records, female current 
drinkers§ 
 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
Ψ  Heavy drinkers, women: mean daily alcohol intake from two 7-day records >13 g/day 
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Figure 4.5   Mean systolic blood pressure‡ by alcohol drinking status, men and women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day; women, mean daily alcohol intake from two 7-
day records >13 g/day  
∆  F-test in analysis of variance  
 
Figure 4.6   Mean diastolic blood pressure‡ by alcohol drinking status, men and women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium  
§  Including occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
Ψ  Heavy drinkers: men, mean daily alcohol intake from two 7-day records >26 g/day; women, mean daily alcohol intake from two 7-
day records >13 g/day  
∆  F-test in analysis of variance  
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Figure 4.7  Mean systolic blood pressure‡ of current alcohol drinkers§ by alcohol drinking 
pattern from two 7-day records, men and women 
 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
 
Figure 4.8  Mean diastolic blood pressure‡ of current alcohol drinkers§ by alcohol drinking 
pattern from two 7-day records, men and women 
 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium 
§  Excluding self-reported occasional drinkers with no alcoholic beverage intake from two 7-day records during data collection 
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Figure 4.9  Mean systolic blood pressure‡ of current alcohol drinkers§ by type of alcoholic 
beverage consumed from two 7-day records, men and women 
 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, and mean daily alcohol intake (from two 7-day records) 
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
 
Figure 4.10 Mean diastolic blood pressure‡ of current alcohol drinkers§ by type of alcoholic 
beverage consumed from two 7-day records, men and women 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, and mean daily alcohol intake (from two 7-day records) 
§  Excluding occasional drinkers with no alcoholic beverages intake (and reported occasional alcohol intake) from two 7-day record 
during data collection 
∆ Combination of alcoholic beverages: beer, wine and spirits 
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Figure 4.11 Tree structured regression‡ of systolic blood pressure on alcohol drinking status, 
men and women 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, alcohol drinking patterns and type of alcoholic beverages consumed  
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Figure 4.12 Tree structured regression‡ of diastolic blood pressure on alcohol drinking status, 
men and women 
 
‡ Adjusted for age, country, years of education, marital status, employment, cigarette smoking, supplement intake, special diet, CVD-
DM diagnosis, family history of hypertension, hours of moderate to heavy physical activity per day, BMI, urinary sodium and 
potassium, alcohol drinking patterns and type of alcoholic beverages consumed  
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Figure 4.13 Median urinary 1H NMR spectrum of INTERMAP of first and repeat urine collections 
of current alcohol drinkers, men  
 
 
Figure 4.14  Median urinary 1H NMR spectrum of INTERMAP of first and repeat urine collections 
of current alcohol drinkers, women  
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Figure 4.15  Median urinary 1H NMR spectrum of INTERMAP of first and repeat urine collections 
of non-current alcohol drinkers, men 
 
 
 
Figure 4.16 Median urinary 1H NMR spectrum of INTERMAP of first and repeat urine collections 
of non-current alcohol drinkers, women 
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Figure 4.17 PLS-DA score plot of non-drinkers, moderate drinkers and heavy drinkers using first 
urine specimens, men 
  
Figure 4.18 PLS-DA score plot of non-drinkers, moderate drinkers and heavy drinkers using first 
urine specimens, women 
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Figure 4.19  Median urinary 1H NMR spectrum of INTERMAP male drinkers by drinking status  
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Figure 4.20  Median urinary 1H NMR spectrum of INTERMAP female drinkers by drinking status  
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Figure 4.21  Cross-validated corresponding OPLS-DA loadings coefficient plot derived from 
urinary NMR spectra of male non-drinkers and male current drinkers, based on the 
first urine collection. 
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Figure 4.22  Cross-validated corresponding OPLS-DA loadings coefficient plot derived from 
urinary NMR spectra of female non-drinkers and female current drinkers, based on 
the first urine collection. 
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5 DISCUSSION 
5.1 Summary of main INTERMAP findings 
In the INTERMAP Study about 82.4% of men and 63.7% of women consumed alcohol.  The 
average alcohol intake of current drinkers from their two 7-day records was 21.2 g for men and 5.6 
g for women.  Alcohol drinking rate for men in Japan (97.2%) was higher than those in PRC 
(72.6%), UK (91.7%) and US (76.1%).  Drinking rates for women in Japan (84.2%) and UK (85.1%) 
were similar; only 18.9% of Chinese women were alcohol drinkers.  More than half of the drinkers 
had moderate consumption (≤26 g alcohol per day for men and <13 g alcohol per day for women).  
Japan had the highest rate of male heavy drinkers (>26 g alcohol per day).  Women were less 
likely to be heavy drinkers (>13 g alcohol per day); most female heavy drinkers were in the UK.  
There was a significant cross-country difference in alcohol consumption. 
Amount of alcohol intake, drinking pattern and alcoholic beverage preference were associated with 
a variety of dietary indicators (e.g. dietary supplement use, on any special diet), and with cigarette 
smoking, exercise, BMI and SES (education level and employment).  This report showed that BP 
differences per unit of alcohol consumed (1 standard drink, 13 g of alcohol) were 1.1 mm Hg  for 
SBP and 0.5 mm Hg for DBP among male current drinkers and 1.3 mm Hg for SBP and 1.4 mm 
Hg for DBP among female drinkers with multiple adjustment.  The adjusted mean SBP and DBP of 
heavy drinkers was significantly higher than for teetotallers, ex-drinkers and moderate drinkers, for 
both men and women.  There were no substantive BP differences between teetotallers, ex-drinkers 
and moderate drinkers.   
Heavy drinkers consumed a significantly greater proportion of their total energy intake from 
alcoholic beverage (13.4% of their total energy intake, kcal/day, for men and 9.6% for women) 
compared to teetotallers, ex-drinkers and moderate drinkers.  Heavy drinkers had a higher animal 
protein intake and higher excretion of urinary 3-methylhistidine and taurine compared to non-
drinkers and moderate drinkers; indicated that heavy drinkers had less healthy diets compared to 
other strata. 
Moderate drinkers and teetotallers had similar food-derived energy intakes for men and women.  
Nutrient composition and foods consumption between teetotallers and moderate drinkers were 
similar for men and for women: moderate drinkers had considerably lower intakes of vegetable 
protein, fibre and vitamin C and higher intakes of animal protein and total fat than teetotallers. 
From the multivariate analysis of 1H NMR spectral data, teetotallers had higher excretion of S-
methyl-L-cysteine sulphoxide and proline betaine than moderate drinkers; reflecting the differences 
in vegetable and fruits consumption between these two groups of participants.   Despite their 
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apparently less healthy diets, moderate drinkers had similar BP levels compared to teetotallers.  
There is therefore some evidence for the benefit of „moderate‟ alcohol intake on BP that is not due 
to confounding by dietary habits. 
Male teetotallers had significantly higher intakes of vegetable protein and lower intakes of animal 
protein, SFA, PUFA, Omega 6 fatty acids and linoleic fatty acid compared to male ex-drinkers.  
Among female non-drinkers, teetotallers had significantly higher intakes of vegetable protein and 
linolenic fatty acid compared to ex-drinkers.  Foods consumption was very similar between 
teetotallers and ex-drinkers; teetotallers had higher consumption of grains and non-alcoholic 
beverages than ex-drinkers.  Teetotallers appeared to have healthier diets compared to ex-drinkers 
but their BP levels were similar BP with adjustment for confounders. 
Most drinkers in the INTERMAP Study consumed alcohol on 1-6 days of 14 days; male heavy 
drinkers were most likely to drink alcohol on 13-14 days of 14 days.  Alcohol intake (g per day) was 
higher in drinkers (both men and women) who drank on 13-14 days than those who drank on 1-6 
days, 7-9 days or 10-12 days.  There were significant adjusted mean BP differences between 
drinkers who drank on 1-6 days and those on 13-14 days for men and women.  However, BP 
differences by drinking pattern became non-significant with adjustment for mean amount of daily 
alcohol intake and other confounders. 
Drinkers who consumed alcohol on 13-14 days of the 14 obtained a high proportion of their total 
energy from alcoholic beverages (14.3% for men and 10.6% for women) and had a significantly 
lower food-derived energy intake than those who drank on 1-6 days.  This group of drinkers had 
higher intakes of total and animal protein, niacin and vitamin B12 and lower intakes of starch, fatty 
acids, minerals and other vitamins (indicators of more healthy diets, e.g. Ca, Mg, vitamin E) and 
dietary amino acids compared to drinkers who drank on only 1-6 days.  Drinkers who drank most 
days had lower intakes of vegetables, fruits, grains and dairy and higher consumptions of meat and 
seafood compared to those drank only 1-6 days.  The BP difference between these two groups of 
drinkers may be due to the dietary differences, as well as the amount of alcohol being consumed. 
Beer consumption was predominant in men (37.3% of male drinkers); and wine was the most 
frequent beverage type consumed by female drinkers (29.5%).  Only male drinkers who consumed 
mostly spirits had a sizably higher adjusted mean SBP than male wine and mixed drinkers, but no 
consistent associations between type of alcoholic beverage (beer, wine, spirits or mixed) and BP 
were found in men and women with adjustment also for mean daily alcohol intake. 
Intakes of food-derived energy and alcohol-derived energy were similar for male beer and wine 
drinkers; male spirits drinkers had a higher proportion of total energy derived from alcohol at 7.5%.  
Among female drinkers, there were no substantial energy intake differences by type of alcoholic 
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beverage consumed.  For men, wine drinkers had significantly higher intakes of vegetable protein, 
starch and carbohydrate and lower intakes of total fat, MUFA and oleic acid compared to beer or 
spirits drinkers.  Intakes of cholesterol, omega 3 PFA, vitamin C and vitamin E (indicators of 
healthier diets) were similar among these different groups of drinkers.  Among female drinkers, 
wine drinkers had significantly higher intakes of starch, carbohydrate and vitamin C, and lower 
intakes of total fat, MUFA and oleic acid; beer drinkers had higher intakes of omega 3 PFA, omega 
6 PFA, linoleic acid and linolenic acid.  Both male and female beer drinkers consumed notably less 
total grains than wine or spirits drinkers; there were no other significant differences in foods 
consumption among drinkers of different type of alcoholic beverages.  
There was a small modification of the alcohol-BP relationship by nutrient/foods models.  The diet-
related coefficient reductions in linear regression were statistically significant with Fe, non-haem 
Fe, P and Mg singly included in the models; combination of minerals and omega 3/omega 6 fatty 
acid also showed a modest reduction in alcohol-BP coefficients. 
The analyse of data from the INTERMAP Study show that lifestyle differences (including exercise, 
education, smoking and dietary factors) may at least partially explain previously reported better 
cardiovascular health in moderate drinkers and the protective effect of wine drinking. 
5.2 Interpretation of the findings 
The analyses of this thesis demonstrate a positive association between an individual‟s total amount 
of alcohol intake and his/her BP, which persists after adjustment for multiple possible confounders 
including age, BMI, smoking, education, exercise, family history of HTN, Na and K intake.  
Adjusted mean BP differences per unit of alcohol consumed (1 standard drink, 13 g of alcohol) 
were 1.1 mm Hg for SBP and 0.5 mm Hg for DBP among male current drinkers and 1.3 mm Hg for 
SBP and 1.4 mm Hg of DBP among female drinkers.  This finding replicates previous observations 
of a direct alcohol-BP relation from cross-sectional studies, prospective and experimental studies 
(Xin et al. 2001; Klatsky 1996b; Gillman et al. 1995; Keil et al. 1989).   
Adverse BP is one of the established major risk factors contributing to the epidemic occurrence of 
CVD; this relation of BP to CVD is strong and independent of other major risk factors. The 
prevalence of pre-hypertension and HTN is high worldwide and most of the population is at 
elevated risk of CVD morbidity, disability and death.  In the past few decades, public health efforts 
have focused mainly on detection, evaluation and treatment of people with high BP.  While 
antihypertensive drugs are prescribed to hypertensive individuals in order to reduce their CVD risk, 
this approach has only limited ability to deal with the populationwide BP problem and offers no 
opportunity to reduce CVD risk for the tens of millions at higher risk due to pre-hypertensive BP 
levels (Chobanian et al. 2003).  Public health measures are needed to address this problem 
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among the large number of people in the pre-hypertensive range of BP – the population approach 
to BP control (Rose 1981).   It is an important public health goal to downshift the population 
SBP/DBP to favourable levels at all ages, to prevent the rise in BP with age and solve the problem 
of epidemic adverse BP levels.   
He and MacGregor (2003) calculated the potential reductions in the number of stroke and CHD in 
England with control of all hypertension to a SBP of 140 mm Hg, using data on HTN prevalence 
from the 1998 Health Survey for England; they reported a progressive decrease in stroke risk of 28 
to 44% and CHD risk of 20 to 35%, depending on age.  This report indicated that reducing alcohol 
intake by 1 unit may reduce SBP by 1-2 mm Hg in middle-aged men and women.  If this small 
reduction of 1-2 mm Hg could be achieved populationwide, it could be of major benefit for the 
prevention of stroke and CHD.  The INTERMAP Study was designed primarily as a study of 
individual-level diet-BP associations, and the samples were not intended to be nationally 
representative, but it is reasonable to infer that findings may be applicable to middle-aged men and 
women from Japan, PRC, UK and USA. 
Heavy drinkers 
In INTERMAP, heavy drinkers had consistently and significantly higher SBP and DBP than 
moderate drinkers and non-drinkers in analyses adjusted for confounders, nutrient intakes, daily 
drinking pattern and type of alcoholic beverage.  Daily intake of more than 2 standard drinks (>26 g 
alcohol) for men or more than 1 standard drink (>13 g alcohol) for women was related to higher 
mean BP levels compared to moderate drinkers or non-drinkers.  The results are consistent with 
Burger et al (2004) who concluded from studies of moderate alcohol consumption (<40 g/day) that 
there were linear BP elevations at drinking levels of >30 g/day for men and >20 g/day for women; 
also with the findings of the INTERSALT study where heavy drinking was defined as 3 drinks/day 
(36 g alcohol/day) in both men and women (Marmot et al. 1994). 
Moderate drinkers, teetotallers and ex-drinkers 
In INTERMAP, moderate drinkers had BP levels similar to those of teetotallers and ex-drinkers.  A 
study in New Zealand of 1,429 men and women ages 50 and older reported a U-shaped 
relationship between alcohol consumption and BP, with light drinkers (0-9 g alcohol/day) and 
moderate drinkers (10-34 g alcohol/day) having lower SBP and DBP than non- and heavy drinkers 
(Jackson et al. 1985).  Okubo and colleagues (2001b) reported a J-shaped association of daily 
alcohol consumption and BP in 2,143 Japanese normotensive men; light drinkers (18.0 ml of 
alcohol per day) had the lowest BP levels compared to non-drinkers, moderate drinkers (18.1-45.0 
ml of alcohol per day) and heavy drinkers (more than 45.0 ml of alcohol per day).  No such relation 
was found in the INTERMAP study; data analysis did not suggest there was any BP difference 
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between non-drinkers and moderate drinkers which may due to the misclassification of heavy 
drinkers.  If heavy drinkers under-reported their alcohol consumptions, they could be classified as 
moderate drinkers in the study.  As heavy drinkers tended to have high BP, BP levels of moderate 
drinkers may be overestimated due to underreporting of alcohol intake by heavy drinkers, who are 
misclassified as moderate drinkers.  In a cross-sectional analysis of 105,378 persons, Klatsky and 
colleagues (2006) investigated the relationship between moderate drinking and assessed blood 
liver transaminase enzyme levels in the positive and negative subgroups at different alcohol intake 
strata.  For participants reporting 1 to 2 drinks per day, the OR of HTN was 1.32 for positive 
persons and 1.16 for negative persons; the positive/negative comparisons showed approximately a 
75% increased prevalence of high liver transaminase enzymes.  For those reporting less than one 
drink per day, the positive/negative difference was 30%.  This study suggested that increased 
prevalence of HTN among persons reporting one to two drinks per day might be partially due to 
underreporting of alcohol intake.  
Ex-drinkers were of lower SES (measured by education levels and employment status) and poorer 
general health (higher BMI, higher prevalence of CVD and DM, more likely to be on 
antihypertensive treatment), and were more likely to be taking regular exercise, taking dietary 
supplements and on a special diet than current drinkers.  The nutrient/food intakes of INTERMAP 
ex-drinkers and teetotallers were similar.  The concern of individuals modifying their diets and 
changing their alcohol drinking habit because of health concerns, so called „sick quitters‟, was 
addressed by controlling for participants on a special diet in all analyses, and by classifying ex-
drinkers and teetotallers separately when investigating the relationship between alcohol intake and 
BP.  In a recent study, almost one third of participants in the Boston, Massachusetts, area said that 
perceived health benefits of alcohol drinking (e.g. red wine for CHD risk reduction) were a factor in 
their choice of drinking (Mukamal et al. 2008).  Thus, new studies may need to control for a „sick 
new drinker‟ effect, created by persons who started or increased alcohol intake because of existing 
illness or symptoms.  An opposite bias might be introduced by low-risk persons who began 
drinking as part of an overall favourable lifestyle.  This study took extensive confounding into 
account (unlike other studies) – associations with BP persisted, especially for heavy drinkers, but 
were of smaller magnitude than reported in some other studies, suggesting that reported BP-
alcohol associations may have been subject to uncontrolled confounding. 
Alcohol drinking patterns and BP 
For the relation of pattern of daily drinking (number of days that alcohol was consumed) to BP, with 
adjustment for confounders including type of alcoholic beverage and amount of alcohol, no 
consistent relation of pattern to BP of current drinkers was observed in the INTERMAP Study.  
Drinkers who consumed alcohol on 13-14 days of the 14 had significantly higher SBP and DBP 
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compared to those who drank on 1-6 days in this study.  However, BP differences by drinking 
pattern became non-significant with adjustment for mean amount of daily alcohol intake and other 
confounders.  Rather, the results of this study suggest that amount of alcohol consumed daily is 
the important determinant of BP levels, not daily drinking pattern or type of alcoholic beverage 
consumed.   
Pattern of alcohol intake has been reported to influence BP (Trevisan et al. 1987; Rakic et al. 
1998).  The INTERSALT Study found that among heavy drinkers a highly variable pattern of 
alcohol consumption was associated with higher average BP level with control for amount of 
alcohol consumed (Marmot et al. 1994). Also, differences in BP between drinkers and non-drinkers 
were greater among “episodic drinkers” (people with the highest daily variation in alcohol 
consumption) than among people who drank a regular amount of alcohol each day.  Similar 
adverse effects of binge drinking on BP level (independent of amount of alcohol consumed) have 
also been observed elsewhere (Stranges et al. 2004).  The findings of the INTERMAP Study in this 
respect were not consistent with those of the INTERSALT Study.  
Knupfer (1987) observed that a pattern of daily light drinking is not common; rather most light 
drinkers do not drink daily and most daily drinkers are not light drinkers (consumers of ≤2 standard 
drinks per day).  INTERMAP findings are similar; most drinkers consumed alcohol on only 1-6 days 
of 14 days and were moderate drinkers; those who drank on 13-14 days were more likely to be 
heavy drinkers, and ingested a high proportion of their total energy intake from alcoholic 
beverages; hence they had less healthy diets than moderate drinkers and non-drinkers.  Previously 
reported health benefits associated with low average number of drinks per day are likely to be 
related to light, weekly drinking and infrequent drinking, rather than to light, daily drinking. 
Type of alcoholic beverage and BP 
In INTERMAP, with control for total amount of alcohol consumed, there were no consistent 
associations between type of alcoholic beverage (beer, wine, spirits or mixed) and BP for men or 
women.  Adjusted BP was highest in male spirits drinkers but the finding was not significant after 
adjustment for amount of alcohol consumed.  There is evidence from cross-sectional studies 
suggesting that type of alcohol beverage consumed may influence BP, i.e. beer or spirit 
consumption may be more strongly associated with BP than wine consumption (Brenn 1986; 
Marques-Vidal et al. 2001b; Klatsky et al. 1986).  However, the results from this report do not 
support these findings; as may be expected from the correlation between type of alcoholic 
beverage and total consumption, most effects associated with beer/spirits drinking become smaller 
or insignificant with control for total alcohol intake.  
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The antioxidant, vasodilator and anti-platelet effects of polyphenolic flavonioids in red wine may 
account for the lower BPs of wine drinkers observed in some studies (Frankel et al. 1993).  In the 
US Kaiser Permanente study, those who preferred wine had the lowest DBP, while those who 
preferred spirits had the highest SBP and DBP (Klatsky et al. 1986).   The PRIME study reported a 
weaker association for wine with BP compared to beer (Marques-Vidal et al. 2001b).  However, 
these studies did not adjust for the dietary differences among wine, beer and spirits users, or for 
differences in drinking patterns.  Reported associations of type of alcoholic drink on BP could be 
due to insufficient adjustment for SES and/or such lifestyle factors as diet, drinking patterns, 
smoking, physical activity.  These were all controlled for in this study. 
Thus, SES and a number of lifestyle factors may relate to beverage preference and uncontrolled 
differences in these factors may be playing a role in the apparent beneficial effects of wine intake 
(Mortensen et al. 2001).  It has been noted that people with different beverage preferences differ 
observed in some studies on health habits, drinking patterns, smoking and personality 
characteristics (Klatsky et al. 1990b).  Some studies have found that wine drinkers had healthier 
diets than those who preferred beer or spirits, and differences in diet associated with preferred 
beverage type may explain the apparent beneficial effect of wine on health (Tjonneland et al. 1999; 
Barefoot et al. 2002; Ruidavets et al. 2004; Gronbaek et al. 1999; McCann et al. 2003).  Stranges 
and colleagues (2006; 2004) found no consistent beverage-specific associations with hypertension 
risk in Americans drinking beer, wine or spirits.  A 4-week cross-over trial in Australia comparing 
the effects of wine, de-alcoholised red wine, beer and water on BP found that increases in BP with 
red wine or beer were similar in magnitude; there was no evidence for a vasodilator effect of red 
wine flavonioids (Zilkens et al. 2005).  A cross-sectional study in Chinese men on associations 
between alcohol intake and hypertension found that spirits drinking was associated with a higher 
odds ratio of isolated systolic hypertension compared to other beverage preferences (Wildman et 
al. 2005).  This finding may have been due to higher total alcohol consumption among spirits 
drinkers although it is not possible to confirm this from the data presented.  In the INTERMAP 
Study, spirits drinkers reported higher alcohol consumption than wine drinkers and beer drinkers 
and had higher BP compared to wine and beer drinkers, non-significant with adjustment for total 
alcohol intake. 
Nutrient and food intakes 
This report investigated the effect of specific nutrient and food groups on relation of alcohol to BP.  
Heavy drinkers consumed more than 10% of their total energy from alcoholic beverage and had 
less healthy diets compared to moderate drinkers, ex-drinkers and teetotallers.  The analyses also 
demonstrated a small modification of the alcohol-BP relationship by intake of nutrients/foods; the 
alcohol-BP association was reduced with adjustment for non-haem iron, phosphorus and 
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magnesium, and vegetables consumption.  Findings from this study indicate that dietary factors 
may at least partially explain previously reported better cardiovascular health of moderate drinkers 
and the protective effect of wine drinking. 
Urinary amino acid and metabolite profile differences 
Metabonomics, a systems biology approach, was used to investigate changes in small-molecule 
intermediate products in urine.  Metabolomics have contributed to studies on alcohol-related lipid 
dysfunction (Crabb and Liangpunsakul 2006; Mutch et al. 2006). It may be able to help define the 
role of metabolic pathways affected by alcohol consumption and provide insight into functionally 
relevant mechanisms contributing to ischemia (Sabatine et al. 2005).  Few significant differences in 
excretion of urinary amino acids were observed between alcohol drinking status groups in the 
INTERMAP Study.  The differences that were observed tended to reflect dietary differences.  
Heavy drinkers had significantly higher excretion of urinary 3-methylhistidine, reflecting higher 
animal protein intake (Long et al. 1975; Elia et al. 1980); and taurine (a biomarker of fish intake) 
(Birdsall 1998; Lourenco and Camilo 2002) compared to non-drinkers and moderate drinkers.  
Dietary data indicated that teetotallers had a more healthy diet than other strata (including higher 
vegetable consumption, lower cholesterol intake); this finding was supported by multivariate 
analysis of 1H NMR spectral data.  Teetotallers had higher excretion of S-methyl-L-cysteine 
sulphoxide (a biomarker of cruciferous vegetable consumption) (Marks et al. 1992; Ichikawa et al. 
2006; Tsuge et al. 2002) and proline betaine (a biomarker of citrus consumption) (Atkinson et al. 
2007; Lever et al. 1994) than moderate drinkers or heavy drinkers. 
Variation in metabolic profiles among different drinker groups was examined via multivariate 
analysis of 1H NMR spectral data. Three alcohol biomarkers (ethanol, ethyl glucoside and acetate) 
and 27 other metabolites were identified from discriminatory (between-group) analyses.  These 
other metabolites were derived mainly from dietary (S-methl-L-cystine sylphoxide, proline betaine, 
scyllo-inositol and N-methylnicotinate), gut microbiomic (4 cresyl sulfate, dimethylamine, hippurate 
and formate) and xenometabolomic (acetaminophen) influences (Heinzmann et al. 2010; Yap et al. 
2010; Loo et al. 2009; Holmes et al. 2008). 
The primary aim of the metabonomic analyses was to identify novel pathways for hypertensive 
effects of excess alcohol consumption. However, none of the discriminating metabolites detected 
here appear to reflect alcohol-BP intermediaries. This null finding could be the result of dominance 
of multivariate models by high concentrations of alcohol metabolites, and/or insufficient power to 
detect small differences in signal intensity in sub-group analyses. A secondary aim of these 
analyses was to evaluate the feasibility of dietary assessment validation via 1H NMR spectroscopy. 
The detection of alcohol metabolites in the urinary spectra of moderate and heavy drinkers 
indicates that NMR spectroscopy could be used to validate subjective dietary assessment tools. 
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Furthermore, these findings demonstrated the utility of global 1H NMR spectroscopy and 
multivariate analyses for efficient simultaneous assessment of multiple 
dietary/xenometabolomic/gut microbiomic metabolites (Bictash et al. 2010). 
5.3 Possible biological mechanisms of effects of alcohol consumption on blood 
pressure 
Alcohol is widely distributed over body fluids and has important actions upon the physicochemical 
properties and biological functions of cell membranes.  Moderate alcohol intake has a putative 
beneficial effect on hypertension (Corrao et al. 2004).  Different dose-dependent effects and 
divergence between acute and chronic actions make the interaction of alcohol intake and BP a 
complex one and it is unlikely that a single mechanism accounts for the association between 
alcohol intake and BP.  An extensive literature exists on possible mechanisms of the putative 
protective effect of alcohol on CHD (Chapter 2.4), however little work has been done on possible 
mechanisms of the possible effects of alcohol on BP.   
Findings from animal (predominantly rat) models have been controversial because of 
inconsistencies in BP outcomes between studies (Chapter 2.2.1).  Many experimental studies 
reported positive associations of chronic alcohol consumption with BP (Puddey et al. 1995; 
Strickland and Wooles 1989; Vasdev et al. 1993).  However, several studies have shown that 
chronic alcohol intake lowered or did not change BP levels in animals (Howe et al. 1989; Beilin et 
al. 1992; Hatton et al. 1992; Khetarpal and Volicer 1979).  There are also inconsistent results in 
vascular reactivity in the rat after chronic ethanol ingestion; Stewart and Kennedy (Stewart and 
Kennedy 1999) reported an increase in vascular reactivity; Strickland and Wooles (Strickland and 
Wooles 1988) and Rhee and colleagues (Rhee et al. 1995) reported a decrease; while Pire and 
colleagues (Pires et al. 1993) reported no change in vascular reactivity after alcohol administration.  
Studies by Chan and colleagues (1982; 1983) identified a pressor response to alcohol 
administration in WKY rats and described an increase in calcium pump activity with decreased 
membrane cholesterol in association with an increase in BP.  Puddey and colleagues (1995) 
reported changes in red cell membrane lipid composition after administration of alcohol.  These 
findings suggest altered membrane function as a potential mechanism for alcohol-induced 
hypertension.   
Several studies have suggested the importance of Mg deficiency in alcohol-induced hypertension 
(Altura and Altura 1985; Altura et al. 1984).  Hsieh and colleagues (1992) reported that Mg 
supplementation prevented the development of hypertension in Wister rats with alcohol; 
suggesting that Mg counteracted an alcohol-related increase in intracellular Ca and suppressed Na 
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pump activity.  Hsieh and colleagues (1995) conducted a study to investigate the effect of alcohol 
reduction on BP of 29 men with untreated mild hypertension (DBP between 90 and 104 mm Hg).  
Data showed that intra-platelet free Mg concentration was lower in drinkers compared with non-
drinkers.  A correlation between increase of serum Mg concentration and decrease in BP during 
alcohol restriction period suggested that a possible hypotensive effect of Mg repletion and a 
decrease in intra-erythrocyte Na (Hsieh et al. 1995). 
A few studies have suggested that moderate alcohol consumption may be associated with reduced 
insulin levels; increased insulin sensitivity improves insulin resistance and provides a better 
postprandial glucose metabolism (Kiechl et al. 1996; Lazarus et al. 1997; Flanagan et al. 2000).  
Insulin resistance involves inadequate glucose uptake in peripheral tissues and impairment of the 
nonoxidative (glycolytic) pathways of glucose metabolism (Ferrannini et al. 1987).  Several 
mechanisms connect insulin resistance with hypertension.  An anti-natriuretic effect of insulin has 
been established by experimental data indicating that insulin stimulates renal sodium re-absorption 
(MILLER and BOGDONOFF 1954; Rocchini 2000).  This anti-natriuretic effect may be increased in 
individuals with insulin resistance and may play an important role for development of hypertension 
(Sechi 1999).  Elevation of oxidative stress and/or nitric oxide (NO) depletion with alcohol ingestion 
may also be an important pathogenic mechanism for the development of hypertension (Romero 
and Reckelhoff 1999).  The renin-angiotensin system (RAS) also plays a crucial role in BP 
regulation, affecting renal function and modulating vascular tone (Ponnuchamy and Khalil 2009).  
Data show that angiotensin II inhibits the action of insulin via angiotensin type 1 receptor in 
vascular muscle tissue, by interfering with insulin signalling through phosphatidylinositol 3-kinase 
(PI3K) and its downstream protein kinase B (Akt) signalling pathway (Sowers 2004).  This 
inhibitory action of angiotensin II is mediated through stimulation of RAS homolog gene family, 
member A (RhoA) activity and oxidative stress; increased RhoA activity and reactive oxygen 
species inhibit PI3K/Akt signalling, resulting in decreased NO production in endothelial cells and 
increased vasoconstriction.  Activated RAS may contribute to the development of hypertension 
(Sowers 2004). 
With respect to epidemiologic data, it has been suggested that alcohol withdrawal is associated 
with increases in BP; several studies did not support this hypothesis (Potter and Beevers 1984; 
Kawano et al. 1992) .  Kawano and colleagues suggested a short-term biphasic effect of alcohol on 
BP.  Blood pressure increase is not an immediate effect of alcohol consumption.  The slow (days) 
alcohol-BP effect raises questions about the relevance of experiment studies in animal dealing with 
acute (minutes or hours) effects.  Other issues in experiment studies include alcohol‟s diverse 
effects on various target organs and differences in health and disease, and aspects related to rate, 
dose, route of alcohol administration, time interval of BP measurement and probably psychic 
factors. 
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In summary, acute and chronic studies in humans and animals have yielded inconsistent findings 
with respect to BP and so far failed to convincingly demonstrate a mechanism in terms of effects on 
peripheral vascular muscle tone, erythrocyte cell membrane changes, magnesium depletion, 
calcium transport and insulin sensitivity.   
5.4 Strengths and limitations 
The INTERMAP Study is a unique investigation of diet and BP, with data on nutrients and foods 
from four in-depth multi-pass dietary recalls, urinary amino acid excretion and 1H NMR spectral 
data from two 24-hr urine collections on 4,680 individuals from 17 diverse population samples from 
Japan, PRC, UK and USA.  Data on average alcohol intake, alcohol drinking pattern and type of 
alcoholic beverage consumed, past alcohol drinking history and reason for changing their alcohol 
drinking habit were obtained for all participants.  Interpretation of the alcohol-BP association is 
influenced by various putative confounders.  In INTERMAP, country, sex, age, SES (years of 
education and employment rate) and health behaviour indicators (dietary supplement use, on any 
special diet, electrolyte intake, smoking, physical activity, BMI and medication) have been 
controlled in most analyses to take account of their possible effect on BP; however residual 
confounding from imperfectly measured variables and unknown/unmeasured confounders may 
persist.   
The response rate of a number of populations were low, although every effort was made to 
increase the participation rate at the start of the study, attrition bias may affect the results as those 
who took part in the study.   Participants of the INTERMAP Study may have different lifestyle and 
SES than those chose not to participate.  People who take part in medical researches may act out 
of self-interest when there is a potential benefit to them; act out of altruism when they expect no 
benefit to themselves but expect benefit to others; act out of fear of the consequences of refusing 
to participant or only agreeing to take part when offered material reward. 
The epidemiological approach in the INTERMAP Study has limitations.  Firstly, it is a cross-
sectional study to investigate the role of multiple dietary factors in the aetiology of unfavourable BP 
in middle-aged individuals (Stamler et al. 2003b).  The cross-sectional epidemiologic approach 
does not allow for determination of the temporality of associations, so it is important that where 
possible, the findings of cross-sectional studies such as INTERMAP are confirmed by prospective 
studies and RCTs.  The rise in BP with age observed in many populations begins during young 
adulthood (Jarvelin et al. 2004) and if lifelong dietary exposures are important, the INTERMAP 
Study could underestimate true effects.   
Secondly, the lack of a gold standard for dietary assessments; the dependence on reporting by 
participants (subject to systematic and non-systematic error); the variation among food tables for 
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different countries; and the variability in day-to-day dietary intake all can effect data on 
associations between nutrient intake and BP (Liu 1988; Grandits et al. 1997).  All dietary recall and 
record methods have their strengths and limitations (Bingham 1987).  The 24-hr recall method 
offers benefits over the food frequency questionnaire, including quantitative data reflecting 
consumption of all foods; open-ended reporting accommodates cultural differences in dietary 
habits and enhances cross-country comparability of nutrient data; and there is no requirement for 
participant literacy.   
The 24-hr dietary recall method was selected to obtain dietary data in the INTERMAP Study after 
careful consideration of strengths and limitations of different approaches to collection of dietary 
information and ways to minimise effects of inter-individual variability.  The use of the average of 
repeated measures (4 x 24-hr dietary recall and 2 x 7-day alcohol records) reduces effects of day-
to-day within-person variability, improves precision and reduces regression dilution bias (Stamler et 
al. 1996a; MacMahon et al. 1990a).  Studies have investigated the number of days required at 
various levels of precision for various nutrients in multiple populations (Bingham et al. 1981; 
Nelson et al. 1989; Miller et al. 1991).  In general, these studies suggest that the minimum number 
of days of intake required for energy intake and macronutrients ranges from 3 to 10 days; for food 
components with large day-to-day variability, such as vitamins, the number of days required 
ranged from 20 to more than 50 days.   
For alcohol consumption, two 7-day records were used to minimise systematic differences in 
alcohol intake on different days of the week [Chapter 3.1.3 (g)].  Even after taking extensive steps, 
alcohol consumption may be underreported in comparison with the general population as heavier 
drinkers are far less likely to participate in surveys and health studies than others; the population 
samples in INTERMAP were mostly occupational and therefore heavy drinkers are likely to be 
under-represented. A related issue is differential under-reporting by heavy drinkers leading to 
misclassification bias and over-estimation of BP in moderate drinkers. Furthermore, the quantity, 
type and pattern of alcohol drinking are highly correlated with socioeconomic and other lifestyle 
behaviours, many of which may be extensively measured, thus leading to residual confounding 
(Naimi et al. 2005). 
Dietary reporting errors in the INTERMAP Study were minimised by extensive quality control 
procedures including observer training, multi-pass methods, open non-leading questioning and 
extensive quality control throughout the fieldwork (Dennis et al. 2003) [Chapter 3.1.3 (a) and (d)].  
Manual coding of 24-hr dietary recall data (Japan, PRC and UK) was subject to error: in the UK, for 
example, approximately 25% of recalls failed initial QC check. However, multiple checks by site 
nutritionists and country nutritionists effectively detected and corrected errors, and observer error 
rates declined with experience and feedback (Conway et al. 2004). 
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Given dietary differences across the four countries of the study, the team of nutritionists at NCC 
enhanced the comparability of the four country-specific nutrient databases [Chapter 3.1.3 (e)] 
(Schakel et al. 2003).  Urinary biomarkers were also used to verify dietary intakes; i.e. 24-hr urinary 
Na excretion as a biomarker of Na intake, 24-hr urinary K excretion as a biomarker of K intake and 
24-h urinary urea excretion as a biomarker of protein intake (Dennis et al. 2003).  These data 
showed correlations of 0.42 to 0.55, comparable to or better than those from other well-conducted 
dietary surveys (Bingham et al. 1997).  Despite the use of repeated measures and multiple 
standardised measurements, the effects of alcohol intake (and other nutrients) on BP may still be 
underestimated due to limited reliability in nutrient measurement (regression-dilution bias). 
However, reliability estimates for alcohol were uniformly high, 89.4% in men and 87.4% in women; 
this percentage is the estimated size of the observed regression coefficient as a percentage of the 
theoretical „true‟ coefficient (i.e., free from regression dilution bias) in univariate regression 
analysis.  
5.5 Future work 
In order to test critically whether light/moderate wine drinking is more beneficial on BP than other 
alcoholic beverages or intake patterns, randomised and blinded intervention trials are needed, with 
participants of varying ages, with solid study end points and with varied durations, no easy set of 
under-takings.  Alcohol is a hazardous substance with severe adverse effects, and as such there 
are ethical considerations to the design of RCTs.  Furthermore, blinding of participants is difficult, 
and trial duration needs preferably to be very3 long as it takes many years for hypertension to 
develop.  Because of ethical and practical considerations, it is unlikely that such studies will be 
performed.   
An in-depth alcohol metabolic study of 28 men and women was set up in 2009 by the current 
author and colleagues at the London Metabonomics Laboratory and urine samples had been 
collected to investigate in detail alcohol metabolism and identify urinary alcohol metabolites using a 
range of analytical techniques including 1H NMR spectroscopy, GC-MS and UPLC.  The aim of this 
pilot study is to provide a benchmark against which to interpret the alcohol metabolites observed in 
the urine samples obtained from the INTERMAP study. Both GC-MS and UPLC-MS methods will 
also be used to validate the results from NMR spectroscopy.  This study would explore the 
potential limitations of NMR analysis in detecting 24-hour urinary alcohol metabolites; validate 1H 
NMR spectra data obtained from the INTERMAP Study and identified pathways for enhanced 
understanding of alcohol-BP mechanisms. 
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5.6 Conclusions 
This report demonstrats that among INTERMAP participants, BP differences per unit of alcohol 
consumed (1 standard drink, 13 g of alcohol) were 1.1 mm Hg for SBP and 0.5 mm Hg for DBP 
among male current drinkers and 1.9 mm Hg for SBP and 0.5 mm Hg of DBP among female 
drinkers, with adjustment for possible confounders.  For the relation of pattern of daily drinking 
(number of days that alcohol was consumed) to BP, with adjustment for multiple confounders 
including type of alcoholic beverage and amount of alcohol, no consistent relation of pattern to BP 
of current drinkers was observed.  Likewise, with control for potential confounders and total amount 
of alcohol consumed, there were no consistent associations between type of alcoholic beverage 
(beer, wine, or spirits) and BP in men or women.  The conclusion from this comprehensive set of 
analyses is that the harmful effect of alcohol intake on blood pressure is related particularly to the 
quantity of alcohol consumed, i.e. average intake per day, not drinking pattern or type of beverage.   
The importance of the relation between alcohol consumption and BP has been recognised in 
international guidelines on the prevention and management of HTN (Chobanian et al. 2003) The 
result showed that reducing alcohol by 1 unit (13 g) reduced SBP by 1-2 mm Hg; a small reduction 
of several mm Hg in population BP could lead to reduced burden of CVD morbidity and mortality; 
this may be achieved by public health recommendation for healthier diet and light/moderate alcohol 
intake corresponding to no more than 2 drinks a day for men or 1 drink a day for women across, 
across all populations (Elliott and Stamler 2005).  Any benefits of moderate alcohol consumption 
on coronary heart disease (Chapter 2.4) are likely to be out-weighed by harmful effects such as 
cancer, diabetes, assault and accidents (Jackson et al. 2005).  Therefore, reduction of excess 
alcohol consumption should continue to form an important part of public health advice for lowering 
BP and achieving optimal cardiovascular health. 
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Appendix A Amino acids standard (Cat. No A6407) information from Sigma-Aldrich  
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Appendix B Amino acids standard (Cat. No A6282) information from Sigma-Aldrich  
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Appendix C Orthogonal projections to latent structures discriminate analysis (OPLS-
DA) of urinary metabolic profiles using full resolution 1H-NMR data 
C1 Loading plot from the OPLS-DA analysis between drinkers and non-drinkers, Japanese 
men 
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C2 Loading plot from the OPLS-DA analysis between drinkers and non-drinkers, Japanese 
women 
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C3 Loading plot from the OPLS-DA analysis between drinkers and non-drinkers, Chinese men 
 
  
213 
 
C4 Loading plot from the OPLS-DA analysis between drinkers and non-drinkers, Chinese 
women 
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C5 Loading plot from the OPLS-DA analysis between drinkers and non-drinkers, UK men 
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C6 Loading plot from the OPLS-DA analysis between drinkers and non-drinkers, UK women 
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C7 Loading plot from the OPLS-DA analysis between drinkers and non-drinkers, US men 
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C8 Loading plot from the OPLS-DA analysis between drinkers and non-drinkers, US women 
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C9 Loading plot from the OPLS-DA analysis between ex-drinkers and teetotallers, men 
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C10 Loading plot from the OPLS-DA analysis between ex-drinkers and teetotallers, women 
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C11 Loading plot from the OPLS-DA analysis between moderate drinkers and teetotallers, men 
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C12 Loading plot from the OPLS-DA analysis between moderate drinkers and teetotallers, 
women 
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C13 Loading plot from the OPLS-DA analysis between heavy drinkers and teetotallers, men 
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C14 Loading plot from the OPLS-DA analysis between heavy drinkers and teetotallers, women 
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C15 Loading plot from the OPLS-DA analysis between moderate drinkers and heavy drinkers, 
men 
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C16 Loading plot from the OPLS-DA analysis between moderate drinkers and heavy drinkers, 
women
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C17 Loading plot from the OPLS-DA analysis between drinkers who drank on 1-6 days and 
drinkers who drank on 13-14 days, men 
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C18 Loading plot from the OPLS-DA analysis between drinkers who drank on 1-6 days and 
drinkers who drank on 13-14 days, women 
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C19 Loading plot from the OPLS-DA analysis between beer drinkers and wine drinkers, men 
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C20 Loading plot from the OPLS-DA analysis between beer drinkers and wine drinkers, women 
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C21 Loading plot from the OPLS-DA analysis between beer drinkers and spirits drinkers, men 
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C22 Loading plot from the OPLS-DA analysis between beer drinkers and spirits drinkers, 
women 
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C23 Loading plot from the OPLS-DA analysis between wine drinkers and spirits drinkers, men 
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C24 Loading plot from the OPLS-DA analysis between wine drinkers and spirits drinkers, 
women
 
